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Caffeine (10 mM) stimulated the outputs of prostaglandin (PG) F2a, PGE2 and PGI2 (measured as 6-keto-PGF,a) from
the day 7 and day 15 guinea-pig uterus superfused in vitro. Caffeine-induced PG production was unaffected by the
removal of extracellular calcium, ryanodine (RY) and ruthenium red (inhibitors of calcium release from ryanodine
receptor (RYR) channel), and calmodulin inhibitors (W-7 and trifluoperazine (TFP)). In fact. W-7 greatly potentiated
the caffeine effect on PGF2a output. TMB-8, an intracellular calcium antagonist, inhibited the increase in PGF2a output
produced by caffeine without preventing the increases in outputs of PGE: and 6-keto-PGFia. Caffeine (1 mM but not
0.1 mM) and theophylline (Theo; 10 mM) also stimulated PG outputs from the day 7 guinea-pig uterus superfused in
vitro. Caffeine and RY both stimulated prostaglandin production from the perfused mesenteric vascular bed of the rat.
Caffeine (10 mM) stimulated the output of PGF2a after 8 h, and the output of 6-keto-PGFla after 2, 8 and 24 h from
the day 7 guinea-pig endometrium in culture. Caffeine (10 mM) inhibited PGF2a output after 2 h, but stimulated PGF2ct
output after 24 h from the day 15 guinea-pig endometrium in culture.
The amounts of PG released from cultured epithelial cells were between 100- to 200-fold and 300- to 1000-fold
higher than those from cultured stromal cells from the day 7 and day 15 endometrium, respectively. Outputs of all three
PGs from epithelial cells, but not from stromal cells, were 4.4- to 5.5-fold higher from cells obtained on day 15 than on
day 7. PGF2a was the major PG released from the epithelial cells obtained from day 15 guinea-pig uterus. Caffeine had
both a stimulatory and an inhibitory effect on PG output from endometrial cells cultured from the day 7 and day 15
guinea-pig uterus. It inhibited the output of PGF2a from the epithelial cells after 8 and 24 h of culture, and stimulated
PGE2 and 6-keto-PGF,a outputs from the stromal cells after 2 h of cell culture. Ryanodine had no effect on the actions
of caffeine, whereas dantrolene (a modulator of calcium release from RYR-channel) inhibited the caffeine-induced
decrease in PGF;ot output from the epithelial cells and potentiated the stimulatory effects of caffeine on PGE2 and 6-
keto-PGF,a outputs from cultured stromal cells. When changes in intracellular calcium levels of the epithelial and
stromal cells were measured, caffeine did not increase the intracellular calcium concentrations ([Ca"+ ]j). In fact it
caused a reduction in the [Ca2*]; of both the epithelial and stromal cells. All of these findings indicate that caffeine
stimulates PG output from the guinea-pig uterus in a time-dependent manner, and this stimulatory effect of caffeine is
not dependent on the presence of extracellular calcium and is not mediated via calmodulin. It also appears that the
stimulatory effect of caffeine on PG release does not involve mobilisation of calcium from an internal calcium store.
Calcium ionophore (A23187) stimulated PGF2a output from the cultured epithelial and stromal cells after 2 h and
inhibited PGF2a output after 8 and 24 h culture. It also inhibited 6-keto-PGFla output from the stromal cells after 8 and
24 h culture. Phospholipase A2 (PLA2) stimulated the outputs of PGF2a and 6-keto-PGF,a from eiptheliai and stromal
cells after 24 h of cell culture. PLA2 also stimulated the output of PGE2 from epithelial and stromal cells after 2 h and 8
h of cell culture. Melittin (a PLA2 stimulator) stimulated the outputs of PGE2 and 6-keto-PGF|a after 2 h and PGF2a
output after 2 and 24 h of epithelial cells culture. Aristolochic acid (a PLA2 inhibitor) inhibited PGF2a output from the
epithelial cells after 8 and 24 h of culture. It also inhibited 6-keto-PGFlci output from the stromal cells after 8 h culture.
Interestingly aristolochic acid significantly stimulated PGE2 output from the stromal cells after 8 h culture. Oestradiol-
17P (3.7 pM) and progesterone (3.7 pM) both caused an inhibition of PGF2a output from the epithelial cells after 8 and
24 h culture and to a much lesser extent PGE2 output from the stromal cells after 8 h culture. These findings indicate
that prostaglandin production by the guinea-pig uterus is controlled by different mechanisms.
A novel cyclooxygenase II (COX-2) inhibitor, NS-398, inhibited PG production by day 7 and day 15 guinea-pig
endometrium homogenates, by day 7 endometrium and myometrium in culture, and by cultured epithelial and stromal
cells obtained from day 7 guinea-pig endometrium. Western blotting analyses showed that the prostaglandin H
synthase-2 (Mr 72 KDa) was present in the soluble extracts of guinea-pig endometrium obtained on both days 6 and 17
of the oestrous cycle.
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1.1.1 History and Discovery
Prostaglandins attracted the attention of scientists long before their structures were
identified. In 1930, American gynaecologists, Kurzrok and Lieb, reported that
fresh human semen caused contraction and relaxation of strips of human uterus in
vitro. Almost five years later von Euler (1935) reported a smooth muscle
contractile action of extracts obtained from the prostatic and related glands of
human, monkey, sheep and goat, and of extracts from sheep seminal vesicles. This
action was also reported independently by another scientist (Goldblatt, 1935). All
these extracts were reported to be acidic and lipid soluble (von Euler, 1936). Since
von Euler (1935) first identified this substance from the prostate gland, he termed
it "prostaglandin" (von Euler, 1939). He described prostaglandin as a lipid-
soluble, unsaturated, hydroxy fatty acid.
A decade later, a Swedish scientist (Bergstrom, 1949) confirmed the chemical
nature of prostaglandin proposed by von Euler. Bergstrom (1949) also reported that
seminal fluid extract contained more than one prostaglandin. Almost another
decade passed before prostaglandin was actually isolated. Bergstrom and Sjovall
(1957) finally succeeded in isolating two prostaglandins from sheep vesicular
l
glands, which these prostaglandins are known today as prostaglandin (PG) Ei and
Fia. These structures were confirmed by the use of mass spectrometry by Bergstrom
et al. in 1963. PGEi and PGFi„ were also identified in extracts from sheep prostate
gland (Bergstrom & Sjovall, 1960a, b). Eliasson (1959) showed that the seminal
fluid prostaglandins originate from the seminal vesicles and not from the prostate
gland. Since these initial studies, many prostaglandins have been isolated and
identified, including the related compounds, namely the thromboxanes (TXs;
Hamberg et al., 1975).
1.1.2 Structure and Chemistry of Prostaglandins
Prostaglandins were found to be a family of structurally related compounds but
with a wide range of biological activities ranging, even within one tissue, from
contraction to relaxation. From the family of prostaglandins, the structures of
PGEi and PGFia were the first to be identified (Bergstrom et al., 1963).
Prostaglandins are 20 carbon-containing, unsaturated fatty acids consisting of a
cyclopentane ring and two side chains of 7 and 8 carbons (prostanoid skeleton),
respectively (Figure 1.1.2.1). Prostaglandins are classified into nine categories
with respect to groups attached to the cyclopentane ring and to the side chain,
namely PGA, PGB, PGC, PGD, PGE, PGF, PGG, PGH, and PGI. Thromboxane,
a prostaglandin related compound, possesses a different ring structure in that an
additional oxygen atom is enclosed in the ring.
The nine categories of prostaglandin and thromboxane mentioned above are further
classified into three sub-groups according to the number of double bonds present in
2
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Figure 1.1.2.1 Structure of prostanoic acid and structural differences
between prostaglandin A to H. The structure for prostaglandin (PGI2) is
shown in Figure 1.1.2.2.
the prostanoid skeleton, and the series classification of any given prostaglandin is
denoted by the subscript numbers 1, 2 or 3 placed after the prostaglandin category
letter. Prostaglandins of " 2-series", or the dienoic prostaglandins, are the most
important biologically, since they are usually the most abundant series formed.
They have double bonds between carbons 5 and 6 and between carbons 13 and 14
(Figure 1.1.2.2).
1.1.3 Prostaglandin Biosynthesis and Metabolism
Prostaglandins differ from all the known locally produced mediators in many ways.
Firstly, almost all cell types, except erythrocytes, have the capability of
synthesising prostaglandins (Christ & Van Dorp, 1972). Secondly, with the
exception of the reserve found in seminal fluid, prostaglandins are not normally
stored but their release is de novo, that is they are synthesised immediately prior to
their release from the cell (Piper & Vane, 1971). Thirdly, prostaglandins have a
very short half-life since they are rapidly metabolised by most tissues, particularly
the lungs, liver and kidney.
All prostaglandins are synthesised from three essential unsaturated fatty acids
which, respectively, give rise to the three series of prostaglandins named earlier
(see structure and chemistry of prostaglandins). The precursor for the 2-series
prostaglandins is 5,8,11,14-all-cis-eicosatetraenoic acid (better known as
arachidonic acid (AA)) which can be obtained from the diet or synthesised from the
essential fatty acid, linoleate, by chain elongation and desaturation. Arachidonic
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Figure 1.1.2.2. Major pathways of biosynthesis of prostaglandins (PG) and
thromboxanes of the '2' series. PGHS-CO: cyclooxygenase component of
prostaglandin H synthase enzyme complex. PGHS-PO: peroxidase componenet of
prostaglandin H synthase enzyme complex. 12-L-hydroxy-5,8,10-heptadecatrienoic
(HHT) and malondialdehyde (MDA) may also be formed from PGH2.
conjugates. Arachidonic acid is then converted to PGH2 by the action of
prostaglandin H synthase (PGHS). This enzyme (i.e. PGHS) is a holoenzyme
which contains two different forms of enzymatic activity, namely a cyclooxygenase
(COX) component and a hydroperoxidase component (Miyamoto et al., 1974). The
cyclooxygenase component, which requires both tryptophan and haemoglobin,
catalyses the bis-dioxygenation of arachidonate to the cyclic endoperoxide and 15-
hydroperoxide derivative, namely PGG2. PGG2 is then rapidly converted to PGH2
by the hydroperoxidase component (Miyamoto et al., 1974). By 1976, the isolation
and purification of prostaglandin endoperoxide synthetase complex was achieved.
The prostaglandin synthetase system of bovine vesicular gland microsomes was
solubilized and separated into Fractions I and II. Incubation of Fraction I with
8,11,14-eicosatrienoic acid, in the presence of hematin, resulted in the formation
of PGG!. The enzyme in Fraction I further catalysed PGG! to PGHj when heme
and tryptophan were supplied. Fraction II catalysed PGH! to PGE! in the presence
of glutathione (Miyamoto et al., 1976). PGH2 is the key intermediate in the
biosynthesis of the prostaglandins and thromboxanes, and the final form of
prostaglandin produced is dependent upon the cell type (Samuelsson et al., 1978).
More recently, it has been shown that there is more than one type of PGHS,
namely PGHS-1 (a constitutive enzyme) and PGHS-2 (an inducible enzyme)
(Hedin et al., 1987; Wong & Richards, 1991). PGHS-1 from ram seminal vesicles
is encoded by a 2.8-kb mRNA and PGHS-2 by a 4-kb mRNA (Lee et al., 1992).
Selective expression of mitogen-inducible prostaglandin H synthase-2 (PGHS-2) in
macrophages stimulated by lipopolysaccharide (LPS) has shown by Lee et al.
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(1992). They reported that the LPS-selective induction of PGHS-2 was completely
inhibited by dexamethasone, whereas PGHS-1 was unaffected. Prostaglandin
formation can be prevented by the glucocorticoids and by the non-steroidal anti¬
inflammatory drugs (NSAIDs) such as aspirin. Steroids inhibit the release of AA
by stimulating the formation and release of lipocortin which reduces PLA2 activity
(Raz et al., 1989), whereas NSAIDs inhibit the cyclooxygenase component of
PGHS (Miyamoto et al., 1976). PLA2 activity in the plasma membrane and
microsomes (i.e. membrane bound) is calcium-dependent (Newkirk & Wait, 1973)
and is inhibited by ethylene diamine tetra-acetic acid (EDTA; McMurray &
Magee, 1972).
Whilst most tissues are capable of metabolising PGs, the major site for inactivation
of PGs in the blood is the lungs. Almost all of the PGF2a and PGE^ in the
circulation are metabolised following just one passage of the blood through the
lungs (Ferriera & Vane, 1967). In the case of prostacyclin (PGI2) and thromboxane
A2 (TXA2), the highly labile nature of these eicosanoids in water results in a rapid
spontaneous formation of 6-keto-PGFia and TXB2, respectively (Hamberg et al.,
1975; Johnson et al., 1976).
From the initial research carried out by von Euler in 1935, the physiological
importance of PGs in many tissues has attracted the attention of many scientists.
One place where PGs play an important role is the female reproductive system (see
Lange, 1984; see Poyser, 1981). In many non-primate mammalian species, the
life-span of the corpus luteum, and consequently the length of oestrous cycle, is
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dictated by the uterus. As a consequence the uterus has been studied extensively in
this respect.
1.1.4 Uterine Prostaglandins
Loeb (1923) was the first to demonstrate the importance of the uterus on the life¬
span of the corpus luteum and hence on oestrous cycle length. He reported that the
excision of this organ from the guinea-pig prevented the regression of the corpus
luteum, and markedly increased the length of the oestrous cycle. A few years later,
Loeb (1927) observed that the removal of the unregressed corpus luteum but not of
the uterus resulted in a new ovulation. This observation led Loeb (1927) to
hypothesis that the guinea-pig uterus secretes a luteolytic factor which effects the
corpus luteum.
The prolongation of corpus luteum life-span after hysterectomy was demonstrated
in other species, including the pseudopregnant rabbit (Asdell & Hammond, 1933),
pseudopregnant rat (Bradbury, 1937), sheep, cow (Wiltbank & Casida, 1956) and
pig (Spies et al., 1958). Moreover, destruction of the endometrial layer of the
guinea-pig uterus was shown to result in luteal maintenance and a prolonged
oestrous cycle (Butcher et al., 1962). However, the corpus luteum life-span after
hysterectomy was not affected in the dog (Cheval, 1934) and human (Jones &
Telinde, 1961; Beling et al., 1970; Doyle et al., 1971), indicating that in these
species the uterus is not involved in the maintenance of the corpus luteum so does
not dictate the length of the oestrous or menstrual cycle.
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The involvement in luteolysis of a vasoconstrictor substance secreted from the
uterus such as PGF2« (Ducharme et al., 1968) was suggested by Pharriss and
Wyndgarden (1969). They demonstrated that infusion of PGF2a into
pseudopregnant rats causes luteolysis. At the same time, other researchers
independently reported that PGF2a also shortened the life-span of the corpus luteum
in many other animals, including the guinea-pig (Blatchley & Donovan, 1969),
rabbit (Gutknecht et al., 1969), ewe (McCracken et al., 1970), monkey (Kirton, et
al., 1972), mare (Douglas & Ginther, 1972) and goat (Ott, et al., 1980), but not in
the ferret (Blatchley & Donovan, 1973). Studies regarding the effect of PGF2« on
luteolysis in the human have proved to be somewhat equivocal. Lehmann et al.
(1972) reported that the intravenous infusion of PGF2a on day 21 of the menstrual
cycle led to a sharp decline in the plasma progesterone concentration, but other
studies reported that the infusion of PGF2a did not affect the length of the luteal
phase, or the pattern of steroid secretion in cycling women or in pregnant women
prior to abortion (Le Maire & Shapiro, 1972; Speroff et al., 1972).
In those animals in which PGF2a administration mimics the effect of the uterine
luteolytic hormone on the ovaries, it was shown that PGF2a, at a time when the
corpora lutea had become fully established and functional, not only caused
structural regression of the corpus luteum (morphological luteolysis), but also
resulted in a drop in ovarian progesterone output (functional luteolysis). Both of
these effects (i.e. morphological and functional luteolysis) were considered as the
preconditions for any substance to be a candidate for the "luteolytic hormone". In
addition, it was shown that the PGF2a concentration increases in uterine venous
7
blood prior to the time of normal luteal regression in sheep (Bland et al., 1971),
pig (Gleeson & Thorburn, 1973), cow (Nancarrow et al., 1973), and guinea-pig
(Blatchley et al., 1972), and that this measured concentration was capable of
reducing plasma progesterone levels (McCracken et al., 1970). In the guinea-pig,
the increase in uterine venous plasma PGF2(X concentration takes place from about
day 11 of the oestrous cycle, and by day 15 of the cycle the plasma PGF2a
concentration has increased significantly and the plasma concentration of
progesterone has decreased (Blatchley et al., 1972). Elevated levels of PGF2a were
maintained throughout the period of luteal regression. The accelerated decrease in
peripheral plasma progesterone levels on day 17 in pseudopregnant rabbits was
found to be associated with an increase in PGF2a levels in uterine venous plasma
(Lytton & Poyser, 1982).
In many species, the uterine horn effects the corpora lutea in the ipsilateral ovary
but not the corpora lutea in the contralateral ovary. It is reported that in hemi-
hysterectomised sheep (Inskeep & Butcher, 1966), guinea-pig (Bland & Donovan,
1966) and rat (Barley et al., 1966), the luteolytic factor affects the corpora lutea
only in the ovary adjacent to the retained uterine horn and that normal luteal
regression occurs in the ovary contralateral to the hemi-hysterectomy.
McCracken (1971) reported a local action for PGF2a. He reported that a dose of
PGF2a, which was luteolytic when administered directly into the ovary, had no
effect on progesterone secretion when administered systemically. Different effects
of PGF2(X infusion were also demonstrated by Liehr et al. (1972). They showed that
the infusion of PGF2a into the uterine horn ipsilateral to the ovary bearing the
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corpus luteum has a different effect when compared to the infusion of PGF2a into
the uterine horn contralateral to the ovary bearing the corpus luteum. PGF2a
administered to cyclic heifers on day 9 resulted in an average cycle length of 11.4
days when infused into the uterine horn ipsilateral to the ovary bearing the corpus
luteum, but 15.2 days when infused into the uterine horn contralateral to the ovary
bearing the corpus luteum (Liehr et al., 1972). Immunisation against PGF2a
prevented luteal regression in sheep (Scaramuzzi et al., 1973) and lengthened
oestrous cycle in guinea-pigs (Horton & Poyser, 1974). Poyser and Horton (1975)
also showed that the intrauterine administration of a NSAID (indomethacin) to
guinea-pigs resulted in increased progesterone concentrations being maintained for
much longer than normal, suggesting that luteal regression had been prevented. All
of the above findings identified PGF2a as the " uterine luteolytic hormone".
1.1.5 Transfer of Prostaglandin From The Uterus to The Ovary
It is logical to assume that, for uterine PGF2a to exert a local luteolytic effect on
the corpus luteum, there must be a local mechanism by which PGF2a is transferred
to the ovary. Bland and Donovan (1969) reported that, in the guinea-pig, ligation
of the vascular tissues to the uterus and ovaries, but not the ligation of the oviduct,
prevents regression of the corpus luteum. A similar effect was found in the rat
(Clemens et al., 1968), hamster (Orsini, 1968) and sheep (Kiracofe et al., 1966).
These results suggested that the vascular system is the means by which PGF2a
travels from the uterus to the ovaries. A study in sheep showed that the structural
arrangement of the vascular system, in particular the position of the ovarian artery
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which runs over the surface of the utero-ovarian vein, is of prime importance in the
transport of PGF2a, since separation of these vessels resulted in luteal maintenance
(Barrett et al., 1971). Infusion of PGF2a labelled with radioactivity into the uterine
vein of sheep at a point before its merger with the utero-ovarian resulted in the
appearance of radioactive PGF2a in the blood passing through the ovarian artery,
but not in the blood passing through the iliac artery (McCracken et al., 1972). As a
result, a counter-current transfer mechanism between the utero-ovarian vein and
ovarian artery was postulated for PGF2a transport from the uterus to the ovary.
However, only 5% of the labelled PGF2a infused into the uterine vein was
transported directly into the ovarian artery. Horton & Poyser (1976) suggested
that, if the efficiency of the counter-current mechanism of transfer of PGF2a from
the uterine vein to the ovarian artery was too high, the levels of PGF2a in the
system would increase and remain high, since most of the tissues involved are
incapable of metabolising prostaglandins. Consequently, if this transfer process
were 100% efficient and no prostaglandin metabolism took place, then there would
be a continuous passage of increasing amounts of PGF2a through the ovary. Thus,
under normal conditions of low PGF2a transfer efficiency, the PGF2a that is not
retained by the counter-current mechanism will pass into the systemic circulation
and be inactivated in the lungs (Ferreria & Vane, 1967).
Studies in the rabbit (Hunter & Casida, 1967), mare (Del Campo & Ginther, 1973)
and guinea-pig (Egund & Carter, 1974) failed to show a counter-current
mechanism of transferring PGF2<X between the uterus and ovary as proposed for the
sheep. Abdel Rahim et al. (1984) proposed that, in sheep, as well as the transfer of
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PGF2a between the uterine vein and the ovarian artery, the transfer of PGF2a
between uterine lymph vessels and the ovarian artery is necessary for complete
luteolysis. They showed that luteal function in the ewes was extended when the
uterine vein was cannulated and all other direct connections between the uterine
horn and the ipsilateral ovary (namely, oviduct and accompanying vessels, broad
ligament, nerves, lymphatics and arteries) were surgically separated (Abdel Rahim
et al., 1984). The counter-current transfer of PGF2tt between the utero-ovarian vein
and artery was not impaired. This experiment indicated that uterine venous blood
alone cannot account for the luteolytic factor passing from the uterus to the
ipsilateral ovary. The presence of PGF2a in the lymph draining from the sheep
uterus at concentrations comparable to those on the uterine venous blood has also
been shown (Abdel Rahim et al., 1983). There is a significant increase in PGF2a
concentrations in uterine lymph towards the end of the oestrous cycle at the time
when luteal regression is taking place (Abdel Rahim et al., 1983). Labelled PGF2a
infused into the uterine lymph vessel is recovered in the adjacent ovarian artery
(Heap et al., 1985). The efficiency of this transfer system was reported to be
similar to the efficiency of transfer of PGF2a from the uterine vein into the ovarian
artery in sheep. These results clearly demonstrated that, in sheep, the transport of
uterine PGF2« to the ovary takes place via both the uterine lymphatic system and
the uterine vascular system.
The precise means of transferring uterine PGF2a to the ovary in the guinea-pig,
rabbit, hamster, rat and mare still is not fully understood. In these species,
extremely limited contact is found between the uterine vein and the ovarian artery
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(Del Campo & Ginther, 1972, 1973). In the pig, the ovarian artery is located
between two of the three channels of the utero-ovarian vein (Ginther, 1974),
indicating that the vascular anatomy of the pig is compatible with a local veno¬
arterial pathway. However, studies by Harrison and Heap (1972) suggested that
PGF201 acts systemically in pig. They demonstrated that autotransplantation of the
left ovary to the right side of the abdominal cavity and removal of the right ovary
had no effect on the length of the oestrous cycle in the pig. Furthermore, infusion
of PGF2a into one anterior uterine vein on day 14 of the pig oestrous cycle caused
a decrease in progesterone concentrations in both the ipsilateral and contralateral
utero-ovarian veins. Nevertheless, the infusion of PGF2a into the jugular vein of
the pig did not cause luteolysis (Kotwica, 1980). This suggested that the lymphatic
system is possibly involved in the transfer of PGF2tt within the sow's reproductive
system, since there is a rich lymphatic system in the sow uterus (Kotwica, 1980).
1.1.6 Mode of Release of Prostaglandin F?„ From The Uterus
Interestingly, the release of PGF2a from the uterus of several species is pulsatile in
nature (see Poyser, 1981). This effect was best demonstrated by Kindhal et al.
(1981) on PGF201 release from the uterus in heifers. They measured the plasma
concentration of the main metabolite of the PGF2a (13,14-dihydro-15-keto-PGF2a;
PGFM) at hourly intervals in heifers over a period of two to three days. They
observed a pulsatile appearance of PGFM with a duration of 1-5 h, together with a
corresponding decrease in plasma progesterone concentrations. The reason for this
pulsatile nature of uterine PGF201 release is not fully established yet. However,
12
Poyser (1991) has proposed that there is a pool of arachidonic acid (AA) in the
endometrial cells of the uterus which may readily be released by the enzymatic
action of PLA2 resulting in depletion of this AA pool. This AA released is then
rapidly converted to PGF2a. Poyser (1991) demonstrated that arachidonic acid
(AA) and PLA2 increased the output of PGF2a from the guinea-pig uterus
superfused in vitro. Similar increase in PGF2a output was observed when AA
treatment was repeated after an interval of 1, 3 or 5 h, but repeating the PLA2
treatment 1 h later failed to stimulate PGF2a output. Furthermore, the uterine
responsiveness to PLA2 was partially restored after 3 h and was fully restored after
5 h. These finding led Poyser (1991) to propose that there is no failure with time
in the mechanism which converts AA into PGF2a in the guinea-pig uterus and that
the refractoriness of uterine PGF2a production following repeated stimulation by
PLA2 occurs at the level of AA release. The time which is required (3-5 h) to refill
this releasable pool of arachidonic acid may be the factor responsible for the
pulsatile release of uterine PGF2a.
1.1.7 Mechanism of Luteal Regression
It is clear that PGF2a is the uterine luteolytic hormone in many non-primate
mammalian species, and that PGF2ct is released from the uterus and then
transported to its site of action (i.e. the ovary). The question then arises how
precisely PGF2a causes the regression of the corpus luteum? Based on the report by
Ducharme et al. (1968) that PGF2a is a vasoconstrictor, Pharriss et al. (1970)
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suggested that PGF2a causes vasoconstriction in blood vessels supplying the corpus
luteum. This brings about luteal anoxia which in turn leads to luteal regression.
However, infusion of PGF2a directly into the ovary of the sheep did not cause a
drop in total ovarian blood flow despite causing a rapid decline in progesterone
output (McCracken et al., 1970; Baird, 1974). Nevertheless, a selective restriction
of the blood flow to the corpus luteum without effecting the total ovarian blood-
flow by PGF2a around the time of luteolysis in the sheep has been reported
(Thorburn & Hales, 1972; Niswender et al., 1975). However, this
"vasoconstriction" hypothesis in not shared among all researchers (O'Shea et al.,
1977), especially as a fall in progesterone output from the corpus luteum prior to
the reduction in luteal blood flow was observed in sheep (Einer-Jensen and
McCracken 1977) and guinea-pig (Hossain et al., 1979). Other mechanisms of
action for PGF2a have therefore been reported with respect to its luteolytic effect.
In many non-primate mammalian species, the corpus luteum is resistant to the
luteolytic effect of PGF2a during the early stage of the oestrous cycle. It is thought
that during this refractory period, the corpus luteum develops 'susceptibility' to the
luteolytic hormone (i.e. PGF2a). In the cow, binding of PGF2a to the receptors on
luteal cell membrane increases as the oestrous cycle progresses (Rao et al., 1979).
Existence of luteal PGF2a receptors have also been reported in the sheep (Powell et
al., 1974a), mare (Kimball & Wyngarden, 1977), and rat (Wright et al., 1979). It
is postulated that an increase in the number and/or affinity of PGF2a receptors may
play a role in luteolysis brought about by the action of uterine PGF2a. Interestingly,
PGF2a receptors on human corpus luteum have also been observed (Powell et al.,
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1974b). However, these human luteal receptors have only very low affinity for
PGF2a, which may be the reason why this prostaglandin is not luteolytic in women
(see Poyser, 1981).
Secretion of progesterone is brought about by the action of luteinizing hormone
(LH) on luteal granulosa cells. The binding of LH to its receptor on luteal
granulosa cells activates adenyl cyclase enzyme which in turn causes an increase in
the amount of cyclic adenosine 3'-5'-monophosphate (cyclic-AMP; cAMP).
Cyclic-AMP acts as a second messenger and stimulates the synthesis and release of
progesterone. Previous experiments on rat and sheep have shown that PGF2a
rapidly blocks the LH-induced increase in cAMP levels of corpora lutea (Lahav et
al., 1976; Fletcher & Niswender, 1982). Luborsky et al. (1984a) reported that the
LH-bound receptors aggregate, and that this receptor aggregation appears necessary
for the activation of adenylate cyclase and cAMP production. PGF2a inhibits LH-
bound receptor aggregation and the stimulation of adenylate cyclase (Luborsky et
al., 1984a). Luborsky et al. (1984b) proposed that PGF2a prevents "up-regulation"
of the LH-induced LH receptors. He also reported that PGF2a may effect luteolysis
by reducing the binding of LH to its receptors, since PGF2a has shown to reduce
the affinity of LH for its receptors in rat (Behrman et al., 1978) and sheep
(Diekman et al., 1978).
Prostaglandin F2a inhibits the activities of several enzymes involved in the synthesis
of progesterone from cholesterol (Dwyer & Church, 1979a, b). It has also been
shown that PGF2a inhibits progesterone production by cultured luteal cells (see
Abayasekara et al., 1993; Pitzel et al., 1993). Dorflinger et al. (1984) reported
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that the treatment of rat luteal cells with the calcium ionophore, A23187, inhibits
LH-sensitive adenylate cyclase and subsequent LH-induced cAMP production. In
rat luteal cells, PGF2a stimulates the phosphatidylinositol (PI) cycle (Raymond et
al., 1983). Since inositol-1,4,5-trisphosphate (IP3) mobilises intracellular calcium
from an internal store (Berridge, 1984), the studies by Raymond et al. (1983)
suggest that in luteal cells PGF2a can release calcium from an intracellular store by
stimulating the formation of IP3. In the rat, it has been shown that PGF2a-induced
luteal regression is associated with increased membrane rigidification which is
dependent on protein, calcium and calmodulin (Riley and Carlson, 1985). Riley
and Carlson (1985) speculated that a calcium-dependent, calmodulin-modulated
mechanism causes phosphorylation of the membrane proteins and subsequent
membrane rigidification which, in turn, prevents the movement and appearance of
LH receptors and hence LH binding to its receptors in the luteal membrane.
1.1.8 Physiological Control of PGF?„ Synthesis by The Uterus
(a) Involvement of Oestrogen and Progesterone in Uterine PGF?„ Synthesis
Since uterine PGF2a output changes during the oestrous cycle, it was thought that
the ovarian steroids may have a regulatory effect on uterine prostaglandin
production. Choudary and Greenwald (1968) demonstrated a luteolytic effect of
oestrogen. A single subcutaneous injection of 10 or 50 pg of oestradiol
cyclopentylpropionate (OECP) but not of progesterone or testosterone, on day 1 of
the oestrous cycle induced premature luteolysis in cyclic guinea-pigs with
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regression of the corpora lutea being complete by day 10 (Choudary & Greenwald,
1968). Thus the life-span of the corpora lutea was reduced by about 5 days, and the
length of the oestrous cycle was decreased. Subcutaneous administration of
oestrogen to guinea-pigs on day 7 of the cycle also causes premature luteolysis.
This effect was abolished by hysterectomy (Bland & Donovan, 1970). In ewes, the
injection of oestradiol on day 10 and day 11 of the oestrous cycle caused early
luteal regression, but failed to affect corpus luteum function in hysterectomised
ewes (Stormshak et al., 1969). Oestrogen treatment reduced the weight of the
corpus luteum in cycling, pregnant and hysterectomised heifers, but progesterone
concentrations were consistently higher in the hysterectomised heifers compared to
the cycling and pregnant animals (Kaltenbach et al., 1964). Therefore, the
luteolytic effect of oestrogen is mediated via the uterus. Oestrogen treatment of
guinea-pigs on days 4 to 6 of the oestrous cycle resulted in increased PGF2a
concentrations in the utero-ovarian venous blood on day 7 (Blatchley et al., 1972),
which accounts for the shortening of the luteal phase and of the oestrous cycle
reported previously (Choudary & Greenwald, 1968; Bland & Donovan, 1968).
These studies suggested that endogenous oestradiol released by the developing
ovarian follicles after day 10 of the oestrous cycle is the physiological stimulus for
the uterine PGF2a synthesis.
It has been shown that progesterone treatment of ovariectomised guinea-pigs
(Blatchley & Poyser, 1974) results in a PGF2a concentration in the utero-ovarian
venous plasma which is similar to the values observed between days 3 and 10 of
the cycle (Blatchley et al., 1972). Oestradiol treatment of ovariectomised guinea-
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pigs alone resulted in a mean utero-ovarian venous plasma concentration of PGF2a
which was higher than that observed for progesterone treatment. However, this
increase occurred only in two of the six animals treated with oestradiol. On the
other hand, ovariectomised guinea-pigs treated with a progesterone for several days
followed by 3 days of oestradiol and progesterone injections were shown to have
the greatest concentration of PGF2a in the utero-ovarian venous blood when
compared to the ovariectomised guinea-pigs treated with progesterone or oestradiol
alone (Blatchley & Poyser, 1974). Therefore, it was proposed that oestradiol acting
on a progesterone-primed uterus was the physiological stimulus for the PGF2a
synthesis by and release from the guinea-pig uterus. Furthermore, it was shown
that the output of oestradiol from the guinea-pig ovary increased after day 10 of the
oestrous cycle (Joshi et al., 1973), immediately preceding the rise in uterine PGF2a
output on day 11 (Blatchley et al., 1972). In sheep, the plasma oestradiol
concentration showed a short-lived rise between day 11 to 12 before the first peak
of PGF2a on day 13 (Cox et al., 1974). The oestradiol concentrations then declined
and the next major rise in oestradiol-170 occurred at pro-oestrus. A similar
relationship between the release of ovarian oestradiol and subsequent increase in
PGF2a output from the uterus has also been shown in the pig (Henricks et al.,
1972), cow (Shemesh et al., 1972) and rat (Welschen et al., 1975).
Antonini et al. (1976) reported that PGF2a output from the guinea-pig uterus in
vivo increased without any changes in the outputs of PGE2. The increased output of
PGF2a preceded a drop in progesterone levels in the non-pregnant animal (Antonini
et al., 1976). Furthermore, the output of PGF2a, but not the outputs of PGEj and
18
6-keto-PGFia, from ovariectomised guinea-pig uteri superfused in vitro
significantly increased in those guinea-pigs which were treated with progesterone
for 7 days followed by 3 days of oestradiol plus progesterone when compared to
ovariectomised guinea-pigs which had received progesterone or oestradiol alone
(Poyser, 1983c). These findings suggest that the ovarian steroid hormones have a
preferential stimulatory effect on PGF2a synthesis by and release from the uterus.
In ovariectomised ewes, plasma PGF2a concentration increased after oestradiol
treatment following a sequence of progesterone injections (Caldwell et al., 1972).
It has also been reported that, in ovariectomised sheep, exogenous progesterone
treatment for seven days significantly increased uterine venous plasma PGF2a
concentrations (Scaramuzzi et al., 1977), whereas 14 day progesterone treatment
caused a decrease in PGF2a output from the sheep uterus compared to the output
after 7 days of treatment. When ewes were infused with progesterone for ten days
starting immediately after oestrus, stimulation of uterine PGF2a output was seen as
an increase in the number of PGF2a peaks of low magnitude on days 9 or 10 of the
treatment. The maximal stimulation of PGF2a secretion from the sheep uterus
occurred following the infusion of oestradiol after pre-treatment with progesterone
(Scaramuzzi et al., 1977).
The combined effect of progesterone and oestradiol treatment was also reported in
mice. Saksena and Lau (1973) showed that there was a significant increase in the
concentration of PGF2a in uterine tissue of ovariectomised mice after 3 days of
treatment with progesterone followed by 3 days of oestrogen treatment when
compared with either treatment alone. All of these findings indicate that
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progesterone-priming followed by oestradiol treatment is the optimum stimulus for
increasing the output of PGF2a from the uterus of several species.
It has been shown that the destruction of ovarian follicles by X-ray irradiation
(Karsch et al., 1970) or mechanically (Ginther, 1970) prevents normal luteal
regression in the sheep and cow (Villa-Godoy et al., 1985). These findings further
support the theory that the release of ovarian oestradiol acting on a progesterone-
primed uterus is the actual physiological stimulus for increased uterine PGF2a
synthesis at the end of the oestrous cycle. However, there is some controversy
regarding the role of ovarian steroids in the stimulation of the uterine PGF2a output
from the sheep, since luteal regression was not delayed following destruction of
ovarian follicles in another study (Warren et al., 1973), or by the injection of an
antisera to oestradiol (Fairclough et al., 1976). Nevertheless, more recent studies
using progesterone and oestrogen receptor antagonists have indicated the
importance of progesterone and oestradiol in the stimulation of PGF2a production
by the uterus. The administration of onapristone (a progesterone receptor
antagonist) or ICI 182780 (an oestrogen receptor antagonist) to guinea-pigs on days
11-14 of the cycle significantly reduced PGF2a output on day 15 (Poyser, 1993).
Concentrations of progesterone in the plasma of onapristone- and ICI 182780-
treated guinea-pigs were still high on day 15 indicating that luteal regression had
been prevented. In another study, the progesterone antagonist, mifepristone (RU
486), when injected i.m. into ewes during the early luteal phase of the oestrous
cycle (i.e. on days 5, 6, 7 and 8) resulted in the failure of luteolysis and the
maintenance of a functional corpus luteum to at least day 24 after oestrus (Morgan
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et al., 1993). Furthermore, RU 486 treatment of sheep inhibited the plasma profile
of PGF2a (measured as PGFM) normally seen on days 12, 13, 14 and 15 (Morgan
etal., 1993).
Although PGF2a is not a luteolytic hormone in human, prostaglandin may have a
role in the female reproductive tract. A very recent study has reported the cloning
of PGF2a receptors from the human uterus (Lake et al., 1994). In women, there is
an increase in the amounts of PGF2a and, to a lesser extent, PGE2 produced by the
endometrium at menstruation (Downie et al., 1974; see Poyser, 1981). There is an
increase in the concentration of PGF2a in the human endometrium from the
proliferative phase to the secretory phase, with peak levels being reached during
menstruation (Downie et al., 1974; see Lundstrom, 1986). PGE2 concentrations
increase only at menstruation. The ratio between the PGF2a and PGEw
concentrations is higher in the secretory and menstrual phases compared with the
proliferative phase (Downie et al., 1974). Since prostaglandins, in particular
PGF2a, contract the uterus (see Lundstrom, 1986) and affect the vasculature, it is
assumed that they have a role in the menstrual process. The plasma concentration
of 13,14-dihydro-15-keto-PGF2a (PGFM) varies between 50-100 pg/ml in women
with dysmenorrhoea. The oral administration of indomethacin decreased the plasma
concentration of PGFM to less than 15 pg/ml (Lundstrom et al., 1976). They also
showed that the intravenous infusion of PGF2a at a rate of 18 pg/ml induced severe
dysmenorrhoeic pain and marked uterine hypertonicity. Lundstrom et al. (1976)
speculated that an overproduction of PGF2a by the endometrium is the probable
cause of dysmenorrhoea. The concentrations of PGF2a and PGE2 in the menstrual
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fluid of women suffering from dysmenorrhoea are much higher than normal
(Lumsden et al., 1983). Lumsden et al. (1983) have reported that the amounts of
PGF201 and PGE2 in the menstrual fluid of women suffering from dysmenorrhoea
are 710 ± 131 and 105 ± 23 ng/ml, respectively while the amounts of PGF2« and
PGE2 in the menstrual fluid of control women are 153 + 27 and 38 + 5 ng/ml
respectively. On the other hand, an excess output of prostacyclin (PGI2) may be the
cause of menorrhagia (Smith et al., 1981). Smith et al. (1981) reported that
production of PGF2a, PGE2 and PGD2 by cultured endometrium from women with
excessive menstrual blood loss (57-186 ml) was similar to that observed for the
endometrium of women with normal blood loss (5-50 ml). However, the
endometrium from women with excessive menstrual blood loss was more effective
than endometrium from women with normal menstrual blood loss at enhancing the
production by the myometrium of 6-oxo-prostaglandin Fi„, the stable metabolite of
prostacyclin. The reasons for abnormal PG production in these disorders of
menstruation are not yet known. However, non-steroidal anti-inflammatory drugs
such as mefenamic acid, flufenamic acid (Anderson et al., 1976; Haynes et al.,
1980) and indomethacin (Lundstrom et al., 1976) reduce significantly the blood
loss in patients with menorrhagia and the pain associated with dysmenorrhoea.
Progesterone (1 pM) suppressed the release of PGE from cells obtained from
proliferative endometrium during the first 24 h in culture (Mitchell & Smith,
1992). After 48 h in culture, progesterone at concentrations of 100 nM and 1 pM
suppressed both the release of PGF2a and PGE2 from the cells, an effect which
lasted for a further 2 days. It has also been shown that progesterone treatment in
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vitro inhibits PGF2a output from both proliferative and secretory endometrium in
culture (Cane & Villee, 1975; Abel & Baird, 1980; Schatz et al., 1985).
Oestradiol treatment, however, stimulates PGF2a output from both proliferative and
secretory human endometrium in culture and this stimulatory effect of oestradiol is
overcome by progesterone treatment (Abel & Baird, 1980; Schatz et al., 1985).
In the guinea-pig, PGF2ct output from the endometrium in culture was stimulated
by oestradiol 17-P and inhibited by progesterone treatment in vitro (Leaver &
Seawright, 1982). However, Riley and Poyser (1987a) reported that oestradiol does
not stimulate endometrial PGF2a output in culture. In fact, oestradiol at a high
concentration (3.7 pM) in vitro inhibited PGF2a output. An inhibitory effect of
progesterone in vitro on PGF2a production by cultured guinea-pig endometrium
was also reported by Riley and Poyser (1987a). It is clear that, while treatment in
vivo with oestradiol following progesterone priming stimulates PGF2a production
by the endometrium, the effect of oestradiol in vitro is variable and the effect of
progesterone in vitro is inhibitory. Riley and Poyser (1987a) reported that
hydrocortisone had no effect on endometrial PG production. These result led Riley
and Poyser (1987a) to speculate that the inhibitory effect of progesterone on
endometrial PG synthesis and release in the guinea-pig is not due to progesterone
having a glucocorticoid-like action.
(b) The Role of Oxytocin in The Reeulation of Uterine PGF2r, Synthesis
In some species, oxytocin is also involved in the control of the uterine PGF2a
production. In sheep, the infusion of oxytocin into the uterine artery after day 14
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of the oestrous cycle caused a marked rise in uterine PGF2a output (Roberts et al.,
1975). Flint and Sheldrick (1985) have also reported that the continuous infusion of
oxytocin blocks luteal regression in cyclic ewes. This stimulatory effect of oxytocin
on uterine PGF2a output has also been shown in the rabbit (Small et al., 1978), rat
(Campos et al., 1980), cow (Wathes et al., 1983) and goat (Cooke & Homeida,
1985). It has been reported that, in sheep, the immunisation against oxytocin
delays luteal regression (Flint et al., 1979; Sheldrick et al., 1980). In ewes, the
stimulatory effect of oxytocin on uterine PGF2a output is potentiated by oestradiol
and progesterone (Sharma & Fitzpatrick, 1974; Homanics & Silvia, 1988).
Therefore, in the sheep, oestradiol acting on a progesterone-primed uterus causes
an initial increase in endometrial PGF2a output which is subsequently maintained
and increased further by oxytocin. However, the maximum responsiveness of the
endometrium to oxytocin occurs after plasma progesterone levels have started to
decline (Sheldrick & Flint, 1985), indicating that progesterone may also have an
inhibitory effect on the action of oxytocin.
A similar result has been shown in the cow in vivo. Mann & Lamming (1995)
studied the effects of oestradiol- 17p on oxytocin-induced PGF2« release using
steroid-treated, ovariectomised cows. Long-term ovariectomised cows were pre-
treated with progesterone for 14 days followed by oestradiol-17P for 2 days to
induce oestrus (Day zero), and were then treated for further 16 days with
physiological doses of progesterone and oestradiol-17(3 to simulate a luteal phase.
On day 11, oestradiol was either withdrawn (low group) or maintained (normal
group). Oxytocin was administered daily by the i.v. injection of 50 IU oxytocin
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from days 12-16, and oxytocin-stimulated PGF2a secretion was monitored by
measuring the concentration of the principal metabolite of PGF2(X (PGFM), in
plasma samples collected before and after the daily injections of oxytocin. In the
"normal group", oxytocin significantly raised plasma PGFM concentrations
following administration on days 12-16. In the "low group", significant elevations
in plasma PGFM concentrations were only seen on days 15 and 16, and were
significantly smaller than those seen in the normal group (Mann & Lamming,
1995). Thus, oxytocin causes greater production of PGF2a by the cow uterus after
treatment with physiological concentrations of both progesterone and oestradiol.
There are conflicting reports regarding the stimulatory effect of oxytocin on PGF2a
outputs from the guinea-pig uterus. It was reported that oxytocin stimulated the
output of PGF2a from the guinea-pig uterus at the end of the oestrous cycle (when
basal PGF2a output is high), but not at mid-cycle (when basal PGF2a output is low)
(Leaver & Seawright, 1982). They also reported that, in the presence of oestradiol-
170, oxytocin stimulated PGF2a output at mid-cycle. However, Riley and Poyser
(1987a) reported that oxytocin had no effect on the endometrial PGF2a output at
any stage of the cycle. Oxytocin was also shown to have no effect on the basal
output of PGF2a from the day 7 and day 15 guinea-pig uterus superfused in vitro
(Poyser & Brydon, 1983). Thus the initial findings of Leaver and Seawright (1982)
have not been confirmed. Furthermore, the injection of oxytocin into the guinea-
pigs failed to affect the length of the oestrous cycle (Donovan, 1961). These
finding suggest that oxytocin is not involved in the physiological control of uterine
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PGF2a output from the guinea-pig uterus, and that the role of oxytocin in
controlling uterine PGF2a output is species-dependent.
(c) Mechanism of Action of Steroids
In many tissues, including the uterus, steroids have been shown to exert their effect
by stimulating protein synthesis (see Brenner & West, 1975). Oestradiol stimulates
protein synthesis in the rat uterus (Kumar et al., 1983; Komm et al., 1986) and
mouse uterus (Henrikson et al., 1987). The importance of fresh protein synthesis
in the uterus in the control of uterine PGF2a output has been demonstrated in the
sheep (French & Casida, 1973) and guinea-pig (Poyser, 1979; Poyser & Riley,
1987; Riley & Poyser, 1989). In the sheep, administration of actinomycin D (an
inhibitor of DNA-dependent RNA synthesis) into the uterine lumen on day 11 of
the oestrous cycle prevented luteal regression (French & Casida, 1973). In the
guinea-pig, the intra-uterine administration of actinomycin D on day 10 of the
oestrous cycle lengthened the oestrous cycle by two-fold and progesterone
concentrations remained elevated throughout the duration of these cycles (Poyser,
1979). In another study, the intrauterine administration of actinomycin D on day
10 of the oestrous cycle reduced the output of PGF2a from the day 15 uterine horn
superfused in vitro (Poyser & Riley, 1987). Oestradiol treatment in vivo did not
reverse the inhibitory effects of actinomycin D on uterine PG production. It has
also been shown that actinomycin D inhibits PGF2a output from guinea-pig
endometrial tissue in culture, but not from guinea-pig myometrial tissue in culture
(Riley & Poyser, 1989). Cycloheximide (an inhibitor of the elongation step of
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protein transcription) and puromycin (a releaser of nascent polypeptide chains
before their synthesis is complete) also reduced PG output from the day 7 and day
15 guinea-pig endometrium in culture (Riley & Poyser, 1989). All these findings
suggest that PGF2« synthesis by the endometrium is dependent upon the synthesis of
fresh protein. These findings led Poyser and Riley (1987) to conclude that
increased protein synthesis is involved in stimulating endometrial PGF2a synthesis
and release. As a result, it was proposed that oestradiol induces the synthesis of a
protein ('lipostimulin') which, when acting on a progesterone-primed uterus,
"switches on" endometrial PGF2a synthesis and release by causing the activation of
endometrial PLA2 (Poyser & Riley, 1987).
Although it is clear that the endometrium is the source of increased PGF2a output
from the guinea-pig uterus, it is not known which cell type is involved. One aim of
this study is to investigate whether the epithelial or stromal cells obtained from the
guinea-pig endometrium are the main site of PGF2a synthesis.
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1.2. INVOLVEMENT OF PHOSPHOLIPASE ENZYMES, CALCIUM,
CALMODULIN, PROTEIN KINASE C, cAMP, G-PROTEIN AND
INOSITOL TRISPHOSPHATE IN UTERINE PROSTAGLANDIN
PRODUCTION.
1.2.1 Phospholipase Enzymes and Calcium
The release of the bound arachidonic acid (AA) from the phospholipids is the rate
limiting step in the synthesis of prostaglandins in tissues (Vogt, 1978). The major
phospholipids include phosphatidylcholine, phosphatidylethanolamine,
phosphatidylserine, phosphatidylinositol and sphingomyelin. In the guinea-pig
uterus, it has been shown that 90% of the total AA is bound to phospholipids, and
that of this proportion 80% is esterified as phosphatidylcholine and
phosphatidylethanolamine (Leaver & Poyser, 1981). A greater uptake of AA into
the phospholipids of the guinea-pig endometrium on day 15 compared to day 7 of
the oestrous cycle (i.e. at the end of the oestrous cycle) was clearly demonstrated
by Ning et al. (1983). This mechanism may be responsible for the compensation of
the higher AA release from phospholipids at the end of the oestrous cycle.
Release of AA from phospholipids is brought about by the action of phospholipase
enzymes. So far, four major phospholipase enzymes have been identified, namely
phospholipase (PL) Ab PLA2, PLC and PLD (Dennis, 1983). It has been reported
in the rat (Dey et al., 1982), guinea-pig (Downing & Poyser, 1983) and human
(Bonney, 1985) that an increase in endometrial prostaglandin synthesis is associated
with an increase in PLA2 activity. It has been shown that phospholipase A2 activity
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is a calcium-dependent, and has an optimum pH of 8-9 in women (Bonney, 1985),
of 8.0 in guinea-pig (Downing & Poyser, 1983) and of 6.0 in the rat (Pakrasi et
al., 1983).
In the guinea-pig, the concentration of PLA2 in the endometrium increases
significantly by 1.4- to 1.8-fold between day 7 and day 16 of the cycle (Downing
& Poyser, 1983). In women, the enzyme activity was low in the early proliferative
phase tissue but rose significantly during the late proliferative phase (Bonney,
1985). Bonney (1985) also reported a 10-fold increase in PLA activity 2-4 days
after ovulation which thereafter declined to reach values which at menstruation
were not significantly different from those of the proliferative phase. These finding
led Bonney (1985) to suggest that PLA2 activity in human endometrium is related
to the stage of the menstrual cycle and that arachidonic acid release may be
influenced by oestradiol and progesterone. Later it was reported that oestradiol
sulphate and testosterone sulphate, but not progesterone, stimulated PLA2 activity
in vitro in human endometrium by 2- to 13-fold. The effect was dose related, linear
with the time, and independent of the stage of the menstrual cycle (Bonney &
Frank, 1987b). Cultured human endometrium (Bonney et al., 1987) treated with
progesterone followed by oestradiol caused a stimulation of PLA2 activity, which
was greater than the increase in PLA2 activity caused by oestradiol alone. These
finding indicate a direct action of steroids on PLA2 activity in vitro.
Stimulation of uterine PLA2 activity by oestradiol has also been reported in the rat
(Pakrasi et al., 1983; Dey et al., 1982). Uterine PLA2 activity showed a 167-fold
increase in ovariectomized animals treated with oestradiol-17(3 as compared to
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those treated with saline-vehicle (Pakrasi et al., 1983). Dexamethasone treatment
reduced the stimulatory effect of oestradiol-173 on uterine PLA2 activity. Also, the
simultaneous treatment of rats with oestradiol-173 and progesterone significantly
reduced the rise in uterine PLA2 activity caused by oestradiol alone. Progesterone
alone had no effect on uterine PLA2 activity in ovariectomised rats (Pakrasi et al.,
1983).
Bonney et al. (1987) reported that there are two isoenzymes of PLA2, namely
PLA2 type 1 and PLA2 type 2. Phospholipase A2 type 1 is a calcium-dependent
enzyme located mainly in the glandular component of the endometrium and its
activity increases in the secretory phase of the menstrual cycle. PLA2 type 2 is a
calcium-independent enzyme found in the stromal cells. These PLA2 isoenzymes
also differ with respect to their pH optimum, and their regulation by steroid
hormones. PLA2 type 1 is optimally active at pH 7.5 to 9, whereas PLA2 type 2 is
optimally active at pH 7.0. (Bonney et al., 1987). Progesterone priming followed
by treatment with oestradiol caused a 2-fold stimulation of PLA2 type 1 but not
PLA2 type 2 (Bonney et al., 1987). Melittin, a PLA2 activator, stimulated the
release of PGF2a from ovine endometrial tissue in culture. Aristolochic acid, an
inhibitor of PLA2 activity, blocked melittin-induced PGF2a production (Lee &
Silvia, 1994).
Another important phospholipase is PLC. In platelets, a source of AA for PG
synthesis was postulated to be phosphatidylinositol. The AA is released by the
action of PLC and diacylglyceride lipase (Bell et al., 1979). It has been shown that
PLC is a calcium-dependent enzyme and has a pH optimum of 5.5 (Bonney &
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Franks, 1987a). In human endometrium, PLC activity was independent of the stage
of the menstrual cycle (Bonney & Franks, 1987a).
In the guinea-pig, Poyser (1987) reported that PLC as well as PLA2 increased
uterine prostaglandin output, in particular the output of PGE2 from the day 7 and
day 15 guinea-pig uterus superfused in vitro. What is important to note that the
PLC used by Poyser (1987) was of bacterial origin which uses phosphatidylcholine
as substrate rather than PLC of mammalian origin, which uses phosphatidylinositol
(PI) as substrate. These data suggest that, in human and guinea-pig, PLC activity is
not associated with increased uterine PGF2a synthesis and release. However,
Bonney & Franks (1987a) suggested that, in human, the PLC concentration may
rise during certain pathological conditions associated with abnormally high PG
output from the endometrium. A role for PLC in oxytocin-induced release of
PGF2a from ovine endometrial tissue was suggested by Flint et al. (1986). Silvia
and Homanics (1988) also reported that oxytocin stimulates endometrial PGF2a
output and activates PLC. A similar finding was reported in another study (Silvia
& Raw, 1993). Silvia and Raw (1993) reported, that in non-pregnant ewes,
oxytocin stimulates the release of PGF2a from endometrial tissue collected on days
14 and 16, but not on days 4 to 7, 10 or 12 after oestrus. The days on which
oxytocin stimulated PGF2a output also coincided with the days on which oxytocin
stimulated the activity of PLC (Silvia & Raw, 1993). In a more recent study, it
was shown that U-73122, a PLC inhibitor, blocked the ability of oxytocin to
stimulate PGF2a output from ovine endometrial tissue in culture but surprisingly
failed to inhibit oxytocin-induced stimulation of PLC activity (Silvia et al., 1994).
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Aristolochic acid (an inhibitor of PLA2) prevented the increased output of PGF2a
from ovine endometrium produced by oxytocin (Lee & Silvia, 1994). These
findings indicate that oxytocin-induced increase in uterine PGF2a release from
ovine endometrium is mediated by PLA2 and not by PLC.
Although the concentration of PLA2 in guinea-pig endometrium increases up to
1.8-fold between days 7 and 16 of the oestrous cycle (Downing & Poyser, 1983),
uterine PGF2oc output increases 22-fold between days 7 and 15 (Poyser & Brydon,
1983). This difference indicated that an increase in the activity of PLA2 is not the
sole factor controlling PGF2a synthesis by the endometrium. Since PLA2 is a
calcium-requiring enzyme it was postulated that the activation of PLA2 by calcium
"switches on" PGF2o synthesis in the uterus (Downing & Poyser, 1983). This
activation of PLA2 leads to the release of AA from phosphatidylcholine and
phosphatidylethanolamine (Ning & Poyser, 1984) which, in turn, results in
increased prostaglandin production, in particular PGF2a synthesis by and release
from the endometrium. The calcium ionophore (A23187) increases the output of
prostaglandins from the guinea-pig uterus superfused in vitro (Poyser & Brydon,
1983) presumably by activating PLA2, a calcium-requiring enzyme. Poyser (1984)
reported that the presence of extracellular calcium is necessary for this stimulatory
effect of A23187. However, the high basal output of PGF2a from the day 15
guinea-pig uterus superfused in vitro was not dependent upon extracellular calcium
for at least 150 min. This suggests that the release of calcium from an internal store
may be important in PG synthesis towards the end of the oestrous cycle. The
intracellular calcium antagonist, 8-(N,N,-diethylamino)octyl-3,4,5-trimethoxy-
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benzoate hydrochloride, (TMB-8) inhibited the A23187-induced rise in uterine PG
output (Poyser, 1985a). The output of PGF2a from day 15 guinea-pig endometrium
tissue cultured up to 3 days was reduced by the lack of extracellular calcium,
EGTA (a Ca2+ chelator) and TMB-8 (Riley & Poyser, 1987b). These findings led
Riley and Poyser (1987b) to suggest that both intracellular and extracellular
calcium were necessary for the PGF2a synthesis by and release from the guinea-pig
endometrium. The extracellular calcium may just be necessary to refill the
intracellular calcium pool.
1.2.2 Calmodulin. Protein Kinase C and cAMP
Calmodulin is a 17 kDa acidic protein which binds calcium at a ratio of 1:4. It has
been shown that calmodulin increases the stimulatory effect of calcium on the
activity of PLA2 from the platelet membrane (Wong & Cheung, 1979), the renal
medulla (Craven & De Rubertis, 1983) and the amnion (Olson et al., 1985).
Trifluoperazine (TFP), a calmodulin inhibitor, prevented both the release of AA
and PG synthesis induced by A23187, vasopressin, NaCl and mannitol in rat renal
medulla (Craven & De Rubertis, 1983). It has also been shown that TFP inhibits
PLA2 activity in platelets (Walenga et al., 1981) and, A23187-induced PGE^
output from human amnion cells (Olson et al., 1985).
The involvement of calmodulin in mediating the calcium-induced increase in PGF2a
output from guinea-pig uterine horns superfused in vitro (Poyser, 1985a, b) and
from guinea-pig endometrium in culture (Riley and Poyser, 1987b) has been
investigated. It was reported that N-(6-aminohexyl)-5-chloro-l-naphtalene-
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sulphonamide (W-7) (Poyser, 1985a) and TFP (Poyser, 1985b), both calmodulin
antagonists, inhibited A23187-induced PG output from the day 7 and day 15
guinea-pig uterus superfused in vitro. Furthermore, these calmodulin antagonists
(i.e. W-7 & TFP) were reported to inhibit basal PGF2a output from day 15 guinea-
pig endometrium cultured in the absence or presence of extracellular calcium
(Riley & Poyser, 1987b). These result suggest that calmodulin may have a role in
mediating the action of calcium in the activation of PLA2 for the subsequent release
of AA and consequent increase in PGF2a synthesis by and release from the guinea-
pig endometrium. As nifedipine and verapamil, both calcium channel blockers,
were ineffective in inhibiting PGF2a output from the cultured guinea-pig
endometrium (Riley & Poyser, 1987b), calcium entry through voltage-dependent
calcium channels appears not to be involved in increased PGF2a production by the
guinea-pig uterus. Poyser (1987a) reported that the depolarisation of the guinea-pig
uterus with K+ caused the uterus to contract, but there was no increase in PGF2a
production. This lead him to conclude that an intermittent synchronous
depolarisation is therefore not responsible for the pulsatile nature of endometrial
PGF2(X production.
Kinases are known to regulate arachidonic acid release, and hence PLA2 activation.
Protein kinase C (PKC) has long been implicated in the activation of AA release
due to the potent stimulatory effects of phorbol esters on macrophages, and the
effects of selective inhibitors of PKC (see Glaser et al., 1993). Wightman et al.
(1982) suggested that PLA2 activity in the murine peritoneal macrophage was also
regulated by the level of cAMP-dependent kinase activity. In the platelet, PKC has
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been shown to be involved in thromboxane synthesis (Mobley & Tai, 1985).
Touqui et al. (1986) reported that PKC prevents PLA2 deactivation in platelets. In
the guinea-pig the PKC activator, phorbol 12-myristate 13-acetate (TPA), had no
effect on the outputs of prostaglandins from cultured day 7 or day 15 endometrium
(Riley & Poyser, 1987b) or from uterine horns superfused in vitro (Poyser, 1987a).
These data indicate that in the guinea-pig PKC activation is not involved in PG
output from the guinea-pig uterus. However, TPA has been shown to stimulate
PGF2a output from cultured human endometrial cells (Skinner et al., 1984), and to
stimulate PLA2 activity in human neutrophils (Stocker & Richter, 1982) and in
human amnion and decidual cells (Schrey & Read, 1986), indicating that species
differences may therefore exist.
It has been reported that there are no differences in the basal levels of cAMP in
guinea-pig endometrium and myometrium between day 7 and day 15 of the
oestrous cycle (Poyser, 1987a). Poyser (1987a) also reported that basal cAMP
levels in the myometrium on day 7 and day 15 were about 8- to 9-fold greater than
cAMP levels in the endometrium on the same day. Forskolin (an activator of
adenyl cyclase) increased cAMP levels in guinea-pig endometrium and
myometrium by 50- and 7-fold, respectively, on both days 7 and 15 of the
oestrous cycle (Poyser, 1987a), but there were no increases in the outputs of
prostaglandins. This study clearly indicated that cAMP has no role in the process
of increased prostaglandin production by the guinea-pig uterus.
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1.2.3 G-proteins
The presence of a G-protein in sheep uterine endometrium has been shown by Flint
(1988). PLA2 has been reported to be activated by a G-protein which is inhibited
by pertussis toxin; hence, pertussis toxin inhibits PG synthesis in several tissues
(Burch et al., 1986; Burgoyne et al., 1987; Axelrod et al., 1988; Wang et al.,
1988; Nakashima et al., 1988). However, pertussis toxin and cholera toxin
stimulate PGI2 synthesis by aortic endothelial cells and PGE^ synthesis by a murine
macrophage cell line via activating a G-protein (Pirotton et al., 1987; Burch et al.,
1988). In guinea-pig neutrophils, A23187 and N-formyl peptide receptor
stimulation cause AA release. Pertussis toxin inhibits AA release caused by the
stimulation of the N-formyl peptide receptor but not by A23187 (Bokoch &
Gilman, 1984). Pertussis toxin has also been reported to inhibit noradrenaline-
stimulated AA release but not noradrenaline-stimulated inositol phosphate
formation (Burch et al., 1986). Fluoride, another activator of G-proteins,
stimulates PGI2 synthesis by rat aorta (Jeremy & Dandona, 1988). Sodium fluoride
(NaF) stimulated the outputs of prostaglandin from the day 7 and day 15 guinea-
pig uterine horn superfused in vitro suggesting that a G-protein is involved in
uterine PG synthesis (Leckie & Poyser, 1990a). The action of NaF was not
inhibited by the lack of extracellular calcium nor by the actions of calmodulin
inhibitors (W-7 & TFP) or neomycin (an inhibitor of PLC). However, TMB-8
inhibited NaF-induced PGF2« output, but not PGE^ or 6-keto-PGFia, outputs from
the day 7 guinea-pig uterus superfused in vitro (Leckie & Poyser, 1990a). These
finding suggest that the action of NaF on PG synthesis is not dependent upon
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extracellular calcium, calmodulin or PLC, but that intracellular calcium may be
involved.
Cholera toxin and pertussis toxin had no effect on the outputs of prostaglandins
from both day 7 and day 15 cultured guinea-pig endometrium indicating that toxin-
sensitive G-proteins are not involved in the processes which control PGF2a release
from the guinea-pig endometrium (Leckie & Poyser, 1990b). Interestingly, 10 mM
NaF induced PGF2a output from the guinea-pig endometrial tissue cultured for 1 h,
but inhibited PGF2a output and protein synthesis from the endometrium cultured
for 6, 12, 18 and 24 h (Leckie & Poyser, 1990b). These reports suggest that NaF
has two effects, i.e. a stimulatory (short term) effect and an inhibitory (long term)
effect. Leckie & Poyser (1990b) suggested that the long term effect of NaF is
probably due to its inhibitory effect on endometrial protein synthesis. The short
term effect may involve a G-protein which is not regulated by toxins. A similar
type of conclusion was also drawn by Burch & Axelrod (1987). They reported that
a pertussis toxin-insensitive G-protein is involved in the activation of PLA2 by
bradykinin in Swiss 3T3 fibroblast cells. In cultured human endometrial epithelial
and stromal cells, NaF stimulated AA release from both cell types when incubated
for periods of up to 90 min (Bonney et al., 1991). This finding raises the question
whether the NaF effect reported on human endometrial cells in culture is the 'short
term effect', as shown by Leckie & Poyser (1990a, b) and whether a long-term
inhibitory effect also exist in human endometrial cells.
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1.2.4 Inositol triphosphate
In sheep, oxytocin stimulates the turnover of endometrial inositol triphosphate
(IP3) and total inositol phosphate (IP) (Mirando et al., 1990). This IP3 turnover is
initiated between days 12 and 16 of the oestrous cycle (Mirando et al., 1990).
Furthermore, when slices of caruncular endometrium from steroid-treated
ovariectomised sheep were incubated with labelled inositol, oxytocin caused a 2.8-
fold increase in the rate of incorporation of labelled inositol into
phosphatidylinositol, and IP3 was the major triphosphate formed (Flint et al.,
1986). The action of oxytocin on phosphoinositide hydrolysis was dose- and time-
dependent, occurring at concentrations within the range observed in plasma during
episodes of secretion in vivo, and with a time course comparable with that of the
action of oxytocin on uterine prostaglandin production (Flint et al., 1986). They
also reported that the effect of oxytocin on incorporation of radioactivity into
inositol phosphate was not affected by inhibitors of prostaglandin synthesis. It was
proposed that the stimulation of endometrial prostaglandin synthesis by oxytocin is
accounted for by hydrolysis of phosphoinositides to diacylglycerol and IP3 with
subsequent release of AA from diacylglycerol (Flint et al., 1986). In another
study, oxytocin stimulated total IP3 by endometrial tissue in culture from day 5 and
day 15 post-partum ewes, and from cycling ewes on day 10 and day 15 (Wallace et
al., 1993). Oxytocin also stimulated PGF2« release to varying levels at all stages of
the cycle in post-partum ewes but only on day 15 of cycling ewes. Thus,
stimulation of endometrial PGF2a synthesis in ewes is associated with increased IP3
levels (Wallace et al., 1993). However, as described in Section 1.2.1, oxytocin-
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induced PGF2a release from sheep endometrium is dependent upon the activation of
PLA2 and not PLC. Thus PGF2a production in the sheep endometrium appears to
be independent of IP3 generation.
Ning & Poyser (1984) reported that phosphatidylcholine is the major phospholipid
in guinea-pig endometrium and phosphatidylinositol is present at a much lower
concentration. There is no increase in inositol turnover in the guinea-pig
endometrium at the end of the oestrous cycle when PGF2a synthesis is high (Ning
& Poyser, 1984). These findings indicate that the stimulation of endometrial PGF2a
synthesis in the guinea-pig is not dependent on the generation of IP3.
It was discussed in Section 1.2.1 that the stimulation of endometrial PGF2a
synthesis is due to an increase in the intracellular calcium concentration which, in
turn, activates PLA2. However, endometrial PGF2a synthesis is dependent upon
intracellular calcium but this calcium is not derived from an IP3-sensitive pool. The
question is then raised from what other pool is this intracellular calcium derived?
1.3. INTRACELLULAR CALCIUM
In the early 1960s it became apparent that, although in narrow smooth muscle cells
the time required for Ca2+ to diffuse from the surface to the interior presents no
kinetic limitation on the rate of tension development, the release of intracellular
Ca2+ is nevertheless involved in agonist induced contraction (Bohr, 1963; Daniel,
9 -4-
1965). The release of intracellular Ca" induced by high doses of agonist is
transient and, in the absence of extracellular calcium, exhausts the Ca2+ store (Van
Breemen, 1969; Van Breemen et al., 1972). Subsequently IP3-induced release of
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calcium from a non-mitochondrial internal store in permeabilized pancreatic acinar
cells (Sterb et al., 1983) and in skinned single cells of porcine artery (Suematsu et
al., 1984) was reported. In cultured and freshly isolated, permeabilized smooth
"7 -4-
muscle cells, IP3-induced Ca release was sufficiently large and rapid, and a half-
maximally effective concentration of approximately 1 pM IP3 was low enough to
account for transient smooth muscle activation (Suematsu et al., 1984; Smith &
Smith, 1987). The IP3-induced calcium release mechanism was also reported to be
activated during the maturation of hamster oocytes (Fujiwara et al., 1993). The
mechanism of action of IP3 is such that its interaction with its receptor (Baukal et
al., 1985; Ferris & Snyder, 1992) opens cation channels, which allows the rapid
discharge of calcium from the sarcoplasmic reticulum (SR) into the cytosol. Saida
et al. (1988) reported that there is a specific GTP requirement for IP3-induced
calcium release from skinned vascular smooth muscle, and that this IP3-induced
calcium release is inhibited by pertussis toxin. Whereas Ghosh et al. (1989)
postulated that there are two intracellular Ca2+ pools distinguishable by IP3-
sensitivity and oxalate-permeability, and that IP3-induced and GTP-activated Ca2+
translocation processes are different. Ross et al. (1992) reported that at least four
different IP3 receptors exist. IP3-evoked channel opening is enhanced by ATP
(Maeda et al., 1991; Ferris & Snyder, 1992). IP3-induced release of calcium from
an internal store is also reported in cat adrenal chromaffin cells (Sorimachi et al.,
1992), bovine chromaffin cells (Stauderman et al., 1991), intact GH4C1 cells
(Tanaka & Tashjian, 1993) and saponian-skinned smooth muscle cells from guinea-
pig portal vein (Tsukioka et al., 1994). However, only part of the intracellular
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calcium store is IP3-sensitive. This was shown in cat adrenal chromaffin cells
(Sorimachi et al., 1992), bovine chromaffin cells (Stauderman et al., 1991), intact
GH4C1 cells (Tanaka & Tashjian, 1993), rat brain (Smith & Nahorski, 1993) and,
at a single cell level, in the rat pancreas (Schmid et al., 1990). They all reported
that, apart from an IP3-sensitive calcium store in the SR, there is at least one IPs-
insensitive calcium store in the SR which is activated by caffeine and ryanodine
(RY).
It is well-documented that caffeine-induced contractions of skeletal (Weber &
Herz, 1988) and cardiac (Blinks et al., 1972) muscles are due to the release of
calcium from a storage pool in the sarcoplasmic reticulum which is distinct from
the IP3-sensitive pool (Vigne et al., 1990; Stauderman et al., 1991). This caffeine-
sensitive, IP3-insensitive store of calcium is known to be released through
stimulation of the "ryanodine" receptor (RYR). Ryanodine is an alkaloid derived
from South American plant, Ryania speciosa Vahl. Ryanodine has been shown to
cause an irreversible contracture in mammalian skeletal muscle (Protica, 1956),
cardiac muscle (Furchgot & De Gubareff, 1956; Hillyard & Procita, 1956), and
smooth muscle (Hillyard & Procita, 1958). Hillyard & Procita (1958) reported
that, in isolated rabbit duodenal strips, RY failed to cause contraction in the
absence of extracellular calcium. Since then, however, a large number of reports
have indicated that RY induces calcium release from an internal store resulting in
an increase in the free cytosolic calcium concentration and a subsequent contraction
(Hwang & Van Breemen, 1987; Ezzaher et al., 1992; Kojima et al., 1994). The
action of RY is due to its interaction with a RYR in the membrane of the
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sarcoplasmic reticulum (SR). However, one of the intriguing aspects of the RY is
that it stimulates calcium release at low concentrations (nM) and inhibits calcium
release at high concentrations (pM).
The RYRs, which are intracellular calcium release channels, were originally
described in the sarcoplasmic reticulum of the skeletal muscle (Type 1; RYR-1) or
cardiac muscle (Type 2; RYR-2) (Flienscher & Inui, 1989). Ryanodine receptors
from skeletal (Lai et al., 1988) and cardiac (Henderson & Meissner, 1987) muscles
have been purified and biochemically characterised, and were found to be
different. Activation of these receptors directly by RY, and indirectly by
extracellular stimuli such as methacholine (a muscarinic receptor agonist;
Sorimachi et al., 1992), hormones and neurotransmitters (see Berridge, 1993) have
been shown to mobilise calcium from an internal store. Ryanodine receptors are
reported to be present in many other tissues such as longitudinal muscle of the
rabbit intestine (Kuemmerle et al., 1994), rat femoral artery (Komija et al., 1994),
rabbit aortic smooth muscle (Hwang & Van Breemen, 1987), guinea-pig ileal cells
(Gagov et al., 1993), sea urchin eggs (Buck et al., 1994) and cat adrenal
chromaffin cells (Sorimachi et al., 1992). Ryanodine receptor of the cardiac type
have been shown to be present in avian embryos at days 4, 5 and 6 of development
(Dutro et al., 1993), and in myocardial fibres of foetal rat (Su & Chang, 1993) and
1-day old neonatal rats (Ostadalova et al., 1993). Ryanodine receptor types 1 and 2
are also modulated by calcium and by caffeine. Caffeine releases calcium from
RY-sensitive calcium pools (Sorimachi et al., 1992; Stauderman et al., 1991;
Kuemmerle et al., 1994). Caffeine-induced calcium release is potentiated by cyclic
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ADP-ribose (Lee, 1993), calcium and ATP (Fliescher & Inui, 1989), and is
inhibited by high concentrations of RY (Sorimachi et al., 1992; Chen & Cheung,
1992; Kostyuk & Kirischuk, 1993), dantrolene (Usachev et al., 1993), Mg2+ (Su
& Chang, 1993), and ruthenium red (Vites & Pappano, 1994).
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In cardiac muscle, calcium release from SR via RYR is regulated by Ca~ influx
through voltage-gated calcium channels in the surface membrane. Hence, this
process is known as calcium-induced calcium release (CICR) (Fabiato & Fabiato,
1979; Sipido & Wier, 1991). The cardiac RYR is apparently more sensitive to
lower concentrations of calcium, and less sensitive to inhibition by Mg2+ and
ruthenium red, than the skeletal muscle form (Henderson & Meissner, 1987). The
SR in smooth muscle cells contains a calcium-gated calcium release pathway with
properties similar to those of skeletal muscle and cardiac ryanodine receptors
(Herrmann-Frank et al., 1991).
Ryanodine receptors in rabbit brain are thought to be mainly of the cardiac type
(RYR-2) (McPherson & Campbell, 1993b). [3H]RY binding to the purified brain
RYR was stimulated by calcium, ATP, KC1, and phosphorylation, and was
inhibited by calmodulin, Mg2+ and ruthenium red. It has been reported that, in the
rat brain, the RYR is similar to the skeletal form but is not identical, as [3H]RY
binding was not inhibited by dantrolene (300 pM) (Smith & Nahorski, 1993).
However, binding studies have shown that there are two types of RYR in mouse
brain, skeletal muscle type (RYR-1) found exclusively in purkinje cells, and the
cardiac muscle type (RYR-2) which is localised mainly at the somata of most
neurones (Kuwajima et al., 1992). This finding led to the postulation that calcium-
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induced calcium release (CICR), probably mediated by the cardiac muscle
ryanodine type receptor, functions generally in various neurones, whereas
depolarisation-induced calcium release, probably mediated by the skeletal muscle
ryanodine type receptor, functions specifically in purkinje cells. In avian sensory
neurones, the current produced by caffeine (10 mM) was inhibited by 10 pM RY
(Ivanenko et al., 1993). The caffeine-induced current was not dependent on
extracellular calcium, suggesting that caffeine raises intracellular free calcium
concentration by activating the release of calcium from an intracellular store, and
that this calcium activates the membrane conductance responsible for the current.
Excitation-contraction uncoupling and muscular degeneration in mice lacking
functional skeletal RYR (i.e. RYR-1) gene has been shown (Takeshima et al.,
1994). Skeletal muscles from mice lacking a functional RYR-1 gene failed to
response to electrical stimulation nor did they show a contractile response to
depolarisation by application of a high K+ (80 mM) concentration. However, slow
contractions were developed when the same electrical stimulation was given in
physiological salt solution containing 12 mM calcium and 10 pM Bay K-8644, an
agonist of the voltage-gated L-type calcium channel. The slow contractions were
abolished by tetrodotoxin (TTX; 10 pM), indicating that the action potentials are
generated in the mutant muscle but the calcium release after depolarisation of
sarcolemma is impaired in the mutant muscle. This indicated that the RYR
functions as the calcium release channel in the skeletal excitation-coupling
(Takeshima et al., 1994). Ryanodine-binding affinity was shown to increase by
ATP (Zarka & Shoshan-Barmatz, 1993). However, McGarry and Williams (1994)
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reported that adenosine discriminates between caffeine and adenosine nucleotide
sites on sheep cardiac SR calcium release channels.
In the vascular endothelial cells of bovine and human, a functional RY-sensitive,
intracellular calcium store seems to be present. Ryanodine (5 pM) caused a slow
increase in intracellular calcium from human aorta endothelial cells, human
umbilical cells and bovine pulmonary artery, but not from rat aorta (Ziegelstein et
al., 1994). However, Low et al. (1993) have reported that RY causes a dose-
dependent increase in tension in the rat aorta. These reports raise the question
whether RY-induced tension in the rat aorta is due to some other mechanism rather
than increasing free cytosolic calcium by activating SR ryanodine receptor. In
another study, it was reported that RY (10 pM) alone had no effect on rat aorta in
both calcium-containing and calcium-free physiological salt solution (PSS),
whereas caffeine (30 mM) caused rat aorta to contract in both types of PSS
(Hisayam et al., 1990). RY (10 pM) treatment before caffeine (30 mM) treatment
in calcium-free solution prevents caffeine from causing calcium release. Caffeine
(10 mM) elicited a rapid rise of intracellular calcium in phaeochromocytoma
(PC 12) cells (Muller & Daly, 1993). In rat ventricular myocytes, 10 mM caffeine
produced a transient increase in the intracellular calcium concentration and
contraction (Donoso et al., 1994), indicating caffeine-induced calcium release from
an internal calcium store. However, sea urchin eggs rarely responded to 10 mM
caffeine, but with 20 mM caffeine they produced a transient rise in intracellular
calcium (Harris, 1994).
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Caffeine (1 to 30 mM) causes a concentration-dependent contraction of the guinea-
pig taenia caecum in calcium-free solution, but increasing the caffeine
concentration produces a decrease in the size of contraction (Hisayama &
Tanakayanagi, 1988). When tissues were loaded with calcium responsiveness to
caffeine was recovered, suggesting that caffeine initially depleted the calcium
stores. Ryanodine (10 pM) treatment of tissues prior to caffeine administration
inhibited the caffeine effect (Hisayama & Tanakayanagi, 1988). Interestingly,
Hisayama & Tanakayanagi (1988) reported a time-dependent inhibitory effect of
RY on caffeine action. The treatment of rat diaphragm strips with 3 nM RY
increased baseline tension 360% above the original resting tension but only if the
diaphragm was concurrently stimulated electrically, whereas caffeine (10 mM) and
100 pM RY induced contracture in quiescent tissue (Zavecz & Anderson, 1992).
Caffeine-induced contractions in calcium-free solution were abolished by 3 nM
RY, indicating that the RY effect does not depend upon extracellular calcium
(Zavecz & Anderson, 1992). In cat adrenal glands, the caffeine-induced rise in
intracellular calcium and catecholamine secretion were strongly inhibited by pre-
treatment with ryanodine (Sorimachi et al., 1992). All of these findings indicate
that RY- and caffeine-induced intracellular calcium release from a ryanodine-
sensitive IP3-insensitive calcium pool may have a role in some of the cellular
mechanisms.
There are two genes encoding the RYR-1 (in skeletal muscle) and RYR-2 (in
cardiac muscle) receptors, respectively (Takeshima et al., 1989; Zorzato et al.,
1990; Otsu et al., 1990). A third gene encoding a new RYR (i.e. RYR-3) has been
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shown in mink lung epithelial cells (Giannini et al., 1992). Calcium release
experiments in MvlLu cells have shown that this RYR (i.e. RYR-3) is sensitive to
RY but not to caffeine. Furthermore, a high affinity binding site for RY has also
been shown in liver microsomal fraction (Shohan-Barmatz et al., 1991), where
expressions of RYR-1 and RYR-2 have not been observed. More interestingly, the
gene for RYR-3 expression is not abundant in liver (Giannini et al., 1992). A
novel RYR has been reported in rabbit brain, and this receptor is composed of
4872 amino acids and shares characteristic structural features with the skeletal
muscle type and cardiac muscle type RY receptors (Hakamata et al., 1992). They
also reported that the gene for the brain RYR is also transcribed in smooth muscle.
Considering the above information, it is clear that RYRs (i.e. caffeine-sensitive
calcium release channels) located on the sarcoplasmic reticulum on the cells are of
great importance in the excitation-contraction coupling of skeletal muscle and
cardiac muscle. The presence of RYR in many other tissues suggests that RYRs
may have a role in the function of these cells. The finding that basal PGF2a output
is not inhibited for at least 150 min in the absence of extracellular calcium (Riley &
Poyser, 1987b) suggested that the release of intracellular calcium is necessary for
PLA2 activity and hence PG synthesis in the guinea-pig uterus. As outlined
previously, it was reported that, in the guinea-pig, increased PGF2a output from the
endometrium is not associated with an increase in inositol turnover (Ning &
Poyser, 1984), indicating the lack of involvement of an IP3-sensitive calcium store
in the stimulation of endometrial PGF2a synthesis. Hence, it is likely that another
internal calcium pool is involved in the synthesis and release of prostaglandins
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from the guinea-pig endometrium. This internal calcium store may be the RY- and
caffeine-sensitive calcium pool. Thus one of the main aims of this study is to
investigate whether a RYR is involved in prostaglandin production by the guinea-
pig uterus, predominantly by the endometrium.
1.4. ISOFORMS OF PROSTAGLANDIN H SYNTHASE
It has been shown that the uterus possesses an increased ability to biosynthesise
PGF2a from endogenous precursors on days 14 and 15 of the oestrous cycle
(Poyser, 1972, 1983a, b). Poyser (1983a) proposed that the increase in endometrial
PG synthesising capacities is probably due to an increase in the amount of
prostaglandin H synthase (PGHS) present in the endometrium. Oestradiol, but not
progesterone, treatment of ovariectomised guinea-pigs stimulated prostaglandin and
thromboxane (TX) synthesis, particularly of PGF2a, by homogenates of the whole
uterus and endometrium, but not by homogenates of the myometrium (Poyser,
1983a). This stimulatory effect of oestradiol on PGF2a synthesis was greater on the
endometrium than on the whole uterus, indicating that endometrium is the major
site of PGF2a production. Progesterone did not alter the stimulation of PGF2a
synthesis by homogenates of the whole uterus, but it reduced by 50% the
stimulatory effect of oestradiol on PGF2a synthesis by homogenates of the
endometrium (Poyser, 1983a). This lead Poyser (1983a) to speculate that oestradiol
stimulates PGHS synthesis in the endometrium which in turn contributes to the
increase in PGF2a synthesis and release. The intra-uterine administration of
actinomycin D, a protein synthesis inhibitor, on day 10 reduced the output of
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PGF2a from the guinea-pig uterus in vitro by 80 to 85 %, and plasma progesterone
levels were high on day 15 due to the reduction in uterine PGF2a output (Poyser &
Riley, 1987). This finding indicates that fresh protein synthesis has a role in the
high output of PGF2a from the guinea-pig uterus towards the end of the oestrous
cycle. This increase in protein synthesis is thought to contribute to the increase in
PGHS concentration.
In sheep, the specific activity of PGHS in uterine microsomes was higher on days
13-15 than on earlier days of the oestrous cycle and reached a maximum on day 14
(Husling et al., 1979). This increase in PGHS activity on days 13-15 resulted from
increases in the concentration of PGHS. Furthermore, Husling et al., (1979)
reported an increase in the specific activity of PGHS in caruncular (which includes
luminal epithelium, vascular endothelium and caruncular stroma) microsomes but
no cyclical changes were seen in the activity of PGHS in microsomes from
myometrium and intercaruncular endometrium. The authors suggested that the
onset of luteolysis depends on an increase in the concentration of caruncular
PGHS, and possibly the stromal cells are the site of the cyclical changes in PGHS
activity. However, a marked cyclical changes in the concentration of PGHS in the
epithelial calls of sheep endometrium has been observed (Salamonsen & Findlay,
1990). Most of the PGHS in sheep endometrium is present in the stromal tissue on
day 4, but PGHS is detectable in the luminal epithelium by day 7 and reaches its
maximum concentration in the epithelium on day 14 (Salamonsen & Findlay,
1990).
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Salamonsen et al. (1991) studied the expression of the gene for PGHS in sheep
endometrium. They reported that, whilst no significant differences were seen in
PGHS mRNA concentrations in endometrial tissue during the oestrous cycle or in
early pregnancy, treatment of ovariectomised ewes with oestradiol-17f) markedly
decreased endometrial PGHS mRNA concentration. There were no differences in
PGHS mRNA concentrations in ewes treated with progesterone, either alone or in
conjunction with oestrogen when compared to ovariectomised controls (i.e. with no
steroid-treatment). In contrast, there was a difference in immunolocalization of
PGHS in uterine tissue from ovariectomised-steroid-treated ewes. In
ovariectomised ewes and those treated with oestrogen, immunocytochemical
staining for PGHS was seen in stromal cells, but little immunoreactive PGHS was
located in the endometrial epithelial cells. However, in ewes treated with
progesterone alone or with oestrogen plus progesterone, PGHS was found in
luminal and glandular epithelial cells and in stromal cells. These findings led
Salamonsen et al. (1991) to speculate that whilst oestrogen lowers PGHS mRNA
concentration in the endometrium, presumably in stromal cells, it may also increase
the stability of the enzyme itself in the stromal cells.
It has been shown that there are two isoforms of PGHS, namely PGHS-1, a
constitutive enzyme and PGHS-2, an inducible enzyme (Hedin et al., 1987; Wong
& Richards, 1991; Takahashi et al., 1994; Miller et al., 1994; Crofford et al.,
1994). Hedin et al. (1987) demonstrated that, in the ovary, the increase in PGHS
concentrations at the time of ovulation is due to an increase in the concentration of
PGHS-2 levels. They showed that the content of PGHS-2 (Mr, 72 kDa) was low in
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granulosa and thecal cells of small antral and preovulatory rat follicles. PGHS-2
was induced preferentially (about 15-fold) in granulosa cells between 1 and 7 h
after human chorionic gonadotrophin (hCG) treatment. This effect was also
reported by Sirois and Richards (1992), who found a distinct isoform of PGHS (Mr
70-72 kD) was induced by human chorionic gonadotrophin in granulosa cells of rat
preovulatory follicles.
It is not known whether this increase in PGHS concentration in guinea-pig and
sheep endometrium after day 10 of the cycle is due to the stimulation of the
inducible form of PGHS (i.e. PGHS-2). Another aim of this study is to investigate
whether the PGHS-2 isoform is present in guinea-pig endometrium, specifically at
the end of the oestrous cycle.
1.5. AIMS
In summary, the aims of this study are:
1. To investigate which cell type in the guinea-pig endometrium is responsible for
increased PGF2a synthesis by the endometrium at the end of the oestrous cycle.
2. To investigate which cell type responds to the known stimulators and inhibitors
of endometrial PG synthesis in the guinea-pig.
3. Whether the stimulation of endometrial PGF2a synthesis in the guinea-pig is
through the stimulation of the ryanodine receptor.
4. Whether a non-uterine tissue (i.e. blood vessels) produces prostaglandins in
response to caffeine and/or ryanodine.
5. Whether prostaglandin H synthase-2 is present in the guinea-pig uterus, in
particular the endometrium at the end of the oestrous cycle.
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SECTION TWO
2. METHODS & MATERIALS
INTRODUCTION
Many general methods have been employed on the work described in this thesis
which are common to a number of experiments. These include: guinea-pig uterine
superperfusion, prostaglandin extraction, rat mesenteric vascular bed perfusion,
endometrium and myometrium tissue culture of guinea-pig uterus, guinea-pig
endometrium homogenization, primary isolation and culture of endometrial
epithelial and stromal cells, intracellular calcium measurement of endometrial
epithelial and stromal cells, SDS-PAGE, Western Blotting, and radioimmunoassay.
These general methods which are fully described in detail as follows:
2.1 GENERAL METHODS
2.1.1 GUINEA-PIG UTERINE SUPERPERFUSION
Virgin, Dunkin-Hartley guinea-pigs (600 - 900 g) were examined daily and a
vaginal smear was taken when the vagina was open. Day one of the oestrous cycle
was taken as the day preceding the post-ovulatory influx of leucocytes when
cornification was at a maximum. All guinea-pigs had exhibited at least three cycles
of normal length (about 16-17 days) before being killed (by stunning followed by
exsanguination) on day 7 or 15 of the cycle. Each uterus was removed and
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separated into its two uterine horns. The uterine horns were blotted dry and
weighed. Each uterine horn was opened by cutting longitudinally down the anti-
mesometrial side, and was suspended in an organ bath with one end attached to an
isotonic leaver under a load of 2 g. Each uterine horn was superfused at 5 ml/min
with Krebs solution (see Section 2.2.7.1 for composition) at 37°C, as described by
Poyser and Brydon (1983), and superfused initially for an equilibrium period of 60
min. Samples of superfusate were then collected for 10 min periods over the next
80 (i.e 8 samples per uterine horn) or 100 min (i.e 10 samples per uterine horn)
depending on the treatment. After collection, the pH of each sample was lowered
to 4.0 with 1 M HC1 and the prostaglandins were extracted by shaking twice with
50 ml ethyl acetate, according to the method described by Poyser (1972). The two
ethyl acetate fractions were combined and evaporated to dryness on a rotary
evaporator. The recoveries of PGF2a and PGE2 by this method are >90% and that
of 6-keto-PGFia is >80% (Poyser & Scott, 1980; Swan & Poyser, 1983). Each
dried extract was redissolved in 10 ml ethyl acetate and stored at -20°C until it was
assayed.
2.1.2 RAT MESENTERIC VASCULAR BED PERFUSION
Male Wistar rats (250 - 300 g) were killed by a blow to the head followed by
exsanguination. The mesenteric vascular bed was dissected out and cleaned from
any connective tissues according to the procedure described by McGregor (1965),
and perfused in a hot water heated chamber at 37°C with McEwen's solution (for
composition see Section 2.2.7.2) at 4 ml/min at 37°C and aerated with 5% carbon
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dioxide and 95% oxygen, as described by Lennon & Poyser (1986). After an initial
equilibrium period of 30 min, samples of perfusate were collected for periods of 1
min and stored at -20°C before being assayed.
2.1.3 GUINEA-PIG ENDOMETRIAL & MYOMETRIAL TISSUE
CULTURE
Tissue culture was performed according to the method of Baker and Neal (1969)
for ovarian tissue, which was later modified for endometrial tissue by Abel and
Baird (1980), and Ning et al. (1983). Uterine horns were removed from the
guinea-pigs as described in Section 2.1.1 except that the whole procedure was
carried out under aseptic conditions. Tissues were then transferred into sterile petri
dishes containing tissue culture medium (TCM) which consists of modified
Medium M199 plus Earle's salts and 2.20 g/1 sodium bicarbonate, L-glutamine
(1.7 pM), amphotericin B (2.5 pg/ml), penicillin (100 U/ml), and streptomycin
(100 pg/ml). After "opening up" each uterine horn as described in Section 2.1.1,
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endometrium was cut away from the myometrium, cut into approximately 1 mm
pieces, and then placed onto sterile lens paper lying across a stainless steel grid in a
vented sterile dish which contained 4 ml of TCM plus any other compound used
according to the nature of the experiment. This set-up allowed the tissues to be
held above the medium but the medium was readily available to the tissues by the
capillary action of the lens paper (Figure 2.1.3.1). The amount of tissue placed in
each petri dish varied between 19 - 35 mg. Petri dishes were then placed into racks






.. - ourt £r
i£-vs TrSZUC OVEA




Figure 2.1.3.1 The above diagram shows the arrangements for culturing uterine
tissue in a petri dish, and how the petri dishes were stacked and gassed (via the inlet
and outlet tubes) in a kilner jar.
to 0.7 kg cm"2 (10 lb in"2) with a 1:1 gas mixture of air/C02 (95% : 5%) and
O2/CO2 (95% : 5%) and incubated at 37°C for 24 h. Medium was collected at 2, 8
and 24 h, and fresh medium was added to the dishes. When the medium in the
dishes was removed and replaced with fresh medium, it was preheated to 37°C
before being used. The jars were then regassed and replaced in the incubator. The
samples were stored at -20°C until they were assayed, without extraction, for
PGF2a, PGE2 and 6-keto-PGFia. At the end of the experiment tissues were blotted
dry and weighed. Myometrial tissue was cultured in the same way.
Since diffusion is the only means by which the cultured tissues receive their
oxygen, measured pressure of this gas was used to overcome problems of diffusion
relative to tissue size. The small amount of C02 present is necessary to set up a
C02/HC0"3 buffer system to maintain the pH of the medium at 7.4. Flistological
examinations previously carried out in this laboratory have shown that tissues
remain viable in culture up to 72 h (Leaver & Seawright, 1982). Hence the tissue
culture procedure used here is more than adequate for a normal maintenance and
survival of both endometrial and myometrial tissues up to 24 h, the only time
period used throughout the studies presented in this thesis.
2.1.4 ENDOMETRIUM HOMOGENISATION
Uterine horns were removed from the animals as described in Section 2.1.1.
Endometrium was separated from the myometrium, and the myometrium was
discarded. Endometrial tissues were then blotted dry, weighed, chopped finely with
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scissors and homogenised in a Fisons glass homogeniser with 5 ml of Krebs
solution containing appropriate treatments. The homogeniser was then washed with
a further 5 ml of the Krebs solution comprising the same treatment. The
homogenate and the washings (total volume 10 ml), were then transferred to a 25
ml conical flask, and incubated for 60 min at 37°C in a shaking (230
oscillations/min) Grant Water bath. Prostaglandins were extracted from the
homogenates as described in Section 2.1.1 except that 2 volumes of 20 ml ethyl
acetate were used. The residue obtained from evaporation of the ethyl acetate
fractions was redissolved in 4 ml of ethyl acetate. The samples were then stored at
-20°C until assayed.
2.1.5 ISOLATION & CULTURE OF GUINEA-PIG ENDOMETRIAL
CELLS
Cells were dissociated according to the method of Satyaswaroop et al. (1979) as
modified by Chaminadas et al. (1986). The uterine horns were prepared as
described in Section 2.1.3. All procedures were carried out under aseptic
conditions. Endometrium was separated from the myometrium and chopped into
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fragments of about 0.5 mm in 10 ml Ham's F-10 medium containing HEPES (20
mM), 30% heat treated newborn calf serum (H-NCS), collagenase Type I (2
mg/ml), L-glutamine (10 mM), amphotericin B (2.5 pg/ml), penicillin (100 U/ml),
and streptomycin (100 pg/ml) in a sterile conical flask and incubated at 37°C in a
shaking (230 oscillations/min) Grant Water bath for 2 h. Tissue fragments were
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further disrupted by gentle, repeated pipetting every 15 min. Digestion was
periodically monitored by decanting a small volume of the suspension into a sterile
tissue culture dish and visualizing the isolated epithelial cells under an inverted
microscope. After dissociation, the undigested fragments were collected by
sedimentation and discarded. The supernatant cell suspension were centrifuged at
100 g for 5 min. The pellet containing epithelial cells was washed twice and then
centrifuged at 100 g for 5 min. The final pellet containing approximately 95% of
epithelial cells and 5% stromal cells was re-suspended in 30 to 40 ml of Cell
Culture Medium (CCM) which consisted of Ham's F-10 medium containing
HEPES (20 mM), L-glutamine (10 mM), 10% H-NCS, amphotericin B (2.5
pg/ml), penicillin (100 U/ml), streptomycin (100 pg/ml), and 2.5 ml aliquots were
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dispensed into each of the 12 wells of the 24-well cell culture plate (2.3 x 10 - 4.5
3
x 10 cells per ml). After epithelial cell isolation, the remaining supernatant was
centrifuged at 400 g for 10 min. The pellet containing the stromal cells was
resuspended in 30 to 40 ml CCM, and 2.5 ml aliquots dispensed into each of the
remaining 12 wells of the 24-well cell culture plate (2.2 x 105 - 5.6 x 105 cells per
ml). Tissue culture plates were then incubated at 37°C in a humidified atmosphere
of 5% C02 : 95% air. By 24 h after plating, the epithelial cells had lost their
shapes and had become flattened to form a monolayer. Stromal cells were attached
to the plastic surface by 24 h, and by day 2 a confluent layer of cells was formed.
The medium was changed every 72 h and 2.5 ml of fresh CCM was added into
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each well. The cells were cultured for 6 days before being treated with any
compound with respect to the nature of the experiment.
Cell viability (at the time of plating and at the end of the experiments) was
determined on the base of trypan blue exclusion. This method is based on the
principle that live (viable) cells do not take up certain dyes, whereas dead (non¬
viable) cells do. Staining facilitates the visualization of cell morphology. The
method used was that according to the procedure described in the "Sigma
catalogue" which is as follows. A cell suspension was prepared in a Hanks
Balanced Salts Solution (HBSS). At the end of each experiment, cells were first
dispersed by a gentle rubbing of the cells with plastic end of a syringe. The cells
were collected and a cell suspension was prepared. Then 0.4 ml of 0.4% trypan
blue Solution was added to 0.1 ml of the cell suspension in a test tube. The
contents were vortexed and allowed to stand for 10 min. The cells were then
counted using a haemocytometer and the percentage cell viability was obtained
from the formula:
viable cells (unstained)
% cell viability = x 100
total cells (stained & unstained)
2.1.6 INTRACELLULAR CALCIUM MEASUREMENT OF
EPITHELIAL & STROMAL CELLS OF GUINEA-PIG ENDOMETRIUM
Cell isolation and preparation was as described in Section 2.1.5. Cells were then
washed twice in Ca2+-containing or a nominally Ca2+-free Krebs solution (from
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which the CaCl2 had been omitted) buffered with 20 mM HEPES pH 7.4, in order
to remove phenol red, re-suspended in the appropriate Krebs solution, and loaded
with 2 pM fura-2 acetoxymethyl ester (fura-2/AM) by incubating for 30 min at
room temperature (25°C). Cells were then washed, resuspended in appropriate
fresh Krebs solution and left to stand for a further 30 min to allow hydrolysis of
the intracellular fura-2/AM. After 30 min the cells were washed, resuspended in
appropriate fresh Krebs solution, and transferred to a quartz cuvette maintained at
37°C. The cells were continuously stirred in the cuvette. Fluorescence was
measured in a Shimadzo (type RF-5000) spectrofluorophotometer at 505 nm with
alternate excitation at 340 nm and 380 nm. The intracellular free calcium
concentration ([Ca2+]j) was then calculated using the equation of Grynkiewicz et
al. (1985):
[Ca2+]i = (lqj) x (b) x [R - Rmin]/[Rmax - R]
and the resultant experimental data of percentage change of [Ca2+]j versus agonist
dose or concentration was obtained, where R is the ratio fluorescence due to
excitation at 340 nm to that at 380 nm. Rmax and Rmjn are the maximal and
minimal fluorescence ratio of fura-2 obtained in Krebs solution containing saturated
levels of calcium with a calcium ionophore, ionomycin (10 pM), and EGTA (30
mM), respectively. The Kj value for the fura-2-Ca2+-complex was assumed to be
225 nM at 37°C (Buchan & Martin, 1991; Grynkiewicz et al., 1985), and b is the
2 . 2ratio of the 380 nm signals in Ca -free and Ca -containing Krebs solution.
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2.1.7 IDENTIFICATION OF PROSTAGLANDIN H SYNTHASE-2 IN
GUINEA-PIG ENDOMETRIUM
2.1.7.1 Preparation of Soluble Cell Extracts
Endometrial tissue from guinea-pigs on days 6 and 17 of the oestrous cycle was
prepared as described in Section 2.1.4. All tissues were chopped finely with
scissors and homogenised in a Fisons glass homogeniser in PE buffer (10 mM
potassium phosphate, pH 6.8, and 1 mM EDTA) containing 10 mM 3-[(3-
cholamidopropyl) dimethyl-ammonio]-l-propane- sulfonate (CHAPS), as described
by Hedin et al. (1987). The homogenates were sonicated three times for 10 s, and
the supernatant (which contained the soluble cell extracts) was obtained by
centrifugation for 5 min at 30000 g at 4°C. The supernatant was stored at -20°C
before electrophoretic analysis.
2.1.7.2 Determination of Total Protein in Soluble Cell Extracts
The protein assay method used to measure the total amount of protein present in
soluble cell extracts was that described by Lowry et al. (1951). This method based
on the ability of protein molecules to combine with tartrate ions and Folin's
phenolic reagent to form a complex which has a spectrophotometry absorbance at
750 nm. The optical absorbance of this complex is linearly proportional to the total
amount of protein present in solution.
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Before the assay, the following stock solutions were prepared as shown below:
solution A 1% (w/v) CuS04.5H20
solution B 2% (w/v) NaK tartrate
solution C 2% (w/v) Na2C03 dissolved in 0.1 M NaOH
solution D Folin's phenolic reagent diluted 1:1.5 with
distilled water
Bovine serum albumin (BSA) 2.5 mg/ml
Six 'standard' BSA solutions of known concentrations were made up as follows:
0, 0.1, 0.2, 0.3, 0.4 and 0.5 ml of stock BSA solution were placed into a separate
test tubes and volumes were made up to 5 ml by adding distilled water. From these
'standard' protein solutions, 0.3 ml was used in the assay. Each 0.5 ml aliquot
therefore contained 0, 15, 30, 45, 60 and 75 pg BSA, respectively.
A mixture of solution A and solution B ( solution A + B) was made by adding 0.5
ml of solution A to 0.5 ml solution B. To this mixture 50 ml of solution C was
added (denoted as solution A + B + C). Three ml of solution A + B + C was
added to each 'standard' tube and to the samples tubes containing 0.01, 0.025,
0.05 and 0.1 ml of each soluble cell extracts. The tubes were then "whirlimixed"
and allowed to incubate for 15 min at room temperature. Solution D (0.3 ml) was
added to each tube, then "whirlimixed" and incubated for further 30 min at room
temperature. Optical absorbance (OA) was then measured using a Cecil™
spectrophotometer at 750 nm. The data obtained from the 'standard' solutions were
used to plot a "Standard Graph". OA values obtained from the sample cell extracts
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were subsequently read off the "Standard Graph" to obtain corresponding protein
concentration for each sample. A new "Standard Graph" was constructed for each
new assay to minimise the possible error due to measurements and incubation
periods (Figure 2.1.7.2.1).
2.1.7.3 SDS-PAGE & Western Blotting
One dimensional SDS-PAGE was carried out according to the method which was
first described by Laemmli (1970). Western Blotting which is a technique for
transferring the separated proteins from gel matrices into membrane surface, where
the proteins are readily accessible, was performed according to the procedure
described by Hedin et al. (1987) which is a modification of the method of Towbin
et al. (1979).
(a) Chloroform/Methanol Precipitation of Protein & SDS-PAGE
To 100 pi of protein sample (containing 70 pg protein), 400 pi of methanol was
added, vortexed and centrifuged for 10 s in an eppendorf microfuge. Chloroform
(CHC13; 100 pi) was then added to the mixture, vortexed and once again
centrifuged for 10 s after which 300 pi of deionised distilled water (MQ water) was
added and the centrifugation process was repeated. The upper layer was carefully
removed, without disturbing the protein layer at the interface, and discarded. Then
300 pi of methanol was added to the protein layer, vortexed vigorously and
centrifuged for 4 min in an eppendorf microfuge. The supernatant was discarded
and the pellet left to dryness. The pellet was resuspended in 10 pi of sample
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Figure 2.1.7.2.1. Standard curve for
Lowery protein assay. Each point
indicates the mean (±SEM, n=5).
(Laemmli) buffer (see Section 2.2.7.7.1 for composition) and boiled for 10 min.
Molecular weight markers (MWM) were diluted (1:5) with Laemmli buffer and
boiled for 10 min. Samples and MWM were allowed to cool and then loaded
directly onto a 10%-15% SDS gels via a sample applicator 8/1 as follows. Lanes 1,
3, 5 and 7 were loaded with 1 pi of Molecular Weight Markers (MWM), 2 and 4
with 1 pi of day 6, and 6 and 8 with 1 pi of day 17 protein samples. Molecular
Weight Marker contained :
Content Mr Content Mr
Phosphorylase b 97400 Carbonic Anhydrase 31000
BSA 68000 Trypsin Inhibitor 20100
Ovalbumin 46000 Lysozyme 14400
Gels were then run on a Pharmacia PhastSystem (separation & control unit)
according to the manufacturers (PhastSystem Owner's Manual) instructions using
SDS-PAGE buffer, on 250 V voltage, 10 mA constant current at 15°C for 25 min.
(b) Western Blotting
A "Transfer Membrane" of equal size to SDS gels was prepared by soaking it in
methanol for 30 s, washing with MQ water, followed by soaking in Transfer
Buffer (see Section 2.2.7.7.2 for composition) at pH 8.2 until use. After the gels
were run, they were then transferred on to a "Transfer Membrane" and run on a
Pharmacia PhastSystem (separation & control unit) according to the manufacturers
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instructions (PhastSystem Owner's Manual) for 15 min. Briefly, gels were taken
out, placed on top of the cutter and cut from the second line on the gels. The
blotting paper ("Transfer Membrane") was then placed on top of the gels and three
filter papers which were soaked in Transfer Buffer were put on top of the blotting
paper, and placed in a Pharmacia PhastSystem (separation & control unit). Then
three more filter papers were added on top of the membrane. The blotting took 15
min after which it was removed from the machine. The filter papers were
discarded; the blotting paper was washed with MQ water 5 times, placed in 10 ml
of 5% BSA in Tris Buffer Saline (TBS) (see Section 2.2.7.7.3 for composition)
solution at pH 7.6, and was shaken gently for 3 h. The 5% BSA was acting as the
blocking agent in order to reduce the background by blocking the site on the
Transfer Membrane. After 3 h, this solution was discarded and replaced with
primary antibody (PGHS-2) (1:10, PGHS-2:MQ water). The "Transfer
Membrane" was incubated with primary antibody at 4°C overnight on a shaking
plate. The following morning, the primary antibody was discarded. The "Transfer
Membrane" was washed 5 times with 3 ml of TBS containing 1% Tween-20
(TTBS; 1% BSA & 0.1% Tween-20, diluted 1:10 with MQ water) for 20 s, and
then three times with 10 ml TTBS for 5 min each time. The TTBS solution was
discarded and the "Transfer Membrane" was incubated with conjugated secondary
antibody (bionated peroxidase labelled anti-rabbit antibody) (5 pi of secondary
antibody in 5 ml of TTBS + 2 drops of solution A & 2 drops of solution B from
Elite ABC Kit Vectastain) for 90 min. The "Transfer Membrane" was then
washed 3 times with 10 ml TTBS for 5 min each time, and incubated with
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peroxidase substrate kit (DAB Kit) for 10 min until colour was developed. The
"Transfer Membrane" was then washed under running tap water five times and
allowed to dry at room temperature.
In order to measure the molecular weights of the unknown protein samples, a
calibration curve was made for protein standards by calculating the relative
migration value (Rf) for each protein. This was done by measuring the migration
distance of each protein standard on the stained Transfer Membrane from the
loading point (used as a reference point). A calibration curve was constructed by
plotting the Rf value for protein standards versus the logarithms of their
corresponding molecular weights (Figure 2.1.7.3.1). The molecular weights of the
unknown proteins were measured by calculating the Rf values and locating the
point on the calibration curve which corresponds to that value.
2.1.7.4 Silver Staining
In order to show that the loaded sample (1 pi) contained protein, silver staining
was carried out. The method used was essentially similar to that described by
Heukeshoven and Dernick (1985) and Blum et al. (1987), with slight modification
(PhastSystem Owner's Manual, 1986) which involved the use of sodium
thiosulphate to decrease non-specific back ground staining. The sensitivity limit for
SDS-PAGE separation of standard proteins is 0.3 to 0.5 ng protein per band.
Alternatively, the use of glutaraldehyde with thiosulphate, alcohol and sodium
acetate buffer results in a considerable increase in sensitivity, i.e. 0.05-0.1 ng

















Figure 2.1.7.3.1. Standard curve for SDS-PAGE obtained with
proteins from the Pharmacia Molecular Weight Calibration Kit. Each
point indicates the mean (±SEM, n=4), although, in most instances
the size of the points are greater than the standard error of the mean.
Rf = the relative migration value.
The following solutions were prepared fresh on the day of use.
1. Wash solution. This consists of 10% ethanol, 5% acetic acid (HAc).
2. Developer, The contents of one formaldehyde ampoule (2% formaldehyde) were
mixed with one bottle of 2.5% sodium carbonate. The mixture was shaken
vigorously for 5 s.
2. Background reducer (pH 5 - 6). One packet of sodium thiosulphate (1.6 g) and
3.7 g Tris.HCl added to 100 ml reagent grade water.
3. Fixing Buffer. This consists of 10 ml 5% glutaraldehyde, 4 ml 1.6% sodium
thiosulphate in water, 30 ml 95% ethanol and 5% isopropanol and 0.3 g of sodium
acetate, made up to 100 ml with reagent grade water.
Silver staining was carried out in the "development unit" of a PhastSystem
according to PhastSystem Owner's Manual (1986) as indicated in Table 2.1.7.4.1.
The solutions were connected to the PhastSystem Developing Unit via tubes in
numerical order and the programme was started. First, the gels were washed by
Wash Solution for 2 and 4 min at 50°C. The gels were then exposed to Fixing
Buffer for 6 min at 50°C. The gels were then washed twice with Wash Solution for
3 and 5 min at 50°C followed by two further washings with Reagent Grade Water
for 2 min at 50°C. The gels were then exposed to Staining Solution for 6.5 min at
40°C followed by twice washing with Reagent Grade Water for 0.5 min at 30°C.
Developer Solution was then run for 4.5 min at 30°C after which the gels were
exposed to Background Reducing Solution for 2 min at 30°C. The Silver Staining
process was terminated by exposing the gels to Stop Solution for 5 min at 50°C.
When the silver staining process finished, the gel was taken out from the
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Table 2.1.7.4.1. Process of Silver Staining, as described in the text.
Step Tube Time Temp
Order Solution order (min) (°C) Remarks
1 10% ethanol,5% HAc 3 2 50 Wash solution
2 10% ethanol,5% Hac 3 4 50 Wash solution
3 "Fixing Buffer" 4 6 50 High sensitivity
fix solution
4 10% ethanol,5 % HAc 3 3 50 Wash solution
5 10% ethanol,5% HAc 3 5 50 Wash solution
6 Reagent grade water 5 2 50 Wash solution
7 Reagent grade water 5 2 50 Wash solution
8 0.4% silver nitrate 6 6.5 40 Staining
solution
9 Reagent grade water 5 0.5 30 Wash solution
10 Reagent grade water 5 0.5 30 Wash solution
11 Developer 7 0.5 30 Developing
solution
12 Developer 7 4.0 30 Developing
solution
13 Background reducer 8 2.0 30 Background
reducing
solution
14 5-10% glycerol 9 5 50 Stop solution
PhastSystem and left to dry at room temperature. The result indicated that the
loaded amounts of samples contained proteins (Figure 2.1.7.3.2).
2.1.8 RADIOIMMUNOASSAY (RIA) OF PROSTAGLANDINS
2.1.8.1 Assay Procedure
Radioimmunoassay which was developed in the 1960s is a very powerful method
for the measurement of PGs. The amount of [ H]PG (tracer) used in each assay
was sufficient to obtain counts of about 15000 - 20000 per tube when counted in a
scintillation counter for 4 min ([3H]PGF2a and [3H]6-ket0-PGFio) or for 10 min
([3H]PGE2). Tracer solutions were prepared by evaporating off the carrier solvent
(i.e. methanol or acetonitrile : water) in a stream of air and then redissolving the
residue in an appropriate quantity of diluent (see Section 2.2.7.6 for composition),
so that a 50 pi aliquot of this solution provided the required number of counts.
The antiserum dilution chosen was that which gave between 60% - 80% binding of
tracer PG in the absence of non-radioactive standard PG (i.e. zero standard). An
aliquot was taken from a 1:100 stock solution of the antiserum in the appropriate
diluent in order to prepare the final dilution required.
Standard PG solutions were made up in the appropriate diluent from a stock
solution of 1 pg/ml in methanol; 200 pi of this solution were blown dry and
redissolved in 20 ml of an appropriate diluent to give a final PG concentration of
10 ng/ml. Series of dilutions (nine for PGE2 and 6-keto-PGFia and ten for PGF2a
assays) were then made from this PG concentration (i.e. 10 ng/ml) so that standard
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PG solutions ranging from 0.02 - 5.12 ng/ml for PGE2 and 6-keto-PGFia
standards, and ranging from 0.005 - 2.50 ng/ml for PGF2a were obtained. The
standard solutions were then kept at -20°C. From each of these standard solutions,
0.5 ml was dispensed in triplicate into 3 ml plastic tubes, as shown in Table
2.1.8.1.1. Counting standards (tubes 5 - 8) and non-specific binding standards
(tubes 1-4) were also prepared and dispensed in quadruplicate as indicated in
Table 2.1.8.1.1. The four counting standards when averaged gave an estimate of
the number of radioactive counts within each tube. The non-specific binding
standards estimate [ H]PG binding to sites other than the specific PG binding sites,
which include the plastic tubes, non-specific sites on the antiserum, and to other
compounds used in the assay. The non-specific binding was always less than 10%
of total binding in every assay. The last four tubes of each assay contained 500 pi
of the appropriate diluent in duplicate (zero standards), and 500 pi of the
appropriate PG (0.08 ng/ml for PGF2a or 0.32 ng/ml for PGE2 and 6-keto-PGFia)
standard solution in duplicate so that the inter-assay coefficient of variation could
be calculated.
The assay procedure is outlined in the flow diagram (Figure 2.1.8.1.1).
Appropriate volumes from the extracted samples in ethyl acetate from the
superperfusion or homogenisation experiments were dispensed in duplicate into
plastic tubes and then dried under a stream of air at 45°C; 0.5 ml diluent was then
added to each tube so that the volumes in the standard and sample-containing tubes
were the same. Samples obtained from the mesenteric vascular perfusion, and from
tissue and cell culture were assayed directly without extraction; however an
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Table 2.1.8.1.1 The concentration and volumes of standard solutions of PGF2a,








1 -4 10 10 500
5 -8 - - -
9 -11 0.005 0.02 500
12 - 14 0.01 0.04 500
15 -17 0.02 0.08 500
18-20 0.04 0.16 500
21 - 23 0.08 0.32 500
24-26 0.16 0.64 500
27-29 0.32 0.128 500
30 - 31 0.64 2.56 500
32 - 35 1.28 5.12 500
36-38 2.56 " 500
Figure 2.1.8.1.1 The procedure used for the measurement of prostaglandins by
radioimmunoassay.
Superfusion & Homoeenate Samples Culture Medium & Perfusion Samples
Dispense an appropriate volume
of each sample into the tubes
Thaw and dispense an appropriate
volume of each sample into the tubes
Evaporate off ethyl acetate in a
stream of air at 45°C
Sufficient amount of the appropriate diluent was added to make up the volumes
equal to the volumes of the standard prostaglandin solution
50 pi of appropriate tracer was added to each tube
50 pi of appropriate diluent antibody was added to each
tube except for the counting standards
Tubes were "whirlimixed" and incubated at room temperature for
lh (PGF2a assay) or 2h (PGE2 and 6-keto-PGFia assays)
50 pi of appropriate diluent NRS and 50 pi DARS were
added to each tube except the counting standards
Tubes were "whirlimixed" and incubated at 4°C overnight
All tubes (except counting standards) were centrifuged
at 13000 g for 30 min at 4°C
Supernatant was discarded
2.5 ml of scintillation fliud was added to each
tube and the tubes were capped
Tubes were whirlimixed and counted in a liquid scintillation counter
for 4 min (PGF2a and 6-keto-PGFia) or 10 min (PGE2)
appropriate amount of diluent was added to each tube so that the volumes in the
standard and sample-containing tubes were the same. When tissue and cell culture
samples were assayed, 100 pi of Medium 199 or Ham's F-10 medium were added
into all tubes containing the standards as well as the zero standard tubes to
minimise the effect of the medium on the PG assay.
Tubes containing the samples and standards were then treated in the same way
throughout the assay. To each tube, 50 pi of the appropriate tracer and antiserum
were added. Tubes were then "whirlimixed" and incubated at room temperature
for 1 h (in case of the PGF2« assay) or 2 h (in the case of the PGE2 and 6-keto-
PGF ia assays). Normal rabbit serum (NRS, 50 pi, 1.14-0 dilution for 6-keto-PGFia
and 1:100 dilutions for both PGF2a and PGE2) and donkey anti-rabbit serum
(DARS; 50 pi; 1:10 dilution for all PGs) were then added to each tube and the
tubes were once again "whirlimixed". NRS was added to ensure that, at dilutions
of the antisera used, there was sufficient gamma-globulin present for adequate
precipitation. DARS was added to separate free PG from antibody-bound PG. The
tubes were then incubated at 4°C overnight. The following day, the tubes were
centrifuged at 13000 g for 30 min at 4°C. The supernatant was poured off and
discarded. 2.5 ml of scintillation fluid were added to each tube (see Section
2.2.7.6.iv). Tubes were then capped and "whirlimixed" to resuspend the pellet,
after which they were counted for 4 min for the PGF2a and 6-keto-PGFia assays or
for 10 min for the PGE2 assay using a Packard Liquid Scintillation Counter.
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The % tracer bound was calculated from the formula:
% bound = (counts in tube x 100)/(average standard counts)
where the "average standard counts" is the average of the counts from tubes 5 - 8
(the counting standards). Data from the counter were passed directly into an IBM -
XT personal computer programmed with the Packard Data Acquisition and
Analysis system (PC-DAAS). The Spline Curve-Fit programme was used which
processes the standards according to a Modified Smooth Spline Algorithm. This
programme subtracted the amount of non-specific binding from all standards then
calculated the co-ordinates for the curve of best fit. Using this standard curve, the
"i"
computer calculated the amount of PG in each sample tube.
The intra-assay coefficient of variation was calculated using the formula:
Intra-assay coefficient of variation =
(standard deviation of sample duplicate x 100) / (mean value of sample
duplicate)
This coefficient was calculated by the computer for each unknown sample assayed
in duplicate. If the coefficient for the sample was greater than 12%, the sample
was re-assayed.
The inter-assay coefficient of variation was calculated using the values obtained
from tubes containing a known standard amount of the appropriate PG (0.32 ng/ml
for PGE2, and 6-keto-PGFia; 0.08 ng/ml for PGF2a), which were included at the
end of the assay, according to the formula below:
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Inter-assay coefficient of variation =
(standard deviation of known PG standard x 100) / (mean of known PG standard)
The inter-assay coefficients of variation values obtained for the PGF2a, PGE2, and
6-keto-PGFia were 6.1, 4.2 and 5.8, respectively.
2.1.8.2 Determination of Cross-Reactivities for PGs and Their Metabolites
Cross-reactivities for each of the prostaglandin antiserum have been determined
previously in this laboratory (Dighe et al., 1975; Poyser & Scott, 1980; Lytton &
Poyser, 1982). The method used was such that standard curves for PGs and their
different PG metabolites were set up. The concentration of the different PG or PG
metabolite which produced a 50% fall in binding from the binding produced by a
zero standard solution of the PG to which the antiserum was raised, was obtained
and the percentage cross -reactivity was calculated using the formula:
% cross-reactivity =
concentration of PG (to which the antisera was raised)
giving a 50% fall in zero standard binding
x 100
concentration of a different PG or PG metabolite
giving a 50% fall in zero standard binding
Cross-reactivities of the antisera used with various prostanoids and their
metabolites for PGF2a, PGE2 and 6-keto-PGFia as determined previously (Dighe
et al., 1975; Poyser and Scott, 1980; Lytton and Poyser, 1982) are shown in
Tables 2.1.8.2.1 to 2.1.8.2.3.
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Table 2.1.8.2.1. Cross-reactivities with various prostanoids and their metabolites
for the PGF2a antiserum (rabbit 5, 6th bleed), measured at 30% binding of tracer.















Table 2.1.8.2.2. Cross-reactivities with various prostanoids and their metabolites
for the PGE2 antiserum (rabbit R5, 6th bleed), measured at 30% binding of tracer.















Table 2.1.8.2.3. Cross-reactivities with various prostanoids and their metabolites
for the 6-keto-PGFia antiserum (rabbit NP1, 6th bleed), measured at 30% binding
of tracer.















2.1.8.3 Standard Curves for Prostaglandin Assays
The standard curves obtained for PGF2a, PGE^ and 6-keto-PGFia are the results of
averaging six consecutive assays for each PG. The values indicate the means ±
s.e.m for each assay. The standard curves are shown in Figures 2.1.8.3.1 to
2.1.8.3.3.
2.2 MATERIALS
The sources of the materials are as follows:
2.2.1 Solvents
Absolute ethanol - J. Boroughs., London, U.K.
Acetone - Rathburn Chemicals Ltd, Walkerburn, U.K.
Acetonitrile - Rathburn Chemicals Ltd, U.K.
2-Ethoxyethanol (reagent grade) Fisons Scientific Equipment, Loughborough,
U.K.
Ethyl acetate* - Rathburn Chemicals Ltd, Walkerburn, U.K.
Methanol - Rathburn Chemicals Ltd, Walkerburn, U.K.
Toluene (reagent grade) - Rathburn Chemicals Ltd, Walkerburn, U.K.
Chloroform (CHC13)
* Redistilled prior to use
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Figure 2.1.8.3.1. Standard curve for PGF2(X
radioimmunoassay. The data indicate the mean (±SEM, n=6)
although, in most instances, the size of the point is greater than
the standard error of the mean, n.s.b. = Non-specific binding
60 -i
ng PGE 2 / tube
Figure 2.1.8.3.2. Standard curve for PGE2
radioimmunoassay. The data indicate the mean (±SEM, n=6)
although, in most instances, the size of the point is greater
than the standard error of the mean, n.s.b. = Non-specific
binding
ng 6-keto-PGFia /tube
Figure 2.1.8.3.3. Standard curve for 6-keto-PGFla
radioimmunoassay. The data indicate the mean (±SEM, n=6)
although, in most instances, the size of the point is greater than the
standard error of the mean, n.s.b. = Non-specific binding
2.2.2 Radioactive Compounds
[5,6,8,9,11,12,14,15(n)-3H] Prostaglandin F2a (Specific Activity 202 - 208
Ci/mmol).
[5,6,8,ll,12,14,15(n)-3H] Prostaglandin E2 (Specific Activity 185 - 200
Ci/mmol).
6-keto-[5,8,9,ll,12,14,15(n)-3H] Prostaglandin Fia (Specific Activity 170 - 180
Ci/mmol).
All [3H] PG stock solutions were diluted to 5 pCi/ml and stored at -20°C before
being used for radioimmunoassay. [3H]PGF2a and [3H]PGE2 were diluted in
methanol and [3H]6-keto-PGFiawas diluted in acetonitrile:water (9:1) for storage.
All radioactive compounds were supplied by Amersham International Ltd.,
Cardiff, U.K.
2.2.3 Chemicals
A23187 ( Calcium ionophore) - Calbiochem-Behring Corp., Nottingham, U.K.
Acetonitrile - Sigma Chemicals Co., Poole, Dorset, U.K.
Actinomycin D - Sigma Chemicals Co., Poole, Dorset, U.K.
Amphotericin B Solution (250 pg/ml) - Sigma Chemicals Co., Poole, Dorset,
U.K.
Aristolochic acid - Sigma Chemicals Co., Poole, Dorset, U.K.
Berberine chloride - Sigma Chemicals Co., Poole, Dorset, U.K.
Bovine serum albumin (BSA) - Sigma Chemicals Co., Poole, Dorset, U.K.
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Caffeine - Sigma Chemicals Co., Poole, Dorset, U.K.
Calcium chloride - B.D.H. Chemicals Ltd, U.K.
(CHAPS) [3-[(3-cholamidopropyl)-dimethyl-ammonio]-l-propane-sulfonate]
Sigma Chemicals Co., Poole, Dorset, U.K.
Cycloheximide - Sigma Chemicals Co., Poole, Dorset, U.K.
Dantrolene sodium salt - Sigma Chemicals Co., Poole, Dorset, U.K.
D-Glucose - B.D.H. Chemicals Ltd, U.K.
Dithiothreitol (DTT) - Sigma Chemicals Co., Poole, Dorset, U.K.
DMSO (dimethyl sulfoxide) - Sigma Chemicals Co., Poole, Dorset, U.K.
EDTA (diaminoethanetetra-acetic acid)) - Fison's Scientific Equipment, Leics.,
U.K.
EGTA (Ethyleneglycol-bis-(P-aminoethyl ether)N,N,N',N'-tetraacetic acid) -
Sigma Chemicals Co., Poole, Dorset, U.K.
Elite ABC Kit VectastainR - Vector Laboratories, Peterborough, U.K.
Forskolin [(7P-acetoxy-la,6P,9oc-trihydroxy-8,13-epoxy-labd-14-en-l l-one); from
Coleus forskohlii] - Sigma Chemicals Co., Poole, Dorset, U.K.
Fura-2 acetoxymethyl ester (Fura-2/AM) - Sigma Chemicals Co., Poole, Dorset,
U.K.
Gelatine - B.D.H. Chemicals Ltd, U.K.
Glycerol - Sigma Chemicals Co., Poole, Dorset, U.K.
Hank's Balanced Salt Solution (HBSS) - Sigma Chemicals Co., Poole, Dorset,
U.K.
Hydrochloric acid (HC1) - B.D.H. Chemicals Ltd, U.K.
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Ionomycin calcium salt (from Streptomyces conglobatus) - Sigma Chemicals Co.,
Poole, Dorset, U.K.
Indomethacin - Merck, Sharpe & Dohme Ltd, Hoddesdon, Herts., U.K.
Magnesium Sulphate - Sigma Chemicals Co., Poole, Dorset, U.K.
Medium 199 (plus Earle's salts & 2.20 g/1 sodium bicarbonate) - Flow
Laboratories, Irvine, U.K.
Melittin - Sigma Chemicals Co., Poole, Dorset, U.K.
2-Mercaptoethanol - Sigma Chemicals Co., Poole, Dorset, U.K.
Molecular weight marker - Sigma Chemicals Co., Poole, Dorset, U.K.
NS-398 (N-(2-cyclohexyloxy-4-nitrophenyl)methanesulphonamide - A Gift from
Taisho Pharmaceutical Co., Ltd. Tokyo, JAPAN
Nutrient mixture Ham's F-10 - Sigma Chemicals Co., Poole, Dorset, U.K.
Oestradiol-17P - Sigma Chemicals Co., Poole, Dorset, U.K.
Penicillin G potassium salt - ICN Biochemicals Inc. Aurora, Ohio, USA.
Peroxidase labelled anti-rabbit antibody - Amersham International Ltd., Cardiff,
U.K.
Peroxidase substrate kit (DAB SK-4100) - Vector Laboratories, Peterborough,
U.K.
PGH Synthase 2 Polyclonal Antiserum - Cascade Biochem Ltd., Berkshire, U.K.
Phospholipase A2 (from Naja naja venom) - Sigma Chemicals Co., Poole, Dorset,
U.K.
Platelet activating factor (PAF) - Sigma Chemicals Co., Poole, Dorset, U.K.
Potassium chloride - B.D.H. Chemicals Ltd, U.K.
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Potassium phosphate - Sigma Chemicals Co., Poole, Dorset, U.K.
PPO (2,5-diphenyloxazole) - B.D.H. Chemicals Ltd, U.K.
Progesterone - Sigma Chemicals Co., Poole, Dorset, U.K.
Prostaglandin F2a - Sigma Chemicals Co., Poole, Dorset, U.K.
Prostaglandin E2 - Sigma Chemicals Co., Poole, Dorset, U.K.
6-keto-Prostaglandin Fia - Sigma Chemicals Co., Poole, Dorset, U.K.
Puromycin - Sigma Chemicals Co., Poole, Dorset, U.K.
Ruthenium red (Ruthenium oxychloride ammoniated) - Sigma Chemicals Co.,
Poole, Dorset, U.K.
Ryanodine - Calbiochem-Novabiochem, Nottingham, U.K.
Sodium azide - Hopkin and Williams Ltd, Essex, U.K.
Sodium chloride - Fison's Scientific Equipment, Leics., U.K.
Sodium dihydrogen orthophosphate - B.D.H. Chemicals Ltd, U.K.
Sodium dodecyl sulphate (SDS) - Sigma Chemical Ltd, U.K.
Sodium hydrogen carbonate - B.D.H. Chemicals Ltd, U.K.
Sodium hydroxide - B.D.H. Chemicals Ltd, U.K.
Streptomycin sulphate - Sigma Chemicals Co., Poole, Dorset, U.K.
Sucrose - B.D.H. Chemicals Ltd, U.K.
Thapsigargin - Sigma Chemicals Co., Poole, Dorset, U.K.
Theophylline - Sigma Chemicals Co., Poole, Dorset, U.K.
TMB-8 (3,4,5-trimethoxybenzoic acid,8-(dimethylamino)octyl ester hydrochloride)
- Sigma Chemicals Co., Poole, Dorset, U.K.
Trifluoperazine dihydrochloride - Sigma Chemicals Co., Poole, Dorset, U.K.
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Tris (hydroxymethyl)methylamine, (Tris) - B.D.H. Chemicals Ltd, U.K.
Tris HC1 - Sigma Chemicals Co., Poole, Dorset, U.K.
Tryptan blue solution (0.4%) - Sigma Chemicals Co., Poole, Dorset, U.K.
Tween-20 - Sigma Chemicals Co., Poole, Dorset, U.K.
W-7 (N-(6-aminohexyl)-3-chloro-l-naphthalenesulfonamide hydrochloride) -
Sigma Chemicals Co., Poole, Dorset, U.K.
2.2.4 Antibodies
Donkey anti-rabbit serum (DARS) & normal rabbit serum (NRS) - Scottish
Antibody Production Unit, Carluke, Scotland, U.K.
PGF2« antiserum, PGE2 antiserum, and 6-keto-PGFia antiserum were all raised in
this laboratory in rabbits (Dighe et al., 1975; Dighe et al., 1978a; Dighe et al.,
1978b).
Stock solutions of antisera and NRS were stored at -20°C. Stock solutions were
diluted with the appropriate diluent and stored at 4°C before use.
2.2.5 Gases
95% air : 5% C02
95% 02 : 5% C02
All gases were supplied by British Oxygen Co. Ltd., Guilford, U.K.
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2.2.6 Other Materials
Petri dishes (vented, 5 cm diameter) - Sterilin Ltd., Teddington, U.K.
Cell culture plates (24-well) - Nunc A/S, Kamstrupvej 90, K-D-4000 Roskilde,
Denmark.
Plastic tubes (3 ml) and caps - Sarsted Ltd., Leicester, U.K.
Micropipette tips - L.I.P. Ltd., Shipley, U.K.
Eppendorf microfuge tubes - Scot Lab. Ltd., Glasgow, Scotland, U.K.
Sample Applicator 8/1 PhastGelR - Pharmacia, Uppsala, Sweden
10%-15% SDS Gels PhastGelR - Pharmacia, Uppsala, Sweden
Filter Paper (50 x 50 mm) PhastGelR - Pharmacia, Uppsala, Sweden
SDS Buffer Strips PhastGel - Pharmacia, Uppsala, Sweden
Immobilon-P™ "Transfer Membrane" (Pore size 0.45 pM) - Pharmacia, Uppsala,
Sweden
2.2.7 Composition of Solutions




10% KH2P04 1.6 ml
10% KC1 3.5 ml
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10% MgS04.7H20 1.4 ml
1 M CaCl2 2.5 ml
* CaCl2 was omitted from nominally calcium-free Krebs solution





10% kh2po4 1.4 ml
10% KC1 4.2 ml
1 M CaCl2 2.5 ml
2.2.7.3 Modified Medium 199 (With Earle's Salts & 2.20 g/1 NaHC03),
(M199)
The medium used for tissue culture in this thesis was modified Medium 199
including Earle's balanced salts solution plus 2.20 g/1 sodium bicarbonate (EBSS)
which was developed by Morgan et al. (1950) by the addition of a synthetic
mixture of inorganic salts supplemented with glucose. The functions of EBSS in
modified Ml99 are:
(i) Sodium bicarbonate (2.20 g/1) present to maintain pH buffer.
(ii) to maintain osmotic pressure.
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(iii) to provide energy by the presence of glucose.
Medium 199 was further supplemented with antibiotics [penicillin (100 U/ml),
streptomycin (100 pg/ml)], and amphotericin B (2.5 pg/ml) to prevent bacterial
and fungal growth as well as L-glutamine (1.7 pM), an essential factor for stromal
viability and good epithelial preservation (Kaufman et al., 1980). The constituents
of M199 are shown in Table 2.2.7.3.
2.2.7.4. Nutrient Mixture Ham's F-10
Cells were cultured in Ham's F-10 medium which was developed from nutrient
mixture F-7 by Ham for the growth of diploid Chinese hamster ovary (strain CHD-
3), strain CHL-1 Chinese hamster lung cells and strain S3-9-IV human Hela cell
line (Ham, 1963). He reported that nutrient F-10 supplemented by fetal calf serum
concentration to 10% or 15% could be used to obtain a good growth rate of the
above mentioned cell lines as well as human diploid cell line and human white
blood cells. Medium Ham's F-10 was not commercially available until late 1960's
(Morton, 1970). The sodium bicarbonate was omitted from the original
formulation and buffered with HEPES to maintain pH. The constituents of the
medium Ham's F-10 are shown in Table 2.2.7.4.
2.2.7.5 Diluent Solution for PG Radioimmunoassays
(i) Diluent Solution for PGF2a Radioimmunoassay
0.05 M Tris buffer pH 8.0
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Table 2.2.7.3 Composition of Medium 199 modified with Earle's salts and 2.20
g/1 sodium bicarbonate without glutamine.
Storage Temperature 2 - 8°C
Ingredient mg/litre Ingredient mg/litre
L-Alanine 25.00 1-Inositol 0.05
L-Arginine.HCl 70.00 Menadione, NaHSO3.3H20 0.019
L-Aspartic acid 30.00 Nicotinamide 0.025
L-Cysteine. HC1. H20 0.11 p-Aminobenzoic acid 0.05
L-Cystine.2HCl 26.00 Pyridoxine.HCl 0.05
L-Glutamic acid 75.00 Riboflavin 0.01
L-Glutamine 100.00 Thiamine. HC1 0.01
Glutathione 0.05 DL-aTocopherolphosphate
disodium salt 0.01
Glycine 50.00 CaCl2 (anhydrous) 200.00
LJlistidine. HC1. H20 21.88 Fe(NO3)3.9H20 0.72
L-Hydroxyproline 10.00 KCI 400.00
L-Isoleucine 20.00 MgS04 (anhydrous) 97.70
L-Leucine 60.00 Vitamin A acetate 0.14
L-Lysine. HC1 70.00 NaHC03
2200.00
L-Methionine 15.00 NaH2P04.H20 140.00
L-Phenyialanine 25.00 Adenine sulphate 10.00
L-Proline 40.00 Adenylic acid 0.20
L-Serine 25.00 ATP, disodium salt 1.00
L-Threonine 30.00 Cholesterol 0.20
L-Tryptophan 10.00 2-Deoxyribose 0.50
L-Tryosine disodium salt.2H20 57.66 D-Glucose
1000.00
L-Valine 25.00 Guanine. HC1 0.30
Ascorbic acid 0.05 Hypoxanthine, Na 0.354
Biotin 0.01 D-Ribose 0.50
Calciferol 0.10 Sodium acetate (anhydrous) 50.00
D-Ca, pantothenate 0.01 Phenol red sodium salt 10.00
Choline chloride 0.50 Thymine 0.30
Folic acid 0.01 Tween 80 5.00
NaCl 6800.00 Uracil 0.30
Xanthine, Na 0.34
Table 2.2.7.4. Composition of Nutrient mixture Ham's F-10 Medium. This
medium contains ingredients at optimum concentrations for supporting the clonal
growth of Chinese Hamster Ovary (CHO) cells. It is now a popular medium for
the growth of fastidious cell lines.
Storage Temperature 20.8°C
Ingredient mg/litre Ingredient mg/litre
L-Alanine 9.00 L-Threonine 3.57
L-Arginine.HCl 211.00 L-Tryptophan 0.60
L-Asparagine. H20 15.00 L-Tyrosine disodium salt.2H20 2.61
L-Aspartic acid 13.30 L-Valine 3.50
L-Cysteine.HCl 31.50 Biotin 0.024
L-Glutamic acid 14.70 D-Ca pantothenate 0.715
L?Glutamine 146.20 Choline chloride 0.698
Glycine 7.50 Folic acid 1.32
L-Histidine.HC1. H20 23.00 1-Inositol 0.541
L-Isoleucine 2.60 Nicotinamide 0.615
L-Leucine 13.00 Pyridoxine.HCl 0.206
L-Lysine.HCl 29.00 Riboflavin 0.376
L-Methionine 4.48 Thiamine. HC1 1.00
L-Phenylalanine 5.00 Vitamin B12 1.36
L-Proline 11.50 CaCl2 (anhydrous) 33.30
L-Serine 10.50 CuS04 (anhydrous) 0.0016
FeS04.7H20 0.834 ZnS04.7H20 0.0288
KC1 285.00 D-Glucose 1100.00
kh2po4 83.00 Hypoxanthine, Na 4.74
MgS04 (anhydrous) 74.60 Lipoic acid 0.20
NaCl 7400.00 Phenol red sodium salt 1.20
Na2HP04 (anhydrous) 153.70 Sodium pyruvate 110.00
NaHC03 1200.00 Thymidine 0.73
0.1 g/1 Sodium azide ;
1.0 g/1 Gelatine
"Tris diluent pH 8"
(ii) Diluent Solution for PGE2 Radioinununoassay
0.05 M Phosphate (6.9 g/1 Na2HP04 (anhydrous) + 1.7 g NaH2P04.2H20/litre)
buffer pH 7.5
0.1 g/1 Sodium azide
1.0 g/1 Gelatine
"Phosphate diluent pH 7.5"
(iii) Diluent Solution for 6-keto-PGFia Radioimmunoassay
0.05 M Tris buffer pH 6.8.
0.1 g/1 Sodium azide
1.0 g/1 gelatine
"Tris diluent pH 6.8"
All diluents were stored at 4°C.
(iv) Scintillation Fluid for PG Radioimmunoassay
1.5 litre Toluene
0.9 litre 2-Ethoxyethanol
10.5 g 2,5-Diphenoxyloxazole (PPO)
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2.2.7.6 Solutions for SDS-PAGE and Western Blotting
2.2.7.6.1 Laemmli or Sample Buffer
62.5 mM Tris-HCl, pH 6.8
2% SDS














1.5 g Tris HC1
7.2 g glycine
100 ml methanol
400 ml MQ water
2.2.7.6.3 Tris Buffer Saline (TBS pH: 7.6)
20 mM Tris-HCl 4.84 g Tris
500 mM NaCl 58.48 g NaCl
Dissolved in 1.5 litre deionized H20, pH was adjusted to 7.5 with HC1, then
volume was adjusted to 2 litre with deionized H20.
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2.3 STATISTICAL PROCEDURES
It is obvious that the results of an experiment should be displayed in a form which
makes them readily comprehensible to the reader. This can be done by presenting
the results in terms of descriptive statistics which summarise certain aspects of the
results. Two types of descriptive statistics are commonly used- one which gives a
measure of central tendency (known as "the most typical value") and one which
gives a measure of dispersion (the variability or spread) for a set of results.
The arithmetic mean most commonly used to measure "the most typical value". It
is the average of a set of scores obtained by adding all scores together and dividing
by the number of scores. Its advantage in theoretical terms is that it gives a better
estimate of the population from which one sample of scores is drawn than the
median, which is in turn better than the mode (Robson, 1977). The mean of a
sample tends to differ less from the mean of the population than the median of the
sample differs from the median of the population. This is because the mean extracts
most information from the sample. One proof of this is that the mean would be
altered by the alteration of any single one of the individual scores, i.e. the mean is
dependent on the values of each of the scores in the sample. In contrast, both the
median and the mode may be unaffected by changing the value of a number of
scores or, on the other hand, they may be greatly affected by changing the value of
a small number of the scores. Again in contrast to the mean, neither the median
nor the mode is affected by extreme scores, either vary high or very low.
If the hypothesis that all samples in each experiments were drawn from the same
population is true (for example treatment does not affect PG output), the within-
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groups variance and between groups variance are both estimates of the same
population variance and so should be about equal (Glantz, 1992). Therefore, F-test
was carried out as follow:
population variance estimated from sample mean
F test =
population variance estimated as average
of the sample variance
Since both the numerator and the denominator are estimates of the same population
variance, F should be about 1. For the random samples the value of F is equal to
1 (Glantz, 1992). If F is a big number, the variability between the samples is larger
than the expected from the variability within the samples, so the hypothesis that all
the samples were from the same population is rejected.
When there were more than two samples, the analysis of variance which is a multi-
dimential "t" test was used. It allows to conclude only that the data are not
consistent with the hypothesis that all the samples were drawn from a single
population (Steel & Torrie, 1980). However, it does not help to decide which one
or ones are most likely to differ from the others. To answer these questions a
procedure that is specifically designed to test for differences in two groups: the "t"
test or students "t" test was employed since standard error of the mean (s.e.m)
quantifies the uncertainty of the estimate of the true population mean based on a
sample. As the sample size increases, the uncertainty in the estimate of the
difference between the test (treated) and the control (untreated) samples decreases
relative to the difference of the means. To formalise this logic, "t" test is used
which is calculated as:
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difference in sample means
"t" test =
standard error of difference
of sample means
When this ratio is small, it was concluded that the data are compatible with the
hypothesis that both samples were drawn from a single population and assesses that
the treatment produced no effect.
"t" test is parametirc test since it is based on mean values and assumes that normal
distribution is valid. Parametric methods generally provide more information about
the treatment being studied and are more likely to detect a real treatment effect
when the underlying population is normally distributed (Glantz, 1992).
This logic, while differing in emphasis from that used to develop the analysis of
variance, is essentially the same (Glantz, 1992). In both cases, the relative
magnitude of the differences in the sample means with the amount of variability
that would be expected from looking within the samples were compared. To
calculate "t" ratio it was necessary to determine (a) the difference of sample means
and (b) the standard error of this difference.
The specific value of "t" one obtains from any two samples depends not only on
whether or not there actually is a difference in the means of the populations from
which the samples were drawn but also on which specific individuals happened to
be selected for the samples. Thus, as for F, there will be a range of possible values
that "t" can take, even when both samples are drawn from the same population.
Since the means computed from the two samples will generally be close to the
means of the population from which they were drawn, the value of "t" will tend to
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be small when the two samples are drawn from the same population. Therefore, as
for F, if the resulting value of "t" is "big" then the treatment had actually affected
the samples. The critical value of "t" like F, have been tabulated and depends not
only on the level of confidence with which one rejects the hypothesis of no
difference- the P value- but also on the sample size. As with the F distribution, this
depends on sample size which enters the table as the degree of freedom, which is
equal to 2(n-l) for this "t" test, where n is the size of each sample. As the sample
size increases, the value of "t" needed to reject the hypothesis of no difference
decreases. The sampler the samples, the greater the difference demand by the "t"
test; otherwise, since big differences occur more frequently as sample get smaller,
the probability of getting a significant result would increase as the sample size
decreases. With the "t" test, then, a big difference is needed to establish significant
if the samples are small. As the sample size increases, smaller and smaller
differences become significant. For instance, to be significant at the 5% level, the
difference between samples of 4 would need to exceed 3.2 x SE-diff. But with
samples of 12. a difference of 2.2 x SE-diff would be significant at this level.
All forms of analysis of variance, including the "t" test are based on the
assumptions that the observations are drawn from normally distributed population
in which the variance are the same even if the treatments changes the mean
responses. These assumptions are often satisfied well enough to make analysis of
variance an extremely useful statistical procedure.
The "t" distribution shares with normal distribution the properties of being
symmetric and of extending from negative to positive infinity. However, it differs
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from the normal in that it assumes different shapes depending on the number of
degrees of freedom. By degrees of freedom is meant the quantity n-1, where n is
the sample size upon which a variance has been based. It will be remembered that
this quantity n-1 is the divisor in obtaining an unbiased estimate of the variance
from a sum of squares (Skol & Rohlf, 1973).
As it was mentioned earlier, the analysis of although the analysis of variance
allows to conclude that the data are not consistent with the hypothesis that all the
samples were drawn from a single population, it does not help to decide which one
or ones are most likely to differ from the others. An approach to the problem of
comparing each treatment mean with every other treatment mean known as
"Duncan's multiple range test" was used to test for a set of significant differences
of increasing size, the size to depend upon the closeness of the mean after ranking,
with the smallest value for adjacent mean and the largest value for extremes (Steel
& Torrie, 1980). In this test the confidence levels are not appropriate; the notion of
confidence is replaced by that of "protection levels" against finding false
significant difference at various stages of testing. It uses a variable level depending
on the number of means involved at any stage. The idea is that as the number of
means under test increases, the smaller is the probability that they will all be alike.
In summary, since interest was on the mean (as it gives more information about a
set of data) and the data was a continuos variable (scales) the Students "t" test was
uesd, and where "t" test was not appropriate Duncan's multiple range test was used





This section deals, in full details, with all the results obtained from the experiments
carried out for this thesis.
3.1 INVESTIGATION INTO THE ROLE OF INTRACELLULAR
CALCIUM IN THE CONTROL OF PROSTAGLANDIN SYNTHESIS BY
AND RELEASE FROM THE GUINEA-PIG UTERUS.
3.1.1 The Effects of Caffeine and Theophylline on Prostaglandin Output
From The Day 7 and Day 15 Guinea-Pig Uterus Superfused In Vitro.
Introduction;
Prostaglandins (PG) produced by the uterus are involved in several reproductive
processes. In many non-primate mammalian species, increased PGF2a production
by the endometrium is responsible for terminating the life-span of the corpus
luteum and thereby regulating the length of an oestrous cycle or pseudopregnancy
and, in some species, a pregnancy (see, Poyser, 1981). It has been shown that, in
the guinea-pig, uterine prostaglandin synthesis is not mediated by cAMP (Poyser,
1987a), increased inositol turnover (Ning & Poyser, 1984) or a toxin-sensitive G-
protein (Leckie & Poyser, 1990a, b). However, it has been postulated that the
release of calcium from an internal store is involved in increased uterine
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prostaglandin production (Riley & Poyser, 1987b). Hence, this set of experiments
was designed to investigate whether caffeine (a releaser of calcium from an internal
store) would affect PG output from the day 7 and day 15 guinea-pig uterus
superfused in vitro.
Methods:
Tissue preparation and the experimental procedures were as described in Section
2.2.1. Briefly, guinea-pigs were killed (by stunning followed by exsanguination)
on days 7 or 15 of the cycle. Each uterus was removed and separated into its two
uterine horns. The uterine horns were blotted dry and weighed. Each uterine horn
was opened by cutting longitudinally down the anti-mesometrial side and suspended
in an organ bath with one end attached to an isotonic lever. Each uterine horn was
superfused at 5 ml/min with Krebs solution (see Section 2.2.7.1 for composition)
at 37°C, as described by Poyser and Brydon (1983), and was superfused initially
for an equilibrium period of 60 min. Samples of superfusate were then collected
for 10 min periods over the next 80 min (i.e 8 samples per uterine horn). After
collection, the pH of each sample was lowered to 4.0 with 1 M HC1 and the
prostaglandins were extracted by shaking twice with 50 ml ethyl acetate, according
to the method described by Poyser (1972). The two ethyl acetate fractions were
combined and evaporated to dryness on a rotary evaporator. Each dried extract was
redissolved in 10 ml ethyl acetate and stored at -20°C until assayed.
After the initial settling period of 60 min, uterine horns in each experiment were
treated as described below. In experiment 1, caffeine (10 mM) was present in the
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Krebs solution superfusing one uterine horn from each of the five animals on day 7
of the oestrous cycle and from five animals on day 15 of the oestrous cycle during
the collection of samples 4 and 5. The other uterine horn from each animal was
untreated and hence acted as control tissue. In experiment 2, theophylline (10 mM)
was present in the Krebs solution superfusing one uterine horn from each of the
four animals on day 7 of the oestrous cycle during the collection of samples 4 and
5. The other uterine horn from each animal was untreated and hence acted as the
control tissue. In experiment 3, caffeine (1 mM) was present in the Krebs solution
superfusing one uterine horn from each of the four animals on day 7 of the
oestrous cycle during the collection of samples 4 and 5, and caffeine (0.1 mM) was
present in the Krebs solution superfusing the other uterine horn from each of the
four animals on day 7 of the oestrous cycle during the collection of samples 4 and
5. All the solutions of caffeine and theophylline were freshly made up in Krebs
solution prior to use. The amount of PGF2a, PGE2 and 6-keto-PGFia in the uterine
extracts were measured by radioimmunoassays as described in Section 2.1.8.
Statistical analyses:
Changes in PG output with time were analysed by Duncan's multiple range test.
Results:
Caffeine (10 mM) significantly (p<0.05, n=5) increased the outputs of PGF2a and
6-keto-PGFia from the day 7 and day 15 guinea-pig uterus, and of PGE2 from the
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Figure 3.1.1.1 Effects of caffeine (10 mM) on mean (± SEM, n=5) outputs of
PGF2(X, PGE2 and 6-keto-PGFl0C from the (i) day 7 and (ii) day 15 guinea-pig
uterus superfused in vitro. * Significantly (p<0.05) higher than before caffeine
treatment.
n=4) increased the outputs of PGF2ct and 6-keto-PGFia, but not that of PGE2 from
the day 7 guinea-pig uterus (Figure 3.1.1.2). Caffeine (1 mM but not 0.1 mM)
significantly (p<0.05, n=4) increased the outputs of PGF2a, PGE2 and 6-keto-
PGFia from the day 7 guinea-pig uterus (Figure 3.1.1.3).
Discussion:
The basal outputs of PGF2a, PGE2 and 6-keto-PGFla from the day 7 guinea-pig
uterus were typically low. However, by day 15 the output of PGF2a from the
uterus had increased approximately by 20-fold, whereas the outputs of PGE2 and 6-
keto-PGFia showed very little changes. This is in agreement with previous reports
by Poyser and Brydon (1983). Poyser (1983b) has reported that this selective
increase in PGF2a output is due to the effect of oestradiol on a progesterone-primed
uterus.
Caffeine (10 mM) caused 3- to 4-fold increases in the outputs of PGF2a and 6-keto-
PGF lot from the guinea pig uterus on days 7 and 15, and of PGE2 from the uterus
on day 15 of the oestrous cycle. There was more variability in the outputs of
PGF2a and, to a lesser extent, of PGE2 and 6-keto-PGFia from the day 15 uterus.
This could be due to the fact that day 15 in one animal may not be exactly
equivalent to day 15 in another animal, as an oestrous cycle may last from 15 to 18
days. Theophylline (10 mM) caused 3.6- to 4.3-fold increases in the outputs of
PGF2a and 6-keto-PGFia, but not of PGE2 from the guinea-pig uterus on day 7.
Caffeine (1 mM but not 0.1 mM) caused 2- to 3-fold increases in the outputs of
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Figure 3.1.1.2 Effects of theophylline (10 mM) on mean (± SEM, n=4) outputs of
PGF2a, PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus superfused in
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Figure 3.1.1.3 Mean (± SEM, n=4) outputs of PGF2cc, PGE2 and 6-keto-PGFl0t
from the day 7 guinea-pig uterus superfused in vitro in the presence of caffeine
(1 mM; •) or caffeine (0.1 mM; o).
* Significantly (p<0.05) higher than before caffeine treatment.
Since caffeine and theophylline are phosphodiesterase inhibitors, they may be
acting to increase adenosine 3'-5 -cyclic monophosphate [cyclic AMP; (cAMP)]
concentrations in the uterus. However, it has been reported that increasing cAMP
concentrations in the day 7 and day 15 guinea-pig uterus (by using forskolin) does
not affect the outputs of PGF2«, PGE2 or 6-keto-PGFia (Poyser, 1987a). Thus it is
unlikely that effects of caffeine and theophylline in increasing uterine PG output
are as a result of an increase in the cAMP concentration.
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3.1.2 The Effects of Lack of Extracellular Calcium, an Intracellular
Antagonist (TMB-8), Inhibitors of Intracellular Calcium Release (Ryanodine
& Ruthenium Red), and Calmodulin Inhibitors (W-7 & Trifluoperazine) on
Caffeine-Induced Increases in The Outputs of Prostaglandins From The
Guinea-Pig Uterus Superfused In Vitro.
Introduction;
It has been reported in the rat, guinea-pig and man that the increase in endometrial
PG synthesis is associated with increased activity of phospholipase A2 (PLA2), a
calcium-dependent enzyme (Dey et al., 1982; Downing & Poyser, 1983; Bonney,
1985). It has also been reported that in the guinea-pig, the increase in uterine PG
production may involve the release of calcium from an internal pool (Leckie &
Poyser, 1990b; Johnson & Poyser, 1991). However, Ning and Poyser (1984) have
reported that there is no increase in inositol turnover in the guinea-pig
endometrium at the end of the oestrous cycle when PGF2a synthesis is high. This
finding indicates that the stimulation of endometrial PGF2a synthesis is not
dependent on the generation of inositol-l,4,5-trisphosphate (IP3) and, therefore,
does not involve the release of calcium from an IP3-sensitive store.
Studies on several cell types have indicated that only part of the calcium stored in
the endoplasmic reticulum is IP3-sensitive and there is another store of calcium
which is sensitive to ryanodine and can be released by caffeine (see Berridge,
1993; Komori & Bolton, 1989; Zhang et al., 1993; Sorimachi et al., 1992;
Cheek et al., 1993). Considering all these reports and findings from the previous
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set of experiments (see Section 3.1.1), the effect of caffeine on prostaglandin
output from the guinea-pig uterus superfused in vitro in the absence of extracellular
calcium was investigated. The effects of other factors which modulate intracellular
calcium such as TMB-8 (an intracellular calcium antagonist, Malagodi & Chiou,
1974), calmodulin antagonists (W-7, Hidaka et al., 1978; and trifluoperazine
(TFP), Levin & Weiss, 1977), ryanodine (RY) and ruthenium red (inhibitors of
caffeine-induced calcium release from the RYR-channel of the endoplasmic
reticulum) (Vites & Pappano, 1994; see Casteels et al., 1992; see Berridge, 1993)
on caffeine-induced prostaglandin production by the guinea-pig uterus superfused
in vitro have been investigated.
Methods:
Tissue preparation and the experimental procedure were as described in Section
2.2.1. After an initial settling period of 60 min, uterine horns in each experiment
were treated as described below. In experiment 1, one uterine horn from each of
the five animals on day 7 of the oestrous cycle was superfused with normal Krebs
solution and the other uterine horn was superfused with Krebs solution from which
the calcium chloride had been omitted (calcium-free Krebs solution). Caffeine (10
mM) was present in both types of Krebs solution during the collection of samples 4
and 5.
In experiments 2 to 6, both uterine horns from four or five guinea-pigs on day 7 of
the cycle were superfused with normal Krebs solution, and caffeine (10 mM) was
present in the solution superfusing both uterine horns during the collection of
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samples 6 and 7. The following additions were made to the Krebs solution
superfusing one uterine horn from each animal during the collection of samples 4
to 7: Exp 2: TMB-8 (150 pM; n=5); Exp 3: RY (2, 20 or 200 pM; n=4); Exp 4:
ruthenium red (10 or 100 pM; n=4); Exp 5: W-7 (150 pM; n=4); Exp 6: TFP
(100 pM; n=4). The other uterine horn from each animal was untreated and hence
acted as the control tissue.
Poyser (1985a, b) has shown that concentrations of W-7 and TFP used in
experiments 5 and 6, are sufficient to inhibit A23187-induced PGF2« release from
the guinea-pig uterus. Cheek et al. (1993) has shown that caffeine (1 to 80 mM)
dose-dependently increased [Ca2+]; in the presence or absence of extracellular
calcium and this effect of caffeine is inhibited in a use-dependent fashion by
ryanodine (10 pM). It has also been shown that caffeine- (1 & 10 mM) induced
transient increase of [Ca2+]; (Donoso et al., 1994; Kuermmerle et al., 1994) is
blocked by 10 pM ryanodine (Usachev et al., 1993), and ruthenium red (0.1 & 1
pM) (Kuemmerle et al., 1994).
Solutions of each compound were freshly made up in Krebs solution prior to use,
except for ryanodine. A concentrated solution of RY was prepared in ethanol and
stored at -20°C. The appropriate concentration of RY in Krebs solution was
prepared by adding up 0.25 ml of the ethanolic stock solution to 250 ml Krebs
solution. The Krebs solutions superfusing the control uterine horn during the same
period contained an equivalent amount of ethanol.
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Prostaglandins were extracted from the samples of superfusate and stored at -20°C
as described in Section 3.1.1. The amounts of PGF2«, PGE2 and 6-keto-PGFia in
each extract were measured by radioimmunoassays as described in Section 2.1.8.
Statistical analyses:
Changes in the PG output with time were analysed by Duncan's multiple range
test. Other comparisons were made using Student's t test, or if the variances of the
two groups were significantly different by the Variance ratio F test, by a modified t
test for unequal variances (see Steel & Torrie, 1980).
Results:
In the absence or presence of extracellular calcium, caffeine (10 mM) significantly
(p<0.05) increased the outputs of PGF2«, PGE2 and 6-keto-PGFia from day 7
guinea-pig uterine horns. However, the caffeine-induced increase in PGF2a output
tended to be less during the first 10 min period of treatment in calcium-free Krebs
solution (Figure 3.1.2.1). TMB-8 caused small, but significant (p<0.05) increases
in the outputs of PGF2a, PGE2 and 6-keto-PGFia from day 7 guinea-pig uterine
horns, an effect reported previously (Poyser, 1985a). However, TMB-8 inhibited
the caffeine-induced increase in PGF2a output, but not the increases in the outputs
of PGE2 or 6-keto-PGFia (Figure 3.1.2.2).
Ryanodine alone had no effect on the outputs of PGF2a and PGE2 from the day 7
guinea-pig uterus, although RY (20 and 200 pM) significantly (p<0.05) increased


























































Figure 3.1.2.1. Effects of caffeine on mean (± SEM, n=5) outputs of
PGF2a, PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus
superfused in vitro in the presence or absence of extracellular calcium.
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Figure 3.1.2.2 Effects of caffeine on the mean (± SEM, n=5) outputs of PGF2a,
PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus superfused in vitro in
the presence or absence of TMB-8. t Significantly (p<0.05) higher than before
TMB-8 treatment alone. * Significantly (p<0.05) increased by caffeine treatment.
▼ Significantly (p<0.05) lower following the end of caffeine treatment but
significantly higher than before TMB-8 treatment.
caffeine-induced increases in the outputs of PGF2a and 6-keto-PGFia from the day
7 guinea-pig uterus (Figure 3.1.2.3). However, RY (20 & 200 pM) delayed both
the increase and subsequent decrease in PGF2a output produced by caffeine (10
mM) such that the 'peak of increased PGF2a release' was flatter and broader. PGE2
output was not affected by neither caffeine nor RY in this experiment (Figure
3.1.2.3).
Ruthenium red alone had no effect on the outputs of PGF2a, PGE2 and 6-keto-
PGFia from the day 7 guinea-pig uterus. Ruthenium red (10 & 100 pM) did not
inhibit the increase in the outputs of PGF2a, PGE2 and 6-keto-PGFia induced by
caffeine from the day 7 guinea-pig uterus (Figure 3.1.2.4).
Trifluoperazine (TFP) alone produced a small increases in the outputs of PGF2a
and 6-keto-PGFia from the day 7 guinea-pig uterus, an effect reported previously
(Poyser, 1985b). However, TFP had no effect on caffeine-induced increases in the
outputs of PGF2a and 6-keto-PGFia from the day 7 guinea-pig uterus. In this
experiment, PGE2 output from the uterus increased after the caffeine treatment had
finished in both the control (i.e. in the absence of TFP) and TFP-treated uterine
horns (Figure 3.1.2.5). W-7 alone had no effect on the outputs of PGF2a, PGE2
and 6-keto-PGFia from the day 7 guinea-pig uterus. W-7 had no inhibitory effect
on caffeine-induced increases in the outputs of PGF2a, PGE2 and 6-keto-PGFia
from the day 7 guinea-pig uterus. In fact, W-7 caused a 3-fold potentiation of the
caffeine-induced increase in PGF2a output. W-7 also caused a much smaller
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Figure 3.1.2.3. Effect of caffeine on the mean (±SEM, n=4) outputs of PGF2a,
PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus superfused in vitro in
the absence and presence of ryanodine (RY) at concentrations of (i) 2 pM, (ii) 20
pM and (iii) 200 pM.
t Significantly (p<0.05) higher than before RY treatment.
❖ Significantly (p<0.05) higher than before caffeine treatment.
T Significantly (p<0.05) lower than following the end of caffeine treatment but
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Figure 3.1.2.4. Effects of caffeine on the mean (± SEM, n=4) outputs of
PGF2(X, PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus
superfused in vitro in the absence and presence of ruthenium red (RR)
at concentrations of (i) 10 pM and (ii) 100 pM. ❖ Significantly (p<0.05)
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Figure 3.1.2.5 Effect of caffeine on the mean (± SEM, n=4) outputs of
PGF2a, PGE2 and 6-keto-PGFla from the day 7 guinea-pig uterus
superfused in vitro in the absence and presence of (i) 150 pM trifluoperazine
(TFP) and (ii) 100 pM W-7. t Significantly (p<0.05) higher than before TFP
treatment alone. ^ Significantly (p<0.05) higher than before caffeine
treatment. T Significantly (p<0.05) lower following the end of caffeine
treament but significantly higher than before TFP treatment. ♦ Significantly
(p<0.05) higher than corresponding control value (i.e. without W-7
treatment) for the same prostaglandin.
keto-PGFia output produced by caffeine from the day 7 guinea-pig uterus (Figure
3.1.2.5).
Discussion:
In some experiments caffeine stimulated PGE^ output, whereas in other
experiments it did not. It became apparent that this differential effect of caffeine on
PGE2 output from the guinea-pig uterus superfused in vitro was age related, i.e.
caffeine was not effective in stimulating PGE2 output in animals <4 month but
stimulated PGE2 output from older animals. The reason for this may be the fact
that the basal PGE2 output from younger animals was much higher than in the
older animals and as a result caffeine was not able to further stimulate PGE2
synthesis.
Caffeine in the presence or absence of extracellular calcium increased the outputs
of PGF2a, PGE2 and 6-keto-PGFia from the day 7 guinea-pig uterus superfused in
vitro, suggesting that the effect of caffeine does not depend on the presence of
extracellular calcium. However, when calcium-free Krebs solution was used, the
increase in PGF2a output but not the increases in PGE2 and 6-keto-PGFi« outputs,
tended to be slower then when calcium containing Krebs solution was used as the
superfusing solution. This suggests that the action of caffeine on PGF2a output, but
not on PGE2 and 6-keto-PGFia outputs, may depend to some extend on the
presence of extracellular calcium. Hence, the mechanism by which caffeine
stimulates PGF2a synthesis and release may be different from the mechanisms by
which caffeine stimulates the synthesis and release of PGE2 and PGI2 (measured as
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6-keto-PGFia). TMB-8 (an intracellular calcium antagonist) completely abolished
the caffeine-induced increase in the output of PGF2a, but had no effects on the
caffeine-induced increases in the outputs of PGE2 and 6-keto-PGFia. These
findings suggest that the stimulation of uterine PGF2a synthesis and release in the
guinea-pig, but not of PGE2 and PGI2 synthesis and release, by caffeine is
dependent on intracellular calcium, or the stimulation of guinea-pig uterine PGE2
and PGI2 synthesis and release is dependent on an intracellular calcium pool which
is not affected by TMB-8. Therefore, these results provide further evidence that the
mechanism by which caffeine stimulates PGF2a output is different from the
mechanisms by which caffeine stimulates PGf^ and PGI2 outputs from the guinea-
pig uterus.
The calmodulin antagonists (W-7 & TFP) did not inhibit the stimulatory effect of
caffeine on uterine PG output, indicating that calmodulin does not mediate this
stimulatory effect of caffeine. In fact, W-7 greatly potentiated the stimulatory
effect of caffeine on PGF2a output and, to a lesser extent, on PGE^ outputs. W-7
had no effect on the caffeine-induced increase in 6-keto-PGFia output. TFP did not
potentiate the stimulatory effect of caffeine on PGF2a and PGE^ outputs. This
suggests that the potentiating effect of W-7 on caffeine-induced increases in PGF2a
and PGE^ outputs from the guinea-pig uterus is not due to the inhibition of
calmodulin. Also, caffeine-induced increases in PGF2a, PGE, and 6-keto-PGFia
outputs from the guinea-pig uterus were affected to a different extent by W-7,
providing further evidence that the mechanism by which caffeine stimulates PGF2a
synthesis and release is different from the mechanisms by which caffeine stimulates
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PGE2 and 6-keto-PGFia synthesis and release from the guinea-pig uterus. The
reason for this potentiating effect of W-7 on caffeine-induced increase on uterine
PGF2« synthesis and release is not clear. A mechanism of calcium release has been
identified in many tissues known as calcium-induced calcium release (CICR) (see
McPherson & Campell, 1993a; Gyorke & Fill, 1993). This process is modulated
by calcium, caffeine and RY. Cyclic ADP-ribose, an endogenous nucleotide, has
recently been suggested as a second messenger which releases calcium from the
ryanodine receptor (RYR) channel and through the CICR mechanism. Cardiac
RYR is activated by cyclic ADP-ribose (Mesza'ros et al., 1993) but inhibited by
calmodulin (Smith et al., 1989). The latter effect may explain the potentiating
action of W-7 on caffeine-stimulated outputs of PGF2a and PGE2. However, Lee et
al. (1994) reported that W-7 dose-dependently inhibits calcium release induced by
cyclic ADP-ribose from L.pictus and S.purpuratus egg homogenates.
Caffeine induces intracellular calcium release from human vascular endothelial
cells (Zhang et al., 1993), skinned myocardial fibres of foetal and adult rats (Su &
Shang, 1993), isolated snail neurones (Kostyuk & Kirischuk, 1993), rat pituitary
cells (Tanaka & Tashjian, 1993), and bovine adrenal chromaffin cells (Cheek et
al., 1993) by acting on ryanodine receptors Types 1 and 2 (RYR-1 & RYR-2), an
effect which is blocked by ruthenium red and high concentrations of RY (see
Sorrentino & Volpe, 1993). Caffeine-induced increases in the outputs of PGF2a,
PGE2 and 6-keto-PGFia from the day 7 guinea-pig uterus were not affected by
ruthenium red or RY. This suggests that caffeine-induced increases in the outputs
of PGF2a, PGE2 and 6-keto-PGFia from the day 7 guinea-pig uterus is not due to
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that activation of RYR-1 or RYR-2 by caffeine. However, both RY and ruthenium
red relaxed the uterine horns and abolished spontaneous contractions, suggesting
that these two compounds were probably preventing the release of calcium from an
intracellular calcium pool. Why RY (20 & 200 pM) alone should increase 6-keto-
PGFia output and alter the time course of caffeine-induced rise in PGF2a output is
not clear and merits further investigation.
A third type of RYR (RYR-3) has been reported in mink lung epithelial cells (see
Sorrentino & Volpe, 1993), and in rat brain and smooth muscle (McPherson &
Campbell, 1993b) which, despite binding RY, is not activated by caffeine. Hence,
it is unlikely that the activation of RYR-3 by caffeine is the mechanism by which
caffeine exerts it effect on uterine PG output. Caffeine sensitive calcium stores are
reported to be present in adrenal chromaffin cells (Sorimachi et al., 1992), liver
(Shoshan-Barmatz et al., 1991), and pancreas (Schmid et al., 1990). The receptor
type involved in the pancreas is not sensitive to RY, but it is blocked by ruthenium
red (Dehlinger-Kremer et al., 1991). This indicates that the receptor type involved
in the pancreas is not one of the three RYR-types described earlier. Also, in the
present study RY or ruthenium red did not inhibit caffeine-induced increases of
PGF2a, PGE2 and 6-keto-PGFia, indicating that caffeine effect on the guinea-pig
uterus is not via activation of any caffeine and/or RY-sensitive calcium pools
described so far. McNulty & Taylor (1993) reported an intracellular calcium pool
in the hepatocytes which is insensitive to RY and theophylline, but is activated by
caffeine and blocked by ruthenium red whereas Donoso et al. (1994) reported that
both caffeine and theophylline mobilize intracellular calcium from an internal store
in cardiac myocytes. Thus, it is possible that the caffeine-sensitive calcium pool
present in the hepatocytes is also present in the guinea-pig uterus which is involved
in the caffeine-induced stimulation of uterine PG output. However, theophylline
also induced a rise in PG outputs from the guinea-pig uterus, an effect which was
not seen in hepatocytes (McNulty & Taylor, 1993), but it is seen in cardiac
myocytes (Donoso et al., 1994). Hence, it can be deduced that the mechanism by
which theophylline induces PG output from the uterus may be different from that
of caffeine or, if caffeine and theophylline are acting through the same mechanism,
then the caffeine effects on hepatocytes and uterus are via different mechanisms. It
can also be deduced that the mechanism by which caffeine and theophylline induce
PG output from the uterus is the same as the mechanism by which caffeine and
theophylline exert their effects on cardiac myocytes.
In summary, caffeine increased the outputs of PGF2a, PGE2 and 6-keto-PGFia
from the day 7 and day 15 guinea-pig uterus superfused in vitro, an effect which is
not dependent upon the presence of extracellular calcium. This uterine
prostaglandin stimulatory effect of caffeine is not modulated by calmodulin
antagonists or inhibitors of calcium release from the RYR channel. However,
TMB-8 blocked the stimulatory effect of caffeine on the output of PGF2a but not on
the outputs of PGE2 or 6-keto-PGFia, suggesting that intracellular calcium may be
involved in the effect of caffeine on PGF2« synthesis.
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3.1.3 The Effects of Caffeine, Theophylline and Ryanodine on Prostaglandin
Output From Day 7 and Day 15 Guinea-Pig Endometrial Tissue in Culture.
Introduction:
The previous sets of experiments (see Sections 3.1.1 & 3.1.2) have indicated that
caffeine and theophylline, but not ryanodine, have the ability to stimulate
prostaglandin synthesis by and release from the day 7 and day 15 guinea-pig uterus
superfused in vitro. It has been previously reported that a number of compounds,
including PLA2, phospholipase C (PLC), A23187 and sodium fluoride (NaF)
(Poyser, 1987a, b; Leckie & Poyser, 1990a) increase PG outputs from the guinea-
pig uterus superfused in vitro. However, Leckie and Poyser (1990b) have also
reported a short-term stimulatory effect and a long-term inhibitory effect of NaF on
PG outputs from the day 15, and to a lesser extent, from the day 7 guinea-pig
endometrium in culture. Considering the above reports, this set of experiments
were designed to investigate whether or not caffeine and theophylline would have
different effects on PG outputs from the guinea-pig uterus in tissue culture in
comparison to the stimulatory effect seen with in vitro superfusion.
Methods:
Endometrial tissue from the day 7 and day 15 guinea-pig uterus was removed and
cultured as described in Methods Section 2.1.3. Briefly, uterine horns were
removed from the guinea-pigs as described in Section 2.1.1 except that the whole
procedure was carried out under aseptic conditions. After "opening up" each
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uterine horn, endometrium was cut away from the myometrium, cut into
3
approximately 1 mm pieces, and then placed onto sterile lens paper lying across a
stainless steel grid in a vented sterile dish which contained 4 ml of tissue culture
medium (TCM) plus any other compound used according to the nature of the
experiment. The amount of tissue placed in each petri dish varied between 19-35
mg. Petri dishes were then placed into racks which were in turn placed into
modified Kilner jars. The jars were then gassed and incubated as described in
Section 2.1.3. From each guinea-pig endometrium, 12-14 tissue cultures dishes
(according to the nature of experiment) were prepared.
In experiment 1, uteri were removed from four day 7 guinea-pigs. Four of the petri
dishes from each animal were left untreated (controls), and the remaining dishes
were treated in duplicate with caffeine (Cf; 1 & 10 mM) and theophylline (Theo; 1
& 10 mM). In experiment 2, uteri were removed from four day 15 guinea-pigs.
Four of the petri dishes from each animal were left untreated (controls), and the
remaining dishes were treated in duplicate with Cf (1 & 10 mM), Theo. (1 & 10
mM). In experiment 3, uteri were removed from four day 7 guinea-pigs. Four of
the petri dishes from each animal were treated with ethanol (20 pi) (controls), and
the remaining dishes were treated with ryanodine (RY; 20 pM). These dishes were
then divided equally; two dishes from the controls and one dish from each of the
duplicate treatments were placed in each of the two modified Kilner jars and placed
in the incubator. Culture medium was changed at 2, 8, and 24 h. Samples of
culture medium were stored at -20°C before radioimmunoassay, without extraction,
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for PGF2a, PGE2, and 6-keto-PGFia. At the end of the experiment, tissues were
blotted dry and weighed.
Solutions of caffeine and theophylline were freshly made up in TCM solution prior
to use. A concentrated solution of RY was prepared in ethanol and stored at -20°C.
The appropriate concentration of RY was prepared by diluting 200-fold in TCM
solution.
Statistical tests:
The results were analysed by one-way analysis of variance (ANOVA) and by the
paired t-test.
Results:
After 2 h of culture, the major prostaglandins produced were 6-keto-PGFia and
PGF2a by the day 7 and day 15 guinea-pig endometrium, respectively. The
amounts of PGF2a, PGE2 and 6-keto-PGFia produced by day 7 endometrium were
84, 46 and 339 pg/mg tissue/h, and by day 15 endometrium were 1541, 111 and
500 pg/mg tissue/h, respectively.
The prostaglandin outputs from the cultured tissues declined with time over 24 h.
However, there was an increase in the output of PGF2a between 8 and 24 h of
culture from day 7 endometrium but not from day 15 endometrium in culture. The
amounts of PGF2a and PGE2 produced by the endometrium obtained from day 15
of the oestrous cycle were 18.4- and 2.0-fold higher than the amounts produced by
the endometrium obtained from day 7 of the cycle, respectively. There was no
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difference in the outputs of 6-keto-PGFia from guinea-pig endometrium in culture
between day 7 and day 15 of the cycle (Figures 3.1.3.1 & 3.1.3.2.).
For day 7 endometrium in culture, Cf (10 mM but not 1 mM) significantly
(p<0.05, n=4) increased the outputs of PGF2a by 1.5-fold after 8 h and 6-keto-
PGFia up to 2.2-fold after 8 and 24 h of culture (Figure 3.1.3.1). Theo (10 mM
but not 1 mM) significantly (p<0.05, n=4) increased the outputs of PGF2a by up
to 9-fold and PGE2 by up to 6.2-fold after 8 and 24 h of culture (Figure 3.1.3.1).
Theo (1 and 10 mM) significantly increased 6-keto-PGFia output by 1.3- to 14.8-
fold after 8 and 24 h (Figure 3.1.3.1). Theo (10 mM) also significantly (p<0.05,
n=4) increased 6-keto-PGFia output after 2 h of culture. The stimulatory effect of
theophylline was between 1.7- to 6.6-fold greater than the stimulatory effect of
caffeine on the same PG output at the same time.
For day 15 endometrium in culture, Cf (10 mM but not 1 mM) showed both an
inhibitory and a stimulatory effect on PGF2a output, but not on the outputs of PGE2
and 6-keto-PGFia. Cf (10 mM) significantly (p<0.05, n=4) inhibited PGF2a
output after 2 h of culture (Figure 3.1.3.2). By 8 h, the inhibitory effect was
reversed, and a significant (p<0.05, n=4) 1.6-fold rise in the output of PGF2a
was seen after 24 h of culture (Figure 3.1.3.2). Cf (10 mM) also stimulated the
outputs of PGE2 and 6-keto-PGFia by 1.5-fold from the endometrium after 24 h of
culture. Theophylline (1 mM) significantly (p<0.05, n=4) increased the outputs
of PGF2a, PGE2 and 6-keto-PGFia by up to 2.6-fold after 8 and 24 h. Theophylline






































Figure 3.1.3.1 Effects of caffeine (Cf) and theophylline (Theo) on the
mean (±SEM, n=4) outputs of PGF2(X, PGE2 and 6-keto-PGFla from the day
7 guinea-pig endometrium in culture.








Hi Cf (1 mM)
■ Cf (10 mM)
771 Thoo. (1 mM)


























Figure 3.1.3.2. Effects of caffeine (Cf) and theophylline (Theo.) on the mean
(+SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFla from the day 15 guinea-pig
endometrium tissue in culture,
t Significantly decreased by caffeine treatment.
* Significantly increased by caffeine or theophylline treatment.
output by 2.5-fold, and 6-keto-PGFia output by 4.7-fold after 24 h of culture
(Figure 3.1.3.2). Ryanodine (20 pM) had no effect on the outputs of all three PG
measured at the end of any culture period (Figure 3.1.3.3).
Discussion:
In this study, the amount of PGF2a produced by the endometrium obtained from
day 15 of the oestrous cycle was 18.4-fold higher than the amount produced by the
endometrium obtained from day 7 of the cycle. The higher output of PGF2a from
the day 15 endometrium compared to day 7 endometrium is in agreement with the
increase in PGF2a concentrations in the utero-ovarian venous plasma of the guinea-
pig at the end of the oestrous cycle (Blatchley et al., 1972; Earthy et al., 1975;
Antonini et al., 1976).
The decline in PG output from the endometrium in culture over a period of 24 h
seen in this study has been previously reported (Riley & Poyser, 1989; Leckie &
Poyser, 1991b). The increase in the PGF2a output between 8 and 24 h of culture
from day 7 endometrium seen in this study has also been reported elsewhere (Riley
& Poyser, 1989). The reason for this increase may be the absence of an inhibitory
influence of progesterone on day 7 endometrium in vitro (Riley & Poyser, 1989).
Caffeine at higher concentration caused both an inhibitory and a stimulatory effect
on the output of PGF2a, but not on the outputs of PGE2 and 6-keto-PGFia, from
the guinea-pig uterus, a property which was not shared by theophylline. This
suggests that caffeine affects PG output from the guinea-pig uterus in a time-




















Figure 3.1.3.3. Effects of ryanodine (RY) on means (±SEM, n=4)
outputs of PGF2a, PGE2 and 6-keto-PGFla from day 7 guinea-pig
emdometrium in culture.
outputs from both days 7 and 15 endometrium in culture than caffeine. The
findings that caffeine stimulated PG output from both the day 7 and day 15 guinea-
pig uterus superfused in vitro (see Sections 3.1.1 & 3.1.2) and from day 7 and day
15 guinea-pig endometrial tissue in culture further support the hypothesis that
mobilization of intracellular calcium may be involved in the stimulatory effects of
caffeine and theophylline on PG output from the guinea-pig uterus. However,
ryanodine had no effect on the outputs of prostaglandin from the day 7 and day 15
guinea-pig endometrium in culture further indicating that ryanodine-sensitive
ryanodine receptor activation is not involved in prostaglandin synthesis by and
release from the guinea-pig uterus.
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3.1.4 The Effects of Caffeine, Theophylline and Ryanodine on Prostaglandin
Production by Day 7 and Day 15 Guinea-Pig Epithelial and Stromal Cells in
Culture.
Introduction:
Previous studies on prostaglandin production by the guinea-pig uterus were mainly
conducted on either in vitro tissue superfusion (Poyser and Brydon, 1983; Poyser,
1984; Poyser, 1987; Leckie & Poyser, 1990a), tissue homogenates (Poyser, 1979,
Poyser, 1983b, Poyser & Riley, 1987) or tissue culture (Riley & Poyser, 1987a, b;
Riley & Poyser, 1989; Leckie & Poyser, 1990b). It has been shown that the
amount of PGF2a produced by the guinea-pig uterus superfused in vitro (Poyser &
Brydon, 1983), by endometrial homogenates (Poyser, 1983b), and by endometrium
in culture (Riley & Poyser, 1989; see Section 3.1.3) depends on the stage of the
oestrous cycle.
The determination of PG output from endometrial cells has previously been
reported in human (Schatz et al., 1985; Smith & Kelly, 1988), cows (Fortier et
al., 1988), ewes (Cherny & Findlay, 1990), and mare (Watson et al., 1992), but
not in guinea-pigs. Studies on endometrial cell cultures of human (Bonney et al.,
1991) and of mares (Watson et al., 1992) have suggested that the PG output from
endometrial cells differs between species, and that there is a difference in response
to activators between epithelial and stromal cells.
Cells were isolated and cultured from the guinea-pig endometrium in order to
identify the major endometrial cell type producing PGF2a, PGE2, and 6-keto-
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PGFia, as well as the effects of stage of the oestrous cycle. Since methylxanthines
showed different actions on the outputs of prostaglandins from guinea-pig uterine
tissue under culture conditions compared with in vitro superfusion, their effect on
the PG output from the endometrial stromal and epithelial cells was also
investigated.
Methods:
Cells were isolated from the endometrium of four day 7 and four day 15 guinea-
pigs, and were cultured as described in Section 2.1.5. Briefly, the uterine horns
were prepared as described in Section 2.1.3. All procedures were carried out under
aseptic conditions. Endometrium was separated from the myometrium and chopped
3
into fragments of about 0.5 mm in 10 ml cell culture medium (CCM) (see Section
2.1.3 for composition) containing 2 mg/ml collagenase type I in a sterile conical
flask. The endometrial pieces were incubated at 37°C in a shaking (230 oscillations
/min) Grant Water bath for 2 h. After dissociation, the undigested fragments were
collected by sedimentation and discarded. Epithelial and stromal cells were
separated by centrifugation and re-suspended in 30 to 40 ml of CCM. Aliquots (2.5
ml) of epithelial cells were dispensed into each of 12 wells of a 24-well cell culture
3 3
plate (2.3x10 -4.5 x 10 cells per ml), and 2.5 ml aliquots of stromal cells were
dispensed into the remaining 12 wells of the 24-well cell culture plate (2.2 x 105 -
5.6 x 105 cells per ml). Cell culture plates were then incubated at 37°C in a
humidified atmosphere of 5 % C02 : 95 % air.
ill
Culture medium was collected after 3 days of culture, denoted as the "first 3-day
period" (3D1), and after 6 days of culture, denoted as the "second 3-day period"
(3D2). The cultured cells were then treated in duplicate. Two wells containing each
cell type were untreated (controls), and the remaining wells were treated with
caffeine (1 & 10 mM), theophylline (1 & 10 mM) or ryanodine (20 pM). The cells
were cultured for a further 24 h, and the culture medium was changed after 2, 8,
and 24 h. Samples of culture medium were stored at -20°C before
radioimmunoassay, without extraction, for PGF2a, PGE2, and 6-keto-PGFia.
Solutions of caffeine and theophylline were freshly made up in CCM solution prior
to use. A concentrated solution of RY was prepared in ethanol and stored at -20°C.
The appropriate concentration of RY was prepared by diluting 200-fold in CCM
solution.
Statistical tests:
The results were analysed by one-way analysis of variance (ANOVA) and by the
paired t-test.
Results:
For endometrial cells obtained from the day 7 guinea-pig uterus (hereafter will be
called the day 7 cells), the outputs of PGF2a and 6-keto-PGFia but the not of PGE2
from 3D2 epithelial cells were significantly (p<0.05, n=4) higher than those from
3D1 epithelial cells. There were no significant changes in the outputs of PGF2a,
PGEj and 6-keto-PGFia from stromal cells between 3D1 and 3D2. For both time
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Figure 3.1.4.1. The basal outputs of PGF2a, PGE2 and 6-keto-PGFla
from cultured (i) epithelial and (ii) stromal cells of day 7 guinea-pig
endometrium. The culture medium was collected on the third (3D1) and
sixth (3D2) days of culture. The data indicate the mean (±SEM, n=4).
* Significantly (p<0.05) higher than the corresponding value obtained
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Figure 3.1.4.2. Effects of caffeine (Cf), theophylline (Theo) and ryanodine
(RY) on means (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFla from
cultured epithelial cells obtained from day 7 endometrium. * Significantly
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Figure 3.1.4.3. Effects of caffeine (Cf), theophylline (Theo) and ryanodine
(RY) on means (±SEM, n=4) outputs of PGF2(X, PGE2 and 6-keto-PGFlafrom
cultured stromal cells obtained from day 7 endometrium.
* Significantly (p<0.05) increased by treatment.
periods, the outputs of all 3 PGs were very much higher (p<0.05) from epithelial
cells than from stromal cells (Figure 3.1.4.1). Similarly, on the final day of cell
culture after 24 h, the basal PG outputs from the day 7 epithelial cells were 200-,
170-, and 150-fold greater than from the stromal cells for PGFza, PGE2, and 6-
keto-PGFia, respectively (Figures 3.1.4.2 & 3.1.4.3).
For epithelial cells, caffeine (10 mM but not 1 mM) significantly (p<0.05, n=4)
decreased the output of PGF201 after 8 and 24 h of culture (Figure 3.1.4.2).
Theophylline (10 mM) significantly (p<0.05, n=4) decreased the output of PGF2a
after 24 h of culture. Theophylline (1 mM) significantly (p<0.05, n=4) increased
PGF2a output after 8 h of culture. Theophylline (1 & 10 mM) significantly
(p<0.05, n=4) increased the output of 6-keto-PGFia by up to 2.7-fold after 8 h of
culture. There were no significant changes in the outputs of any of the three
prostaglandins measured due to RY treatment (Figure 3.1.4.2).
For stromal cells, caffeine and theophylline had no significant effects on PGF2a
output (Figure 3.1.4.3). Caffeine (10 mM) significantly (p<0.05, n=4) increased
the outputs of PGE2 by 1.3-fold after 24 h, and 6-keto-PGFia by up to 1.5-fold
after 2 and 8 h of culture. Theophylline (10 mM) significantly (p<0.05, n=4)
increased the output of PGE2 by up to 1.5-fold after 8 and 24 h of culture.
Theophylline (10 mM) caused a significant (p<0.05) increase in the output of 6-
keto-PGFia by 1.9- to 2.5-fold after 2, 8, and 24 h of culture (Figure 3.1.4.3).
Theophylline (1 mM) and ryanodine (20 pM) had no effects on the outputs of any
of the 3 PGs measured from stromal cells in culture (Figure 3.1.4.3).
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For endometrial cells obtained from the day 15 guinea-pig uterus (hereafter will be
called the day 15 cells), 6-keto-PGFia output from 3D2 epithelial cells was
significantly (p<0.05, n=4) higher than that from 3D1 epithelial cells. There were
no changes in the outputs of PGF2a and PGE2 from the epithelial cells between
3D1 and 3D2. Also there were no significant changes in the outputs of PGF2a,
PGE2, and 6-keto-PGFia from stromal cells between 3D1 and 3D2 (Figure
3.1.4.4). On the final day of cell culture, the basal outputs of PGF2a, PGE2, and 6-
keto-PGFia after 24 h were 800-, 330-, and 330-fold greater from day 15 epithelial
cells than from day 15 stromal cells, respectively (Figures 3.1.4.5 & 3.1.4.6).
For day 15 epithelial cells, caffeine (10 mM) significantly (p<0.05, n=4)
decreased the output of PGF2a after 2, 8 and 24 h of culture. Theophylline (1 mM
but not 10 mM) significantly (p<0.05, n=4) increased the outputs of PGE2 by
1.5-fold and 6-keto-PGFia by 2.3-fold after 8 h of culture. Caffeine (1 mM) and
ryanodine (20 pM) had no significant effects on the outputs of the PGs measured
(Figure 3.1.4.5).
For stromal cells, there were no significant changes in the outputs of PGF2a and 6-
keto-PGF ia after 2, 8 and 24 h treatment with caffeine (1 & 10 mM), theophylline
(1 & 10 mM) or RY (20 pM) (Figure 3.1.4.6). However, the outputs of PGE2
were significantly (p<0.05, n=4) increased by caffeine (1 & 10 mM) by up to
1.3-fold after 2 h, by theophylline (10 mM) by up to 1.4-fold after 2 and 24 h, and
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Figure 3.1.4.4. The basal outputs of PGF2a, PGE2 and
6-keto-PGFlcx from cultured (i) epithelial and (ii) stromal cells of
day 15 guinea-pig endometrium. The culture medium was
collected on the third (3D1) and sixth (3D2) days of culture. The
data indicate the mean (+SEM, n=4). * Significantly (p<0.05)
higher than the corresponding value obtained from the first 3 days
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Figure 3.1.4.5. Effects of caffeine (Cf), theophylline (Theo) and ryanodine (RY) on
means (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFla from cultured
epithelial cells obtained from the day 15 guinea-pig endometrium.
* Significantly (p<0.05) increased by theophylline treatment,







H Cf (1 mM)
■ Cf (10 mM)
E23 Thoo. (1 mM)
□ Theo. (10 mM)














Figure 3.1.4.6. Effects of caffeine (Cf), theophylline (Theo) and ryanodine (RY)
on mean (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFl0t from
cultured stromal cells obtained from day 15 guinea-pig endometrium.
* Significantly (p<0.05) increased by caffeine or theophylline treatment.
Discussion:
In the previous studies on the guinea-pig, the amount of prostaglandins produced
by uterine homogenates (Poyser & Riley, 1987a), by the perfused uterine horn
(Poyser & Brydon, 1983; Poyser, 1987c; Leckie & Poyser, 1990a) and by cultured
endometrial tissue (Leckie & Poyser, 1990b; Riley & Poyser, 1987a, b) have been
measured. By isolating endometrial cell types, it was apparent that the outputs of
prostaglandins from both the epithelial and stromal cells were 2.5- to 8-fold higher
on day 15 than on day 7 of the cycle, a difference which has been reported for both
the superfused uterus (Poyser & Brydon, 1983) and cultured endometrial tissue
(Leaver & Seawright, 1982; Riley & Poyser, 1987a). This difference between days
of the cycle was more pronounced after 8 and 24 h of cell culture.
After 2 h of culture, the basal outputs of PGF2a, PGE2, and 6-keto-PGFia were
200-, 170-, and 150-fold greater from epithelial cells than from stromal cells
obtained from day 7 guinea-pig endometrium. Similarly, the basal outputs of
PGF2(X, PGE2, and 6-keto-PGFia were 800-, 305-, and 300-fold greater from
epithelial cells than from stromal cells obtained from day 15 guinea-pig
endometrium. These findings indicate that, in the guinea-pig, the epithelial cells
are the major cell type involved in the synthesis and release of prostaglandins in
particular PGF2a from the endometrium. This difference in PG output between cell
types has also been reported in the mare after 24 h but not after 2 and 8 h of cell
culture (Watson etal., 1992).
In many species such as human (Smith & Kelly, 1988, 1989), cow (Fortier et al.,
1988), mare (Watson et al., 1992) and sheep (Kim & Fortier, 1995), endometrial
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epithelial and stromal cells have been shown to possess different characteristics
with regard to prostaglandin production. Watson et al. (1992) have reported a
gradual increase in the amounts of PGs produced by the epithelial and stromal cells
of mare over a 24 h period. In the present study the outputs of all three PGs from
the day 7 cells decreased rapidly after 2 h of cell culture, with no changes between
8 and 24 h of culture, but PG outputs from the day 15 cells declined between 2 and
8, and 8 and 24 h of culture. The reason for the gradual increase in the amounts of
PGs produced by mare endometrial cell in culture is that the time period of culture
has not been taken into account by Watson et al. (1992) such, that by increasing
the time of culture, more PG was produced by the cells.
Kim and Fortier (1995) have reported that, by 36 h of culture, sheep epithelial
cells produce more PGF2o (by about 40-fold) than the stromal cells, whereas
stromal cells produce more PGE2 (by about 35-fold). However, in the present
study, the amounts of PGF2a and PGE2 produced by epithelial cells obtained from
the day 7 and day 15 guinea-pig endometrium were much greater than the amounts
of PGF2a and PGE2 produced by stromal cells in culture, suggesting that the
relative amounts of PGF2a and PGEj produced by endometrial cells is species
specific.
In the previous sets of experiments (see Sections 3.1.1 & 3.1.2), caffeine and
theophylline increased the outputs of PGF2a, PGE2, and 6-keto-PGFia from the
guinea-pig uterus superfused in vitro. The stimulatory effects of caffeine and
theophylline were also apparent on day 7 endometrium in tissue culture (see
Section 3.1.3). Caffeine had both a stimulatory and an inhibitory effect on the
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output of PGF2a from the day 15 endometrium in culture (see Section 3.1.3).
However, in this set of experiments caffeine inhibited, in particular, the output of
PGF2a from epithelial cells obtained from day 7 and day 15 endometrium.
It has been previously reported that sodium fluoride (NaF) produces both a
stimulatory and an inhibitory effect on the outputs of prostaglandins from the
guinea-pig uterus (Leckie & Poyser, 1990a, b). It has been shown that NaF inhibits
protein synthesis in the guinea-pig endometrium in culture (Leckie & Poyser,
1990b), so the inhibitory effect of NaF on PG output from the guinea-pig
endometrium in culture is thought to be due to its ability to inhibit protein synthesis
(Leckie & Poyser, 1990b). The differences in the effects of methylxanthines on the
outputs of prostaglandins from the superfused guinea-pig uterus, endometrium
tissue culture and endometrial cells in culture may be explained by assuming that
these compounds possess a 'short term' effect which was seen on superfusion and a
'long term' effect which was apparent in culture conditions (particularly in cell
culture condition). It has been shown that caffeine affects protein synthesis. In the
rat striatum caffeine induces neurotensin and CCK mRNA synthesis (Schiffmann &
Vanderhaeghen, 1993). However, in rat brain caffeine decreases glial cell numbers
(Marret et al., 1993). Hence, it is possible that, in the long term, caffeine inhibits
PGF2<x output by modulating protein synthesis from the guinea-pig endometrial
cells in culture, as it has been shown that protein synthesis inhibitors decrease
prostaglandin output from the cultured guinea-pig endometrial tissue (Poyser &
Riley, 1987; Riley & Poyser, 1989). However, this suggestion requires further
study. One other explanation is that, to see a true effect of methylxanthines on
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guinea-pig uterine PG output, it is necessary that the epithelial and stromal cells
should be in direct contact with each other. Interactions between stromal and
epithelial cells (Roberts et al., 1988) and between individual stromal cells (Parmley
et al., 1990) have been shown in the human endometrial cycle. Roberts et al.
(1988) have reported four significant changes in the transition from early
proliferative (days 5 to 9) to early secretory (days 15 to 19) phases. These changes
include: (1) an increase in the number and size of lamina densa distribution, (2) an
increase in the number and size of gap junctions, (3) an increase in the number of
epithelial cells, and (4) an increase in close contacts between stromal and epithelial
cells (Roberts et al., 1988). Finally, the ineffectiveness of ryanodine in producing
a change in PG output from the epithelial and stromal cells derived from guinea-
pig endometrium once again indicates that ryanodine-sensitive RYR channels are
not involved in the synthesis and release of prostaglandins from the guinea-pig
endometrium.
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3.1.5 The Effects of TMB-8 and Calmodulin Inhibitors (W-7 &
Trifluoperazine) on The Action of Caffeine on PG Output, and The Effects of
PLA2 and A23187 on PG Output From Cultured Endometrial Cells of The
Day 7 Guinea-Pig Uterus.
Introduction:
The effects of calmodulin inhibitors (W-7 & TFP) on basal PG output, and their
effects on A23187-induced PG output from the guinea-pig uterus superfused in
vitro (Poyser, 1985a, b) have previously been reported. In the earlier experiment
(see Section 3.1.2), it was observed that W-7 or TFP had no inhibitory effects on
the caffeine-induced rise in the outputs of prostaglandins from guinea-pig uterine
horns superfused in vitro, and TMB-8 inhibited only the caffeine stimulated rise in
PGF2a output without affecting the increases in outputs of PGE2 and 6-keto-PGFia.
In fact, W-7, but not TFP, potentiated the caffeine effect on PGF2a synthesis by
and release from the guinea-pig uterus. However, in the previous experiment (see
Section 3.1.4), it was seen that caffeine had a stimulatory and an inhibitory effect
on the outputs of prostaglandins from endometrial cells in culture. Hence, this
experiment was designed to investigate whether calmodulin inhibitors and TMB-8
would have different effects on the outputs of PG from cultured endometrial cells
in comparison to in vitro superfusion of the uterine horns. The possible effects of
these agents on caffeine-induced changes in the outputs of prostaglandin from
endometrial cells in culture were also investigated.
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Phospholipase A2 and the calcium ionophore, A23187, increase the outputs of
PGF2a, PGE2 and 6-keto-PGFia from the day 7 and day 15 guinea-pig uterus
superfused in vitro (Poyser, 1987a; 1991). A23187 has been reported to have
differential effects on human endometrial epithelial and stromal cells in culture.
A23187 stimulates arachidonic acid release from human epithelial but not from
stromal cells in culture (Bonney et al., 1991). Here, it was decided to investigate
the actions of PLA2 and A23187 on cultured endometrial cells so that a comparison
could be made regarding their effects on the superfused uterine horn and cultured
endometrial cells.
Methods:
Epithelial and stromal cells from the endometrium of four day 7 guinea-pigs were
isolated and cultured as described in Section 2.1.5. Culture medium was changed
every 3 days and on the sixth day cells were treated in duplicate. In experiment 1,
two wells containing each cell type were untreated (controls), and the remaining
cells were treated with caffeine (10 mM), W-7 (100 pM), TFP (150 pM), caffeine
(10 mM) plus W-7 (100 pM) or caffeine (10 mM) plus TFP (150 pM). In
experiment 2, two wells from each cell type were untreated (controls), and the
remaining cells were treated with caffeine (10 mM), TMB-8 (150 pM), caffeine
(10 mM) plus TMB-8 (150 pM), PLA2 (2 U/ml), or A23187 (1 pg/ml). Culture
medium was changed at 2, 8, and 24 h. The concentrations of the PLA2 and
A23187 used in this experiment have been shown to stimulate PG output from the
guinea-pig uterus superfused in vitro (Poyser, 1985a, b; Poyser & Ferguson,
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1993). Samples of culture medium were stored at -20°C before radioimmunoassay,
without extraction, for PGF2a, PGE2, and 6-keto-PGFia. Solutions of caffeine,
TMB-8, W-7, TFP and PLA2 were freshly made up in CCM solution prior to use.
A concentrated solution of A23187 was prepared in ethanol and stored at -20°C.
The appropriate concentration of A23187 was prepared by diluting 100-fold in
CCM solution.
Statistical tests:




For epithelial cells, caffeine (10 mM) significantly (p<0.05, n=4) inhibited the
output of PGF2a from epithelial cells after 2, 8 and 24 h of culture (Figure
3.1.5.1). The output of PGF2a was significantly (p<0.05, n=4) inhibited by W-7
(100 pM) after 8 and 24 h, and by TFP (150 pM) after 2, 8 and 24 h of culture.
Caffeine plus W-7 and caffeine plus TFP also significantly (p<0.05, n=4)
inhibited the output of PGF2a after 2, 8 and 24 h of culture. There were no
significant changes in the outputs of PGE2 and 6-keto-PGFia from epithelial cells
in culture due to any of these treatments, except W-7 alone which significantly
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Figure 3.1.5.1. Effects of caffeine (Cf), W-7, trifluoperazine (TFP) and
caffeine in the presence of W-7 or TFP on mean (±SEM, n=4) outputs of
PGF2a, PGE2 and 6-keto-PGFia from cultured epithelial cells obtained
from the day 7 guinea-pig endometrium.
* Significantly (p<0.05) lower than the corresponding control value.
For stromal cells, the output of PGF2a was significantly (p<0.05, n=4) inhibited
by caffeine after 2, 8 and 24 h, by W-7 after 8 and 24 h and by TFP after 2, 8 and
24 h of culture (Figure 3.1.5.2). Caffeine plus W-7 and caffeine plus TFP also
significantly (P<0.05, n=4) inhibited the output of PGF2a after 8 and 24 h of
culture. There were no significant changes in the outputs of PGE2 and 6-keto-
PGFia from stromal cells in culture due to these treatments, except W-7 and TFP
alone which significantly (p<0.05, n=4) inhibited the output of 6-keto-PGFia
after 24 h of culture (Figure 3.1.5.2).
Experiment 2:
For epithelial cells, caffeine (10 mM) significantly (p<0.05) inhibited the output
of PGF2a after 2, 8 and 24 h of culture (Figure 3.1.5.3). TMB-8 (150 pM)
significantly (p<0.05, n=4) inhibited the output of PGF2a after 8 and 24 h of
culture. Caffeine and TMB-8 alone had no significant effect on the outputs of
PGE2 and 6-keto-PGFia from epithelial cells in culture. Caffeine plus TMB-8
significantly (p<0.05, n=4) decreased the output of PGF2a after 2, 8 and 24 h of
culture. Caffeine plus TMB-8 had no effect on the outputs of PGE2 and 6-keto-
PGFia. PLA2 (2 U/ml) significantly (p<0.05, n=4) increased the outputs of
PGF2(X by 1.7-fold after 24 h, PGE2 by 1.6- to 2.6-fold after 2, 8 and 24 h, and 6-
keto-PGFia by 1.2-fold after 24 h of culture. Calcium ionophore (A23187; 1
pg/ml) significantly (p<0.05, n=4) increased the output of PGF2a by 1.7-fold










Figure 3.1.5.2. Effects of caffeine (Cf), W-7, trifluoperazine (TFP) and caffeine in
the presence of W-7 or TFP on mean (±SEM, n=4) outputs of PGF2a, PGE2 and
6-keto-PGFla from cultured stromal cells obtained from day 7 guinea-pig
endometrium.
* Significantly (p<0.05) lower than the corresponding control value.
of culture. A23187 had no effect on the outputs of PGE2 and 6-keto-PGFia (Figure
3.1.5.3).
For stromal cells, caffeine had no effect on the outputs of PGF2a, PGE2 and 6-
keto-PGFia, except it significantly (p<0.05, n=4) increased the output of PGE2
by 1.2-fold after 24 h of cell culture (Figure 3.1.5.4). TMB-8 alone had no effect
on the outputs of PGF2a, PGE2 and 6-keto-PGFia from cultured stromal cells.
Caffeine plus TMB-8 also had no effect on the outputs of PGF2a and 6-keto-PGFia,
but significantly (p<0.05, n=4) increased the output of PGE2 by 1.2- to 1.3-fold
after 2 and 24 h but not after 8 h of culture. PLA2 caused significant (p<0.05,
n=4) increases in the outputs of PGF2« by 1.7-fold and 6-keto-PGFia by 1.4-fold
after 24 h of culture, and in the output of PGE2 by 1.5- to 1.6-fold after 2, 8 and
24 h of culture (Figure 3.1.5.4). A23187 Significantly (p<0.05, n=4) increased
the output of PGF2a by 1.3-fold after 2 h but significantly (p<0.05, n=4)
decreased PGF2a output after 24 h of culture. A23187 also significantly (p<0.05,
n=4) decreased the output of 6-keto-PGFia after 8 and 24 h of culture. A23187
had no effect on PGE2 output from the stromal cells in culture (Figure 3.1.5.4).
Discussion:
It has been previously reported that the increase in the endometrial prostaglandin
synthesis and release in the rat (Day et al., 1982), guinea-pig (Downing & Poyser,
1983), and human (Bonney, 1985) is associated with an increase in the activity of
phospholipase A2, a calcium dependent enzyme. In the guinea-pig, it is thought
that the activation of PLA2 by calcium (Downing & Poyser, 1983) leads to the
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Figure 3.1.5.3 Effects of caffeine (Cf), TMB-8, PLA2, A23187 and caffeine in
the presence of TMB-8 on mean (+SEM, n=4) outputs of PGF2(X, PGE2 and
6-keto-PGF,a from cultured epithelial cells obtained from day 7 guinea-pig
endometrium. * Significantly (p<0.05) higher than the corresponding control
value, t Significantly (p<0.05) lower than the corresponding control value.
PGF2a
■ Control
B CI (10 mM)
■ TMB-8 (150 jiM)
B Cf +TMB-8
□ PLA2 (2 U/ml)


















Figure 3.1.5.4. Effects of caffeine (Cf), TMB-8, PLA2, A23187 and caffeine
in the presence of TMB-8 on mean (±SEM, n=4) outputs of PGF2a, PGE2
and 6-keto-PGFla from cultured stromal cells obtained from day 7
guinea-pig endometrium.
* Significantly (p<0.05) higher than the corresponding control value.
+ Significantly (p<0.05) lower than the corresponding control value.
release of arachidonic acid from phosphatidylcholine and phosphatidylethanolamine
(Ning & Poyser, 1984) which, in turn, results in increased PGF2a synthesis by and
release from the endometrium. Poyser (1987a, b) also suggested that A23187-
induced increase in PG output from the guinea-pig uterus is via activation of PLA2.
PLA2 and A23187 have been reported to increase PGF2a, PGE^ and 6-keto-PGFia
outputs from superfused guinea-pig uterine horns (Poyser, 1991). In this study, the
PLA2 stimulated the outputs of PGF2a and 6-keto-PGFia from epithelial and
stromal cells only after 24 h of cell culture, whereas PLA2 stimulated the output of
PGE^ from both cell types after 2, 8 and 24 h of culture. These findings suggest
that the exogenous PLA2 tends to preferentially stimulate PGEj synthesis by and
release from the guinea-pig endometrial cells. The reason for this limited action of
PLA2 on PGF2o and 6-keto-PGFia output from cultured endometrial cells remains
to be identified.
The effect of A23187 on PG outputs was somewhat unexpected. The outputs of
PGE^ and 6-keto-PGFia from epithelial and stromal cells were not affected by
A23187. Nevertheless, during the first 2 h of cell culture, A23187 stimulated
PGF2a output from cultured epithelial and stromal cells, an effect reported for
perfused uterine horns (Poyser, 1987a, b; Poyser, 1991; Poyser & Ferguson,
1993). By 24 h of cell culture, this stimulatory effect was reversed and inhibition
of PGF2a output from both epithelial and stromal cells was seen. Following
repeated stimulation, a partial refractoriness to A23187 has been shown on PG
output from the guinea-pig uterus superfused in vitro (Poyser, 1991; Poyser &
Ferguson, 1993). This refractoriness is thought to occur at the level of arachidonic
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acid release, since there is no refractoriness to repeated stimulations with
arachidonic acid as regards uterine prostaglandin production (Poyser, 1991). There
appears to be one or several bound pools of arachidonic acid which are releasable
but which take about 3-5 h to refill (Poyser, 1991). Thus, it seems that the lack of
a stimulatory effect of A23187 on PGF2a output from cultured cells after 8 h of
culture was probably due to this refractoriness. However, this phenomenon of
refractoriness does not explain the inhibitory effect of A23187 on the output of
prostaglandins after 24 h of cell culture.
It has been reported that A23187 affects epithelial and stromal cells differently.
A23187 stimulated a dose- and time-dependent release of arachidonic acid from
human endometrial glands without affecting stromal cells (Bonney et al., 1991). In
the present study, A23187 stimulated PG output from both epithelial and stromal
cells after 2 h of culture indicating a species difference with regard to A23187
activity on the uterine tissue.
TMB-8 causes a transient increase in the output of PGF2a from the guinea-pig
uterus superfused in vitro (Poyser, 1985b; Leckie & Poyser, 1991a; see Section
3.1.2). However, in this present set of experiments, TMB-8 inhibited PGF2a
synthesis by and release from cultured epithelial cells and, to a lesser extent, from
stromal cells suggesting a role for intracellular calcium in uterine PG output.
Caffeine alone and TMB-8 alone increased PGE2 output from epithelial cells after
24 h but not after 2 and 8 h of culture. However, caffeine plus TMB-8 significantly
increased PGE2 output from epithelial cells after 2 h of culture, suggesting that in
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the short term, these compounds have synergistic stimulatory effect on the output
of PGE2 from cultured epithelial cells.
Calmodulin inhibitors (W-7 and TFP) have been shown to inhibit A23187-induced
prostaglandin output from the guinea-pig uterus superfused in vitro (Poyser, 1985a,
b). In this study, the calmodulin antagonists (W-7 and TFP) inhibited the output of
PGF2a and to a much lesser extent the output of 6-keto-PGFia from both epithelial
and stromal cells in culture suggesting that calmodulin is involved in the basal PG
output from the cultured day 7 guinea-pig endometrial cells.
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3.1.6 The Effects of Ryanodine, Dantrolene, Thapsigargin and Berberine on
The Actions of Caffeine on Cultured Epithelial and Stromal Cells Obtained
From Day 7 Guinea-Pig Endometrium.
Introduction:
Dantrolene is reported to be a potent muscle relaxant and an inhibitor of
ryanodine-binding to the skeletal type ryanodine-receptor (RYR) (Pessah et al.,
1986; Shoshan-Barmatz et al., 1991), but does not inhibit RY binding to rat brain
RY receptors (Smith & Nahroski, 1993). Thapsigargin (TG) decreases intracellular
calcium uptake in rabbit pancreatic acinar cells (Van de Put et al., 1993), depletes
calcium from the sarcoplasmic reticulum (Chen & Van Breemen, 1993), and
abolishes agonist-induced calcium uptake (Kuemmerle et al., 1994). Berberine is
reported to block calcium release from the sarcoplasmic reticulum (Chiou et al.,
1991). In the previous experiments the effects of caffeine on PG output from
endometrial cells were somewhat (see Sections 3.1.4 & 3.1.5) different from its
action on PG output from perfused uterine horns (see Sections 3.1.1 & 3.1.2).
However, RY alone consistently had no effect on PG output from superfused
uterine horns, and from endometrial epithelial and stromal cells in culture (see
Sections 3.1.1, 3.1.2 & 3.1.4). Thus, this set of experiments was designed to
investigate whether these substances which modulate concentration of free
intracellular calcium would affect the outputs of PG from the guinea-pig uterus.
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Methods:
Epithelial and stromal cells from the day 7 guinea-pig endometrium were isolated
and cultured as described in Section 2.1.5. Culture medium was changed every 3
days and on the sixth day cells in culture were treated in duplicate. In experiment
1, two wells containing each cell type were untreated (controls), and the remaining
cells were treated with caffeine (10 mM), dantrolene (300 pM), RY (20 pM),
caffeine (10 mM) plus dantrolene (300 pM) or caffeine (10 mM) plus RY (20
pM). In experiment 2, two wells containing each cell type were untreated
(controls), and the remaining wells were treated with caffeine (10 mM),
thapsigargin (1 pM), berberine (20 pM), caffeine (10 mM) plus thapsigargin (1
pM) and caffeine (10 mM) plus berberine (20 pM). Culture medium was changed
after 2, 8, and 24 h of culture. Samples of culture medium were stored at -20°C
before radioimmunoassay, without extraction, for PGF2a, PGE^ and 6-keto-
PGFia.
Solutions of caffeine, dantrolene and berberine were freshly made up in CCM
solution prior to use. Concentrated solutions of RY and thapsigargin were prepared
in ethanol and DMSO, respectively and stored at -20°C. The appropriate
concentration of RY and thapsigargin were prepared in CCM solution. These
compounds were diluted 200- and 150-fold with CCM before use, respectively.
Usachev et al. (1993) has shown that, in rat sensory neurones, caffeine-evoked
[Ca2+]j transients were effectively blocked by RY (10 pM) and dantrolene (10
pM). However, Smith and Nahorski (1993) have reported that [3H]RY-binding to
cortical membrane in the rat brain was enhanced by caffeine (10 mM) and inhibited
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by ruthenium red (107 - 10"4 M), whereas dantrolene (300 pM) was ineffective.
Xu and Forsberg (1993) have shown that thapsigargin (1 pM) induced increase in
[Ca2+]; an effect which was blocked by pre-treatment with 40 mM caffeine.
Berberine (107 - 3x10~5 M) causes dose-dependent relaxation of phenylephrine-
induced contraction (Chiou et al., 1991). Therefore, the concentrations of
ryanodine, dantrolene, thapsigargin and berberine chosen in the present study were
in the expected range to produce effects.
Statistical tests:
The results were analysed by one-way analysis of variance (ANOVA) and by the
paired t-test.
Results:
In experiment 1, caffeine (10 mM) and caffeine (10 mM) plus RY (20 pM) caused
a significant (p<0.05, n=4) decrease in the output of PGF2a from epithelial cells
after 8 and 24 h in culture (Figure 3.1.6.1). Caffeine (10 mM) also significantly
(p<0.05, n=4) inhibited the output of 6-keto-PGFia from epithelial cells after 8 h
of culture. Caffeine had no effect on PGE2 output from epithelial cells. Caffeine
(10 mM) significantly (p<0.05, n=4) stimulated the outputs of PGE2 after 2 and 8
h and 6-keto-PGFia after 2, 8 and 24 h from stromal cell in culture (Figure
3.1.6.1). Caffeine had no effect on PGF2a output from stromal cells.
Dantrolene (300 pM) alone had no effect on PGF2a output from epithelial cells, but
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Figure 3.1.6.1. Mean (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFla from day 7
endometrial (i) epithelial and (ii) stromal cells in culture. Cells were treated with nothing
(control), caffeine (Cf), dantrolene (DN), ryanodine (RY), Cf + DN or Cf + RY for 2, 6 and 16
h. * Significantly (p<0.05) higher than the corresponding control value. + Significantly
(p<0.05) lower than the corresponding value. ♦ Significantly (p<0.05) higher than the value
obtained by Cf and/or DN alone for the same PG during the same culture period.
1.9- to 2.0-fold after 2 and 8 h of culture. Dantrolene plus caffeine significantly
(p<0.05, n=4) stimulated the outputs of PGE2 by up to 2.4-fold and 6-keto-
PGFia by up to 3.5-fold from epithelial cells after 2, 8 and 24 h of culture (Figure
3.1.6.1). Dantrolene significantly (p<0.05, n=4) stimulated the outputs of PGE2
by up to 2-fold and 6-keto-PGFia by up to 4-fold after 2, 8 and 24 h from stromal
cells. Dantrolene (300 pM) plus caffeine (10 mM) caused a significant (p<0.05,
n=4) increase in the outputs of PGF2a by 2.3- to 3.4-fold, PGE2 by 2.1- to 2.8-
fold and 6-keto-PGFia by 4.9- to 7-fold after 2, 8 and 24 h from stromal cells
(Figure 3.1.6.1). Dantrolene (300 pM) plus caffeine (10 mM)-induced increases in
the outputs of PGE2 after 2 and 24 h, and of 6-keto-PGFia after 24 h from stromal
cells were significantly (p<0.05, n=4) greater than caffeine alone- and/or
dantrolene alone-induced increases in the outputs of these prostaglandins from
stromal cells after the same time periods of treatment (Figure 3.1.6.1).
Ryanodine (20 pM) alone had no significant effect on the outputs of PGF2a, PGE2
and 6-keto-PGFia from epithelial or stromal cells in culture (Figure 3.1.6.1).
Caffeine plus RY had no effects on the outputs of PGF2a, PGE2 and 6-keto-PGFia
from epithelial or stromal cells, except for a significant (p<0.05, n=4) inhibitory
effect on PGF2a output from epithelial cells after 24 h of culture, and a significant
(p<0.05, n=4) stimulatory effect on 6-keto-PGFia from stromal cells after 2 h of
culture (Figure 3.1.6.1). Ryanodine did not significantly modify the responses
produced by caffeine alone.
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In experiment 2, caffeine (10 mM) significantly (p<0.05, n=4) decreased the
outputs of PGF2a after 8 and 24 h, and 6-keto-PGFia after 8 h from epithelial cells
in culture, an effect similar to that seen in experiment 1 (Figure 3.1.6.2). Caffeine
(10 mM) also significantly (p<0.05, n=4) increased the outputs of PGEj by 1.3-
fold and 6-keto-PGFia by 1.4-fold from stromal cells after 2 h of culture (Figure
3.1.6.2). Caffeine alone had no effect on PGE2 output from epithelial cells.
Thapsigargin (1 pM) alone significantly (p<0.05, n=4) increased the output of
PGF2a from epithelial cells after 2 h, an effect which was lost by 8 h, and was
reversed to a significant inhibition (p<0.05, n=4) after 24 h of cell culture
(Figure 3.1.6.2). Thapsigargin had no effect on PGF2a output from stromal cells,
or on the outputs of PGE2 and 6-keto-PGFia from epithelial and stromal cells.
Thapsigargin (1 pM) plus caffeine (10 mM) significantly (p<0.05, n=4)
decreased the output of PGF2a from epithelial cells after 8 and 24 h, but this
response was not significantly different from caffeine or thapsigargin alone.
Caffeine plus thapsigargin had no effect on PGF2a output from epithelial cells after
2 h, so the presence of caffeine significantly (p<0.05, n=4) inhibited the
stimulatory action of thapsigargin (Figure 3.1.6.2). Caffeine plus thapsigargin
significantly (p<0.05, n=4) increased the outputs of PGE2 and 6-keto-PGFia by
up to 1.4-fold from stromal cells after 2 h of culture. These effects are probably
entirely due to the actions of caffeine, since caffeine alone produced the same
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Figure 3.1.6.2. Mean (±SEM, n=4) outputs of PGF2(X, PGE2 and 6-keto-PGFla from
cultured day 7 (i) epithelial and (ii) stromal cells. Cells were either untreated
(control) or treated with caffeine (Cf), thapsigargin (TG), berberine (Berb), Cf +TG or
Cf+Berb. for 2, 6 and 16 h. * Significantly (p<0.05) higher than the corresponding
control value, t Significantly (p<0.05) lower than the corresponding control value.
♦ Significantly (p<0.05) lower than TG alone treatment during the same period of
culture.
thapsigargin had no effect on the outputs of PGE2 and 6-keto-PGFia from
epithelial cells and of PGF2a from stromal cells (Figure 3.1.6.2).
Berberine (20 pM) alone significantly (p<0.05, n=4) decreased the output of
PGF2a from epithelial cells after 8 and 24 h culture (Figure 3.1.6.2). Berberine (20
pM) plus caffeine (10 mM) significantly (p<0.05, n=4) decreased the output of
PGF2<x form epithelial cells after 8 and 24 h, and significantly (p<0.05, n=4)
increased the outputs of PGE2 and 6-keto-PGFia by up to 1.4-fold from stromal
cells after 2 h of culture (Figure 3.1.6.2). These stimulatory effects are probably
due to the actions of caffeine, as caffeine alone produced the same effects whereas
berberine alone failed to do so. Berberine alone or together with caffeine had no
effect on the outputs of PGE2 and 6-keto-PGFia from epithelial cells, and on PGF2a
output from stromal cells (Figure 3.1.6.2).
Discussion:
Ryanodine (RY) alone did not affect the outputs of prostaglandins from the
cultured endometrial cells. This is in agreement with the results obtained in earlier
experiments (see Sections 3.1.2, 3.1.3 & 3.1.4). Ryanodine did not affect the
actions of caffeine on the outputs of prostaglandins from the epithelial and stromal
cells. These results indicate that caffeine-induced changes in the outputs of
prostaglandins from the endometrial cells is not mediated by the activation of a
RY-sensitive receptor. Hence, it seems that in the guinea-pig endometrium, RY
and a RYR-channel is not involved in prostaglandin production. However,
dantrolene, a RY-like modulator of calcium release from RYR-channel, stimulated
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prostaglandin outputs from both epithelial and stromal cells in culture. Dantrolene
also blocked the inhibitory effect of caffeine on the output of PGF2a from epithelial
cells, and potentiated caffeine-induced PGE2 and 6-keto-PGFia production by the
cultured stromal cells. Dantrolene inhibits RY-binding and RY-induced calcium
release in longitudinal muscle of the intestine of the guinea-pig (Kuemmerle et al.,
1994), but is ineffective as regards RY-binding to the rat cortical membrane (Smith
& Nahroski, 1993). It has been shown that the skeletal muscle type RYR is more
sensitive to dantrolene than cardiac type. Thus, these findings suggest that either
there is a skeletal type RYR-like protein which is modulated by dantrolene or
dantrolene is exerting a non-specific effect on the outputs of prostaglandins from
the guinea-pig uterus. The latter explanation seems more likely since RY has no
effect on PG output from endometrial cells.
The effects of thapsigargin on PGF2a output from epithelial cells were similar to
the action of A23187 (see Section 3.1.4). Thapsigargin stimulated the output of
PGF2o from epithelial cells after 2 h and inhibited PGF2a output after 24 of cell
culture. Thapsigargin releases calcium from internal pools (Herchuelz & Lebrun,
1993; Wegner, et al., 1994; Toescu & Petersen, 1994; Diarra & Sauve, 1992;
Jancezewski & Lakatta, 1993) and inhibits the caffeine-induced rise in intracellular
calcium in chick ciliary ganglion cells (Sorimachi, 1993). Hence, it is possible that
the stimulatory effect of thapsigargin on PGF2a output may be due to its ability to
release calcium from an internal store. Its inhibitory effect on PGF2a output from
epithelial cells may be due to inhibition of the endoplasmic reticulum Ca2+/ATPase
and subsequent depletion of an internal calcium pool and, in turn, lack of calcium
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to maintain basal PG output. Thapsigargin did not prevent the increases in the
outputs of PGE2 and 6-keto-PGFia induced by caffeine during the first 2 h of
culture, indicating that, if this stimulatory action of caffeine is dependent upon the
release of intracellular calcium, the calcium pool which is involved in the outputs
of PGE2 and 6-keto-PGFla is not thapsigargin sensitive. On the other hand,
caffeine inhibited thapsigargin-induced rise in PGF2a output from epithelial cells
after 2 h of culture. This finding indicates that either the inhibitory effect of
caffeine on PGF2a output has overcome the stimulatory effect of thapsigargin, or
caffeine inhibited a thapsigargin-induced rise in free intracellular calcium by
2 +
interfering possibly with Ca /ATPase of the endoplasmic reticulum. However,
more studies are required to elucidate further the above hypotheses.
It is thought that berberine inhibits caffeine-induced contractions by inhibiting
calcium release from the sarcoplasmic reticulum (Chiou et al., 1991). In the
present study, berberine alone inhibited only the output of PGF2a from epithelial
cells after 8 and 24 h of cell culture. Thus, PGF2a output from epithelial cells may
dependent upon the release of intracellular calcium. The effects of caffeine on the
outputs of prostaglandins from endometrial cells were not affected by berberine.
Thus, an inhibitor of calcium release from the endoplasmic reticulum did not block
the actions of caffeine. In summary, it was found that the caffeine-induced changes
in the outputs of PGF2a, PGE2 and 6-keto-PGFia from endometrial cells in culture
are modulated by dantrolene, but not by RY, thapsigargin or berberine in the
concentrations used.
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3.1.7 The Effects of Forskolin (An Activator of Adenyl Cyclase) on The
Outputs of Prostaglandins From Endometrial Tissue and Endometrial Cell
Cultures of Day 7 Guinea-Pig Uterus.
Introduction:
In the previous experiments (see Sections 3.1.1, 3.1.2 & 3.1.3), it was shown that
caffeine and theophylline stimulated prostaglandin production from the guinea-pig
uterine horn superfused in vitro and from endometrial tissue in culture. However,
caffeine showed a stimulatory and an inhibitory effect in the outputs of
prostaglandin from epithelial and stromal cells in culture (see Sections 3.1.4 to
3.1.6). Caffeine and theophylline are phosphodiesterase (PDE) inhibitors. It is
possible that these compounds exert their inhibitory effect on PG output from the
endometrial cells by inhibiting PDE activity and, as a result, by increasing the
amount of cAMP. This increase in cAMP level may result in a decrease in
intracellular calcium level and hence inhibiting PLA2 activity. However, an
increase in cAMP level did not affect prostaglandin synthesis by and release from
the guinea-pig uterine horns superfused in vitro (Poyser, 1987a). Experiments
carried out so far in the present study have indicated that prostaglandin synthesis
and release from guinea-pig uterus due to various treatments, including caffeine,
depends on the experimental protocol. To further elucidate a possible role for the
involvement of cAMP in the inhibitory effects of caffeine, the effects of forskolin,
which increases cAMP levels, were examined on endometrial tissue and cell
cultures from the day 7 guinea-pig uterus.
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Methods:
In experiment 1, epithelial and stromal cells from the endometrium of four day 7
guinea-pigs were isolated and cultured as described in Section 2.1.5. Culture
medium was changed every 3 days and on the sixth day, cells in culture were
treated in duplicate. Two wells containing each cell type were untreated (controls),
and two wells from each cell type were treated with forskolin (10 pM). This
concentration of forskolin is known to raise cAMP levels in guinea-pig
endometrium and myometrium homogenates (Poyser, 1987a).
In experiment 2, tissue preparation and culture set up was as described in Section
2.1.3. Six tissue culture dishes were prepared from the endometrium obtained from
each guinea-pig. Four of these petri dishes were left untreated (acted as controls),
and the remaining dishes were treated in duplicate with forskolin (10 pM). In both
experiments, culture medium was changed after 2, 8, and 24 h of culture. Samples
of culture medium were stored at -20°C before radioimmunoassay, without
extraction, for PGF2a, PGE2, and 6-keto-PGFia.
A concentrated solution of forskolin was prepared in DMSO and stored at -20°C.
The appropriate concentration of forskolin was prepared by diluting 160-fold with
cell culture medium or tissue culture medium solutions for use in experiments 1
and 2, respectively.
Statistical tests:




Forskolin had no inhibitory effect on the outputs of PGF2a, PGE2 and 6-keto-
PGFia from both epithelial and stromal cells after 2, 8 and 24 h of culture. In fact,
forskolin significantly (p<0.05) increased PGF2a output from epithelial cells after
8 h of cell culture (Figure 3.1.7.1). Forskolin had no effects in the outputs of
PGF2a, PGE2 and 6-keto-PGFia from the guinea-pig endometrium in culture
(Figure 3.1.7.2).
Discussion:
In the guinea-pig, an increase in the endometrial cAMP level by forskolin is not
associated with a change in the basal outputs of prostaglandins from the guinea-pig
uterus superfused in vitro (Poyser, 1987a). In the present study, forskolin
stimulated PGF2a output from the epithelial cells after 8 h of cell culture,
suggesting a role for cAMP in the PG output from the guinea-pig uterus. If cAMP
were involved in the uterine PG synthesis and release, it would be expected that
forskolin exerts an inhibitory effect rather than a stimulatory effect, since increase
in cAMP concentration reduce intracellular free calcium level. However, forskolin
had no inhibitory effect on the outputs of any of the 3 PGs measured from the
cultured endometrium, indicating that cAMP is not involved in the regulation of
endometrial prostaglandin synthesis and release. Thus, it is unlikely that cAMP is
involved in the stimulation of PGF2a output from epithelial cells, and that this
stimulatory effect of forskolin may be due to some other non-specific action on
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Figure 3.1.7.1. Effects of forskolin (FKN) on mean (±SEM, n=4) outputs of
PGF2a, PGE2 and 6-keto-PGF-|a from cultured (i) epithelial and (ii) stromal
cells obtained from the day 7 guinea-pig endometrium.
* Significantly (p<0.05) increased by forskolin treatment.
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Figure 3.1.7.2. Effects of forskolin (FKN) on mean
(±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFla
from day 7 guinea-pig endometrium in culture.
epithelial cells. However, a rise in cAMP level is associated with an increase in
ovarian prostaglandin production (Zar et al., 1977).
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3.1.8 Effects of Methylxanthines, Ryanodine (RY), Phospholipase (PL) A2
(PLA2) and Platelet Activating Factor (PAF) on the Intracellular Free Calcium




Mobilisation of intracellular Ca is mediated by two major mechanisms. Surface
receptor activation stimulates phosphoinositide metabolism resulting in production
of inositol triphosphate (IP3), a second messenger for releasing Ca from
endoplasmic reticulum (Sterb et al., 1983; Berridge, 1984; see Berridge & Irvine,
1989; see Berridge, 1993). The second mechanism for calcium mobilisation is
calcium-induced calcium-release (CICR). This mechanism which mediates RYR is
best characterised in skeletal and cardiac muscles and has been shown to be
modulated by substances such as caffeine and RY, (Komori & Bolton, 1989; Lee,
1993; Stauderman, et al., 1991) as well as theophylline (Pessah et al., 1993;
Donoso et al., 1994). Other agents such as histamine (Diarra & Sauve, 1992;
Stauderman et al., 1991), calcium ionophore (A23187) (Zimanyi et al., 1992),
muscarinic receptor agonist such as methacholine (Sorimachi, et al., 1992), and
thapsigargin (Chen & Van Breemen, 1993) have been shown to release calcium
from one or more internal calcium stores, resulting an increase in free cytosolic
calcium levels within the cells. Since results obtained from the previous
experiments in this thesis have suggested that mobilisation of calcium from an
internal store may be responsible for the stimulatory effects of caffeine,
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theophylline and PLA2 on PG outputs from guinea-pig uterus, this experiment was
designed to further investigate the above hypothesis by measuring the internal
calcium levels in the presence of these substances using a calcium-sensitive dye
(fura-2 AM).
Methods;
For detailed methods of epithelial and stromal cell isolation and preparation see
Section 2.1.5, and for loading of cells with fura-2/AM and intracellular calcium
measurements see Section 2.1.6. Briefly, cells were loaded with 2 pM fura-2
acetoxymethyl ester (fura-2/AM) by incubating for 30 min at room temperature
(25°C). Cells were then washed, re-suspended in appropriate fresh Krebs solution
buffered with 20 mM HEPES, pH 7.4 and left to stand for a further 30 min to
allow hydrolysis of the intracellular fura-2/AM. After 30 min the cells were
washed, re-suspended in appropriate fresh Krebs solution, and transferred to a
quartz cuvette maintained at 37°C. The cells were continuously stirred in the
cuvette. Fluorescence was measured in a Shimadzo (type RF-5000)
spectrofluorophotometer at 505 nm with alternate excitation at 340 nm and 380
2 +
nm. The intracellular free calcium concentration ([Ca ];) was then calculated
using the equation of Grynkiewicz et al. (1985):
[Ca2+]i = (kd) x (b) x [R - Rmin]/[Rmax - R]
and the resultant experimental data of percentage change of [Ca2+]; versus agonist
concentration was obtained, where R is the ratio of fluorescence due to excitation
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at 340 nm to that at 380 nm. Rmax and Rm;n are the maximal and minimal
fluorescence ratios of fura-2 obtained in Krebs solution containing saturated levels
of calcium with a calcium ionophore, ionomycin (10 nM), and EGTA (30 mM),
2 4"
respectively. The K<j value for the fura-2-Ca -complex was assumed to be 225 nM
at 37°C (Buchan & Martin, 1991; Grynkiewicz et al., 1985), and b is the ratio of
the 380 nm signals in Ca2+-free and Ca2+-containing Krebs solution.
Solutions of caffeine, theophylline and PLA2 were freshly made up in calcium-free
Krebs solution prior to use. Concentrated solutions of RY, PAF and ionomycin in
ethanol were prepared and stored at -20°C. The appropriate concentration of these
compounds were then prepared by diluting at least 10-fold in calcium-free Krebs
solution.
Statistical tests:
The results were analysed by one-way analysis of variance (ANOVA) and by the
paired t-test.
Results:
In the presence of extracellular calcium, caffeine (10 & 20 mM) significantly
(p<0.05, n=3) lowered the basal intracellular calcium concentration ([Ca2+];) of
stromal cells obtained from day 15 guinea-pig endometrium by up to 65.3% but
had no effect on [Ca2+]; in day 7 stromal cells or in day 7 and day 15 epithelial
cells (Figure 3.1.8.1). In the absence of extracellular calcium, caffeine (10 & 20
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Figure. 3.1.8.1. Effects of caffeine (Caff.) (10 & 20 mM) and theophylline
(Theo.) (10 mM) on changes in [Ca2+]j of epithelial and stromal cells of day
7 and day 15 guinea-pig endometrium in the presence (+) or absence (-) of
extracellular calcium.
* Significantly (P< 0.05, n = 3) lower than baseline.
mM) significantly (p<0.05, n=3) reduced [Ca2+]; in day 7 and day 15 stromal
cells, and in day 15 (but not day 7) epithelial cells, by 25.4% to 63.3% (Figure
3.1.8.1). Theophylline (10 mM) had no significant effect on [Ca2+]i in day 7 or 15
epithelial and stromal cells in the presence or absence of extracellular calcium
(Figure 3.1.8.1). Cumulative increasing concentrations of ryanodine (RY; 1 nM to
1 mM) had no effect on [Ca2+]; in day 7 and day 15 epithelial and stromal cells in
the presence or absence of extracellular calcium (Figure 3.1.8.2).
Cumulative increasing concentrations of PLA2 (1 to 10 U/ml) caused significant
changes in [Ca2+]; in day 7 and day 15 epithelial and stromal cells in the presence
or absence of extracellular calcium. In the presence of extracellular calcium, PLA2
(1 to 10 U/ml) significantly (p<0.05, n=3) increased [Ca2+]; in day 7 and day 15
stromal and epithelial cells by 21.9- to 72.1-fold (Figure 3.1.8.3). In the absence
of extracellular calcium, PLA2 (1 to 10 U/ml) significantly (p<0.05, n=3)
increased [Ca2+]; in day 15 stromal cells, and day 7 and day 15 epithelial cells by
2.8- to 6.1-fold. PLA2 also increased [Ca2+]; in day 7 stromal cells but these
increases were not statistically significant (Figure 3.1.8.3). In the presence or
absence of extracellular calcium, PLA2 (4 to 10 U/ml) was significantly (p<0.05,
2 -f*
n=3) more effective in increasing [Ca ]; of epithelial cells than of stromal cells
from day 15 endometrium (Figure 3.1.8.3).
Platelet activating factor (PAF) (2 to 20 pM) significantly (p<0.05, n = 3)
increased [Ca2+]; in day 7 and day 15 epithelial and stromal cells by 5.4- to 69.2-
fold in the presence of extracellular calcium, and in day 15 (but not day 7)
epithelial and stromal cells by 13.2- to 13.4-fold in the absence of extracellular
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Figure. 3.1.8.2. Effects of cumulative increasing
concentrations of ryanodine (1 nM to 1 mM) on changes
in [Ca2+]j of epithelial and stromal cells of day 7 and day
15 guinea-pig endometrium in the presence (+) or
absence (-) of extracellular calcium.
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Figure.3.1.8.3. Effects of cumulative increasing concentrations of
PLA2 (1 to 10 U/ml) on changes in [Ca2+]j of epithelial and stromal
cells of day 7 and day 15 guinea-pig endometrium in the presence
(+) or absence (-) of extracellular calcium.
* Significantly (P<0.05, n = 3) higher than baseline.
♦ Significantly (p<0.05, n=3) higher than the corresponding value
obtained for stromal cells at the same concentration of PLA2.
calcium (Figure 3.1.8.4). In the presence of extracellular calcium, PAF (4 to 20
2. ■+■
pM) was significantly (p<0.05, n=3) more effective in increasing [Ca ], of
stromal cells than of epithelial cells from day 7 endometrium (Figure 3.1.8.4). In
the presence of extracellular calcium, PAF (20 pM) was also significantly
(p<0.05, n=3) more potent in increasing [Ca2+][ of stromal cells than of epithelial
cells from day 15 guinea-pig endometrium.
Discussion:
Caffeine and ryanodine interact with a RYR-channel on the membrane of
sarcoplasmic reticulum (SR) and release calcium (Chen & Cheung, 1992;
McPherson & Campbell, 1993a, b; Zahradink & Palade, 1993). As a result the
concentration of cytosolic free calcium increases, and this increase is thought to be
responsible for many cellular mechanisms including the activation of endometrial
PLA2 in the human (Bonney, 1985), rat (Dey, 1982) and guinea-pig (Downing &
Poyser, 1983). The results obtained from Sections 3.1.1 and 3.1.2 suggested that
caffeine may increase the intracellular calcium by interacting with a novel receptor
in the membrane of the endoplasmic reticulum, thereby releasing calcium from an
internal pool and consequently stimulating prostaglandin production by the guinea-
pig uterus. However, in this study, caffeine and theophylline failed to increase
intracellular calcium concentrations in day 7 and day 15 epithelial and stromal
cells. In fact, caffeine and, to a lesser extent, theophylline decreased the basal free
intracellular calcium concentration. These findings indicate that the caffeine- and
theophylline-induced stimulations of prostaglandin production by guinea-pig uterus
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Figure.3.1.8.4. Effects of cumulative increasing concentrations of PAF (2
to 20 pM) on changes in [Ca2+]| of epithelial and stromal cells of day 7 and
day 15 guinea-pig endometrium in the presence (+) or absence (-) of
extracellular calcium.
* Significantly (P< 0.05, n = 3) higher than baseline. ♦ Significantly
(p<0.05, n=3) higher than the corresponding value obtained for epithelial
cells at the same concentration of PAF.
are not associated with an increase in [Ca2+]; in endometrial epithelial and stromal
cells. However, the decrease in PGF2<x output from epithelial cells in culture
induced by caffeine may be due to a decrease in intracellular free calcium
concentration produced by caffeine.
Ryanodine did not affect PG output from guinea-pig uterus in any experimental
protocol. Ryanodine also did not increase the intracellular calcium concentration in
day 7 or day 15 guinea-pig epithelial or stromal cells. These findings indicate that
there does not appear to be any RYR type 1, RYR type 2 or RYR type 3 present in
the guinea-pig epithelial and stromal cells.
PLA2 has been shown to stimulate PG output from guinea-pig uterus superfused in
vitro (Poyser, 1991; Poyser & Ferguson, 1993) and from cultured endometrial
epithelial and stromal cells (see Section 3.1.5). In the present study, PLA2
significantly increased the intracellular calcium concentration in both epithelial and
stromal cells in the presence or absence of extracellular calcium. These finding
indicate that the increases in PG output from guinea-pig uterus produced by PLA2
are associated with an increase in intracellular calcium concentration in endometrial
epithelial and stromal cells, and that this increase in intracellular calcium
concentration is due, at least in part, to the release of intracellular calcium.
PAF has been shown to stimulate PG output in the presence or absence of
extracellular calcium from the guinea-pig uterus superfused in vitro (Norman &
Poyser, 1992). In the present study, PAF dose-dependently increased the
intracellular calcium concentration in both epithelial and stromal cells obtained
from the day 7 and day 15 guinea-pig endometrium, suggesting mobilisation of
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calcium from an internal store. This is in agreement with a recent report by Ahmed
et al. (1994). Ahmed et al. (1994) have shown that PAF increases intracellular
calcium concentration in human endometrial HEC-1B cell line in the presence or
absence of calcium. These finding indicate that PAF-induced PG output from the
guinea-pig uterus is associated with an increase in intracellular calcium
concentration in endometrial and stromal cells, and that this increase in
intracellular calcium concentration is due, at least in part, to the release of
intracellular calcium. Nevertheless, Ahmed et al. (1994) have reported that the
activation of PAF receptors in human endometrial HEC-1B cell line is linked to
inositol lipid hydrolysis. They have shown that PAF dose-dependently increased
IP3 accumulation in human endometrial HEC-1B cell line. It is not known whether
the increase in intracellular free calcium concentration induced by PAF in guinea-
pig endometrial cells is due to an increase in the concentration of IP3. The findings
that PLA2 was more effective in increasing [Ca2+]; of epithelial cells whereas PAF
was more potent on stromal cells indicates that PLA2 may increase PG output from
epithelial cells to a greater extent then from stromal cells whereas PAF may
increase PG output from stromal cells to a greater extent than from epithelial cells.
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3.2 THE EFFECTS OF CAFFEINE AND RYANODINE ON
PROSTAGLANDIN SYNTHESIS BY AND RELEASE FROM THE RAT
MESENTERIC VASCULAR BED.
Introduction:
From the experiments carried out so far, it was concluded that there are no
ryanodine receptors of type 1, type 2 or type 3 in guinea-pig endometrium.
However, the existence of RYR in cardiac muscle is well established (see
McPherson & Campell, 1993a; Kijima et al., 1993; see Sorrentino & Volpe,
1993). Caffeine and RY have been reported to cause contractions in vascular
smooth muscles as well as cardiac muscles. These effects are thought to be
mediated by activation of the cardiac type RYR, resulting in an increase in free
cytosolic calcium level (Gyorke & Fill, 1993; see McPherson & Campell, 1993a;
Jino et al., 1994; Ezzaher et al., 1992; Hisayama et al., 1990). Considering these
reports and finding from the experiments carried out so far in this study, it became
necessary to design an experiment to examine whether a non-uterine tissue would
produce prostaglandins in response to caffeine and/or ryanodine.
Methods:
The preparation of tissue and experimental set up were as described in Section
2.1.1. The mesenteric vascular bed was dissected out and cleaned from any
connective tissues according to the procedure described by McGregor (1965) and
by Lennon & Poyser (1986). After an initial equilibrium period of 30 min, samples
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of perfusate were collected for periods of 1 min and stored at -20°C before being
assayed. After an initial equilibrium period of 30 min, samples of perfusate were
collected for periods of 1 min, according to the nature of the experiment, and
stored at -20°C before being assayed. In experiment 1 (n=6), increasing caffeine
doses (1 pg to 1 mg) were injected into the perfusing McEwans solution at 15 min
intervals. In experiment 2 (n=4), 1 mg caffeine at 15 min intervals was injected
into the perfusing McEwans solution on three successive occasions. In experiment
3 (n=7), 10 pg and 50 pg RY were injected into the perfusing McEwans solution
with an interval of 3 min between each dose. In experiments 1 and 2, samples of
perfusate were collected from 2 min before to 6 min after, and at 9 and 13 min
after caffeine administration. In experiment three, samples of perfusate were
collected from 1 min before the first dose to 2 min after the second dose of RY
(i.e. for 6 min altogether). The amounts of 6-keto-PGFia, PGE2 and PGF2tt in the
samples of perfusate were measured by radioimmunoassay without extraction.
A solution of caffeine was prepared freshly in McEwans solution prior to use. A
concentrated solution of RY was prepared in ethanol and stored at -20°C. The
appropriate concentration of RY was by diluting 200-fold prepared in McEwans
solution.
Statistical tests:




The major prostaglandin released from the mesenteric vascular bed of the rat was
6-keto-PGFia; the basal outputs of PGE2 and PGF2a were 50-70% lower than that
of 6-keto-PGFia. Caffeine significantly (p<0.05) increased the outputs of 6-keto-
PGFia at doses between 1 pg and 1 mg by 1.7- to 3.3-fold. The maximum effect
was obtained with 5 pg caffeine (Figure 3.2.1). Caffeine at doses of 100 pg and 1
mg significantly (p<0.05, n = 6) increased the outputs of PGE2 and PGF2a between
1.3- to 2.4-fold. The maximum increase in PG output due to caffeine usually
occurred within the first minute of administration, and this increase in PG output
lasted for at least 2 min (Figure 3.2.1). Caffeine (1 mg) administered three times at
15 min intervals significantly (p<0.05, n=4) increased the output of 6-keto-PGFia
between 2.4- and 3.6-fold following each dose of caffeine. However, the outputs
of PGE2 and PGF2a were also increased between 1.4- to 2.3-fold, but this increases
were not significant (Figure 3.2.2).
Ryanodine (10 pg) increased the outputs of 6-keto-PGFi«, PGE2 and PGF2a by
1.3- to 1.6-fold, but these increases were statistically significant (p<0.05, n=7)
only for PGE2 and PGF2a. Ryanodine (50 pg) significantly (p<0.05, n=7)
increased the outputs of 6-keto-PGFia, PGE2 and PGF2a by 2.8-, 2.7- and 2.0-
fold, respectively (Figure 3.2.3).
Discussion:
Since prostaglandins are not stored in tissues, their release is immediately preceded
by their synthesis. The rate-limiting step in PG synthesis is the release of
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Figure 3.2.1. Effects of caffeine on mean (±SEM, n=6) outputs of
6-keto-PGFla, PGE2 and PGF2afrom the perfused mesenteric













































Figure 3.2.2. Effects of a high dose of caffeine (1 mg) administered
three times on means (±SEM, n=4) outputs of 6-keto-PGFla, PGE2
and PGF2(X from the perfused mesenteric vascular bed of the rat.




Fig.3.2.3. Effects of ryanodine on means (±SEM, n =
outputs of 6-keto-PGF1a, PGE2 and PGF2afrom the
perfused mesenteric vascular bed of the rat.
* Significantly (P<0.05) increased by ryanodine.
arachidonic acid from phospholipids (Ning & Poyser, 1984), usually by the action
of PLA2 (Dey et al., 1982; Bonney, 1985). This enzyme is activated by calcium
(Downing & Poyser, 1983), so the compounds which stimulate PG synthesis and
release usually have to increase the intracellular free calcium concentration.
Caffeine and RY have been shown to release calcium from cardiac muscle as well
as from vascular smooth muscle (Gyorke & Fill, 1993; Hisayama et al., 1990;
Komori & Bolton, 1989; Watanabe et al., 1992; Zhang et al., 1993 and Chen &
Van Breemen, 1993; Donoso et al., 1994), by activating a RYR. Ryanodine and
caffeine both released PGI2 (measured as 6-keto-PGFia), PGF2a and PGE2 from the
perfused rat mesenteric vascular bed. After allowances are made for ryanodine's
higher molecular weight, caffeine and RY were of similar potency. Hence, caffeine
and RY may be initiating vascular PG synthesis and release by the same
mechanism, i.e. through releasing intracellular calcium by activating a RYR.
This experiment has shown that caffeine stimulates prostaglandin production by the
perfused mesenteric vascular bed as well as from the superfused guinea-pig uterus,
indicating that the PG-releasing effect of caffeine is not unique to the uterus.
However, in contrast to uterus where ryanodine had no effect, ryanodine stimulated
PG production by the rat mesenteric vascular bed. This finding suggests that, if
caffeine and ryanodine are stimulating PG synthesis through the same mechanism
in blood vessels, then caffeine probably stimulates prostaglandin synthesis in the
uterus by a different mechanism.
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3.3 THE EFFECTS OF THE PLA2 ACTIVATOR (MELITTIN), PLA2
INHIBITOR (ARISTOLOCHIC ACID), STEROIDS (OESTRADIOL &
PROGESTERONE), AND PROTEIN SYNTHESIS INHIBITORS
(CYCLOHEXIMIDE, ACTINOMYCIN D & PUROMYCIN) ON THE
OUTPUTS OF PROSTAGLANDINS FROM ENDOMETRIAL CELLS OF
THE DAY 7 GUINEA-PIG UTERUS.
Introduction:
In the guinea-pig, oestradiol acting on a progesterone-primed uterus is the
physiological stimulus for the increase in the output of PGF2a at the end of the
oestrous cycle (Poyser, 1983b). It has been shown that many actions of oestradiol
on the uterus are mediated through increased protein synthesis (see Brenner &
West, 1975). Previous experiments have shown that protein synthesis inhibitors,
such as actinomycin D, cycloheximide and puromycin, inhibit prostaglandin output
from the guinea-pig uterus (Poyser & Riley, 1987; Riley & Poyser, 1989) and
increase the length of the oestrous cycle (Poyser, 1979). In the guinea-pig,
increased prostaglandin synthesis is associated with an increase in PLA2 activity
(Downing & Poyser, 1983). Melittin, an activator of PLA2, stimulates
prostaglandin output from the guinea-pig uterus (Johnson & Poyser, 1991).
Aristolochic acid, an inhibitor of PLA2, prevents oxytocin-induced PGF2a release
from the sheep uterus (Lee & Silvia, 1994). Considering these reports the effects
of protein synthesis inhibitors, oestradiol 17-[3, progesterone, melittin and
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aristolochic acid on the outputs of prostaglandins from guinea-pig endometrial cells
in culture were investigated.
Methods:
Epithelial and stromal cells from day 7 guinea-pig endometrium were isolated and
cultured as described in Section 2.1.5. Culture medium was changed every 3 days
and on the sixth day cultured cells were treated in duplicate. In experiment 1, two
wells containing each cell type were untreated (controls), and the remaining cells
were treated with oestradiol 17-P (3.7 pM), progesterone (3.7 pM), melittin (2
pg/ml), or aristolochic acid (50 pM). In experiment 2, two wells containing each
cell type were untreated (controls), and the remaining cells were treated with
actinomycin D (10 & 50 pg/ml), cycloheximide (10 & 50 pg/ml), or puromycin
(10 & 50 pg/ml).
In both experiments, culture medium was changed after 2, 8, and 24 h of culture.
Samples of culture medium were stored at -20°C before radioimmunoassay,
without extraction, for PGF2«, PGE2, and 6-keto-PGFia.
The concentrations of the oestradiol and progesterone used here are at the higher
end of the concentrations which have been shown to effect PG output from the
guinea-pig endometrium in culture (Riley & Poyser, 1987a). Melittin (2 pg/ml) has
been shown to increase prostaglandin output from the guinea-pig uterus superfused
in vitro (Johnson & Poyser, 1991). Aristolochic acid at concentrations of 10, 50
and 100 pM has been shown to completely inhibit prostaglandin output from the
guinea-pig endometrium in culture (Norman S.J. & Poyser N.L., unpublished
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observations). Lee and Silvia (1994) have also reported that 10 pM aristolochic
acid blocked ovine endometrial PGF2a production stimulated by oxytocin, ALF"4 or
melittin. Protein synthesis inhibitors at concentrations used in this set of
experiments have been reported to inhibit PG output from the guinea-pig
endometrium in culture (Poyser & Riley, 1987; Riley & Poyser, 1989).
Statistical tests;
The results were analysed by one-way analysis of variance (ANOVA) and by the
paired t-test.
Results:
In experiment 1, oestradiol 17-0 and progesterone significantly (p<0.05, n=4)
decreased the outputs of PGF2a from epithelial cells and PGE^ from stromal cells
after 8 h of cell culture (Figure 3.3.1). Oestradiol 17-0 also significantly (p<0.05,
n=4) decreased the outputs of PGF2a from epithelial cells after 24 h of cell culture.
Aristolochic acid, a PLA2 inhibitor, significantly (p<0.05, n=4) inhibited the
outputs of PGF2a from epithelial cells after 8 and 24 h (Figure 3.3.1). Aristolochic
acid had no significant effect on the outputs of PGF2a from stromal cells and of 6-
keto-PGFia from epithelial cells, but it significantly (p<0.05, n=4) decreased 6-
keto-PGFia output from stromal cells after 8 h of culture. Surprisingly, aristolochic
acid significantly (p<0.05, n=4) increased the output of PGE2 from stromal cells
after 2 h of culture (Figure 3.3.1). Melittin, a PLA2 activator, significantly




■ Prog. (3.7 nM)
0 Melit. (2 ng/ml)








■ Prog. (3.7 nM)
m Melit. (2 i^g/ml)














Figure 3.3.1. Mean (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGF1(X
from cultured day 7 (i) epithelial and (ii) stromal cells. Cells were either
untreated (control) or treated with oestardiol 17-(3 (Oest), progesterone (Prog),
melittin (Melit) or aristolochic aicd (Arist.A) for 2, 6 and 16 h. * Significantly
(p<0.05) higher than the corresponding control value, t Significantly (p<0.05)
lower than the corresponding control value.
1.5-fold from epithelial cells after 2 of culture (Figure 3.3.1). Melittin also
significantly (p<0.05, n=4) increased PGF2« output from epithelial cells by 1.3-
fold after 24 h of culture. Melittin had no effects on the outputs of PGF2«, PGE2
and 6-keto-PGFia from stromal cells (Figure 3.3.1).
In experiment 2, after 2 h of treatment with cycloheximide (10 & 50 pg/ml) or
puromycin (10 & 50 pg/ml), a significant (p<0.05, n=4) inhibition in the output
of PGF2a from epithelial cells was apparent (Figure 3.3.2). This inhibition became
greater as the length of treatment was increased. By 8 and 24 h, actinomycin D
(10 & 50 pg/ml), cycloheximide (10 & 50 pg/ml) and puromycin (10 & 50 pg/ml)
significantly (p<0.05, n=4) inhibited PGF2a output from epithelial cells.
Actinomycin D (10 & 50 pg/ml), cycloheximide (10 & 50 pg/ml) and puromycin
(10 & 50 pg/ml) significantly (p<0.03, n=4) inhibited PGF2a output from stromal
cells after 2, 8 and 24 h of cell culture. This inhibition was greater after 8 and 24 h
compared to that after 2 h (Figure 3.3.2).
The inhibition of PGE2 output by protein synthesis inhibitors was somewhat
selective. Cycloheximide (10 pg/ml) after 2 h, actinomycin D (10 & 50 pg/ml)
and puromycin (50 pg/ml) after 8 h, and puromycin (10 pg/ml) after 24 h caused a
significant (p<0.05, n=4) inhibition in the output of PGE2 from epithelial cells
(Figure 3.3.2). PGE2 output from stromal cells was significantly (p<0.05, n=4)
inhibited by actinomycin D (50 pg/ml) and puromycin (50 pg/ml) after 2, 8, and
24 h, by actinomycin D (10 pg/ml) and puromycin (10 pg/ml) after 8 and 24 h,
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Figure 3.3.2. Mean (±SEM, n=4) outputs of PGF2a, PGE2 and 6-keto-PGFl0C
from cultured day 7 (i) epithelial and (ii) stromal cells. Cells were either
untreated (control) or treated with actinomycin D (A-D; 10 & 50 (ig/ml),
cycloheximide (Cys; 10 & 50 ^ig/ml) or puromycin (PuM; 10 & 50 |ig/ml) for 2,
6 and 16 h.
+ Significantly (p<0.05) lower than the corresponding control value.
Cycloheximide (50 pg//ml) and puromycin (50 pg/ml) after 2 h, actinomycin D
(10 pg/ml), cycloheximide (10 pg/ml) and puromycin (50 pg/ml) after 8 h of cell
culture significantly (p<0.05, n=4) inhibited the output of 6-keto-PGFia from
epithelial cells (Figure 3.3.2). By 24 h, all protein synthesis inhibitors at all
concentrations caused a significant (p<0.05, n=4) inhibition of 6-keto-PGFia
output from epithelial cells in culture. For stromal cells, 6-keto-PGFia output was
significantly (p<0.05, n=4) inhibited by all protein synthesis inhibitors at all
concentrations used after 2, 8 and 24 h (Figure 3.3.2).
Discussion:
Oestradiol 17-P and progesterone inhibited the outputs of PGF2« and PGE2 from
epithelial and stromal cells, respectively. This is in agreement with a report which
has shown that oestradiol 17-P and progesterone inhibit PG output from guinea-pig
endometrium in culture (Riley and Poyser, 1987a), but not with the findings of
Leaver and Seawright (1982) who reported that oestradiol stimulated PG output
from guinea-pig endometrium in culture. Furthermore, it has been also reported
that progesterone suppresses PGF2a and PGE release from epithelial cells of human
proliferative endometrium (Mitchell & Smith, 1992), and from epithelial and
stromal cells of pig endometrium (Zhang & Davis, 1991). Considering these
reports and the findings from the present study, progesterone in vitro clearly exerts
an inhibitory effect on endometrial cells with respect to PG output in several
species. The effect of oestradiol in vitro seems to vary among species. Oestradiol
in vitro inhibits PG output from guinea-pig endometrium and endometrial cells,
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whereas it stimulates PGF2a output from human endometrium in vitro (Abel &
Baird 1980; Schatz etal., 1985).
Melittin has been shown to increase prostaglandin output from the guinea-pig
uterus superfused in vitro (Poyser & Johnson, 1991). In this study melittin
stimulated the outputs of PGF2a, PGE2 and 6-keto-PGFia from cultured epithelial
but not from stromal cells. The stimulatory effect of melittin was the greatest on
PGF2a output indicating that the endogenous PLA2 activated by melittin is directed
towards the synthesis and release of mainly PGF2«- The ineffectiveness of melittin
on PG output from stromal cells suggests that melittin selectively activates
epithelial PLA2 but not stromal PLA2 in the guinea-pig endometrium.
Aristolochic acid inhibited the outputs of PGF201 and, to a lesser extent 6-keto-
PGFia, from the cultured epithelial but not from the stromal cells, indicating that
aristolochic acid inhibited an endogenous PLA2 which is present in epithelial cells
and is responsible for the release of mainly PGF2a but not the release of PGE2.
Surprisingly, aristolochic acid stimulated the output of PGE2 from stromal cells in
culture. However, it is unlikely that the stimulatory effect of aristolochic acid on
PGE2 output is mediated via PLA2 mechanism.
The intrauterine administration of actinomycin D to guinea-pig on day 10 inhibits
the output of PGF20C from the day 15 uterus superfused in vitro by 80 to 85%
(Poyser & Riley, 1987). In the present study, all three protein synthesis inhibitors
were more effective in inhibiting the output of PGF2« and 6-keto-PGFia than the
output of PGE2 from endometrial cells in culture. After 2 h of cell culture,
cycloheximide and puromycin were more effective than actinomycin D. These
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findings are in agreement with a previous report (Poyser & Riley, 1987) who
showed that these 3 protein synthesis inhibitors inhibit PG output from guinea-pig
endometrium in culture.
The finding that the output of PGF2« was affected more than the outputs of PGE2
and 6-keto-PGF ia by these protein synthesis inhibitors indicate that PGF2a synthesis
is more dependent upon increased protein synthesis.
Overall these findings indicate that prostaglandin synthesis and release, in
particular PGF2a from the cultured guinea-pig endometrial cells is affected by
protein synthesis inhibitors, ovarian steroids and modulators of PLA2 activity.
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3.4 INVESTIGATIONS OF THE EFFECT OF A NOVEL
PROSTAGLANDIN H SYNTHASE-2 INHIBITOR (NS-398) ON PG
PRODUCTION FROM THE GUINEA-PIG UTERUS: A COMPARATIVE
STUDY WITH INDOMETHACIN.
Introduction:
It is well-documented that PGF2a output from the guinea-pig uterus increases
towards the end of the oestrous cycle. The synthesis of PGF2a involves the action
of prostaglandin H synthase (PGHS) on arachidonic acid. Non-steroidal anti¬
inflammatory drugs (NSAIDs) such as indomethacin, have been shown to inhibit
prostaglandin synthesis by the PGHS enzyme (Miyamato et al., 1974; Rome &
Lands, 1975; Miyamato et al., 1976). In the guinea-pig, indomethacin increases
the length of the oestrous cycle (Horton & Poyser, 1973) by inhibiting PGF2a
synthesis (Poyser & Horton, 1975). In the guinea-pig, the endometrial PGHS
concentration increases after day 11 of the cycle (Poyser, 1983a). Recently, it has
been shown that there are two isoforms of prostaglandin H synthase, namely
PGHS-1 and PGHS-2. PGHS-1 is a constitutive enzyme and PGHS-2 is an
inducible enzyme (Maier et al., 1990; Fu et al., 1990; Sirois & Richards, 1992;
Wimsatt et al., 1993). It is widely believed that NSAID drugs exert their
therapeutic effects by inhibiting PGHS-2 and their side-effects by inhibiting PGHS-
1.
A new NSAID, NS-389, (Futaki et al., 1993) has been shown to have an anti¬
inflammatory potency equal to that of indomethacin with no side-effects such as
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gastric ulceration (Futaki et al., 1993; Arai et al., 1993). It is also reported that
NS-398 selectively inhibits PGHS-2 activity in vitro without affecting PGHS-1
activity (Futaki et al., 1994). In this set of experiments, the effects of NS-398 on
prostaglandin production by day 7 and day 15 guinea-pig endometrial
homogenates, by day 7 endometrium and myometrium in culture, and by cultured
epithelial and stromal cells obtained from day 7 guinea-pig endometrium were
investigated. Poyser (1987a) has shown that indomethacin at similar concentrations
used here inhibits PGF2« synthesis from guinea-pig uterus in vitro.
3.4.1 The Effect of NS-398 on Prostaglandin Synthesis by Homogenates of
the Day 7 and Day 15 Guinea-Pig Endometrium.
Methods:
Endometrium from the uterus of four day 7 and four day 15 guinea-pigs was
obtained as described in Section 2.1.1. Tissue homogenisation was as described in
Section 2.1.4. Briefly, both uterine horns were removed from each animal, and the
endometrium was separated from the myometrium and divided into 5
approximately equal amounts. Tissues were blotted dry, weighed, and chopped
finely with scissors, and then homogenised in 5 ml Krebs solution containing either
100 pi ethanol (control) or treated with indomethacin (14 & 28 pM) or NS-398 (16
& 32 pM). The homogeniser was then washed with a further 5 ml Krebs solution
containing the same treatment. The homogenate and the washings (total volume 10
ml) were then transferred to a 25 ml conical flask, and incubated for 60 min at
158
37°C in a shaking (230 oscillations/min) Grant Water bath. Prostaglandins were
extracted from the homogenates as described in Section 2.1.1 except that 2
volumes of 20 ml ethyl acetate were used. The residue obtained from evaporation
of the ethyl acetate fractions was redissolved in 4 ml of ethyl acetate. The samples
were then stored at -20°C. Concentrated solutions of indomethacin and NS-398
were prepared in ethanol and stored at -20°C. The appropriate concentrations of
indomethacin and NS-398 in Krebs solutions were prepared by adding up either 50
pi (in case of 14 pM indomethacin and 16 pM NS-398) or 100 pi (in case of 28
pM indomethacin and 32 pM NS-398) of the ethanolic stock solutions to 10 ml
Krebs solution. The amounts of PGF2a, PGE2 and 6-keto-PGFia in the samples
were measured by radioimmunoassay as described in Section 2.1.8.
Results:
Homogenates of day 15 guinea-pig endometrium synthesised 3.0-, 1.7- and 1.4-
fold more PGF2a, PGE2 and 6-keto-PGFia than homogenates of day 7 guinea-pig
endometrium, respectively (Figure 3.4.1.1). Indomethacin (14 & 28 pM)
significantly (p<0.05, n=4) reduced the amounts of PGF2a, PGE2 and 6-keto-
PGFia produced by both day 7 and day 15 guinea-pig endometrial homogenates
(Figure 3.4.1.1). There were no significant differences between the potency of
indomethacin 14 pM and indomethacin 28 pM in inhibiting production of the same
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Figure 3.4.1.1. Effects of indomethacin (Indo; 14 & 28 pM) and NS-398
(16 & 32 pM) on the mean (+SEM, n=4) production of PGF2a, PGE2 and
6-keto-PGFl0C by endometrium homogenates of (i) day 7 and (ii) day 15
guinea-pig uterus.
* Significantly (p<0.05) inhibited by indomethacin or NS-398 treatment.
▼ Significantly (p<0.05) lower than the corresponding value obtained by
NS-398 treatment.
NS-398 (16 & 32 pM) significantly (p<0.05, n=4) reduced the amount of PGF2a,
PGE2 and 6-keto-PGFia produced from both day 7 and day 15 guinea-pig
endometrial homogenates (Figure 3.4.1.1). There was no significant difference in
the potency of NS-398 (16 pM) and NS-398 (32 pM) in inhibiting production of
the same PG by guinea-pig endometrium homogenates obtained from the same day
of the oestrous cycle. Indomethacin at an approximately similar concentration was
significantly (p<0.05, n=4) more potent than NS-398 in inhibiting PGF2a and
PGE2 production by homogenates of day 7 but not of day 15 guinea-pig
endometrium (Figure 3.4.1.1).
3.4.2 The Effect of NS-398 on Prostaglandin Synthesis by and Release From
the Day 7 Guinea-Pig Endometrium and Myometrium in Culture.
Methods:
The preparation of guinea-pig endometrial and myometrial tissue and the culture
set-up was as described in Section 2.1.3. From the endometrium and myometrium
obtained from each guinea-pig, ten tissue culture dishes were prepared. Four of
these tissue culture dishes were left untreated (controls), and the remaining dishes
were treated in duplicate with indomethacin (14 pM), indomethacin (28 pM) or
NS-398 (16 pM). In order to minimise the effect of the vehicle ethanol (20 pi) was
added to the controls. Culture medium was changed after 2, 8, and 24 h of culture.
The appropriate solutions of indomethacin and NS-398 were prepared by diluting
up to 120-fold in tissue culture medium. Samples of culture medium were stored at
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-20°C before radioimmunoassay, without extraction, for PGF2a, PGE2, and 6-keto-
PGFia. Concentrated solutions of indomethacin and NS-398 were prepared in
ethanol and stored at -20°C.
Results:
After 2 and 8 h of culture, the major prostaglandin release from both the
endometrium and myometrium in culture was 6-keto-PGFia. The outputs of PGEj
and 6-keto-PGFia from both endometrium and myometrium, and the output of
PGF2a from myometrium declined with time over 24 h of culture. However, the
output of PGF2a from endometrium declined between 2 and 8 h of culture but then
increased between 8 and 24 h of culture (Figure 3.4.2.1). This is in agreement
with the results obtained from the earlier experiments (see Section 3.1.3).
Indomethacin (14 & 28 pM) and NS-398 (16 pM) significantly (p<0.05, n=4)
inhibited the outputs of PGF2a and 6-keto-PGFia from both endometrium and
myometrium, and the output of PGE2 from endometrium after 2, 8 and 24 h of
culture. The output of PGEw from myometrium was significantly (p<0.05, n=4)
inhibited by indomethacin (14 & 28 pM) and NS-398 (16 pM) after 2 h but not
after 8 or 24 h of culture (Figure 3.4.2.1). NS-398 was as effective as
indomethacin at inhibiting the output of all 3 PGs from both day 7 and day 15
guinea-pig endometrium and myometrium in culture, except for 6-keto-PGFia
output from the myometrium. Indomethacin at both concentrations was
significantly (p<0.05, n=4) more potent than NS-398 in inhibiting the output of
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Figure 3.4.2.1. Effects of indomethacin (Indo; 14 and 28 pM) and NS-398 (16 pM) on
mean (±SEM) outputs of PGF2a, PGE2 and 6-keto-PGFla from the day 7 guinea-pig (i)
endometrium and (ii) myometrium in culture. * Significantly (p<0.05) reduced by
indomethacin or NS-398 treatment. ▼ Significantly (p<0.05) lower than the
corresponding control value but higher than the values obtained by indomethacin
treatment during the same culture period.
3.4.3 The Effect of NS-398 on Prostaglandin Synthesis by and Release From
Cultured Epithelial and Stromal Cells Obtained From Day 7 Guinea-Pig
Endometrium.
Methods:
Epithelial and stromal cell obtained from the endometrium of four day 7 guinea-
pigs were isolated and cultured as described in Section 2.1.5. Culture medium was
changed every 3 days and on the sixth day, cells in culture were treated in
duplicate. Two wells containing each cell type were left untreated (controls), and
the remaining wells of each cell type were treated in duplicate with indomethacin
(14 pM) or NS-398 (16 pM). Concentrated solution of indomethacin and NS-398
were prepared in ethanol and stored at -20°C. The appropriate solutions of
indomethacin and NS-398 were prepared by diluting 200-fold in cell culture
solution. In order to minimise the vehicle effect, ethanol (20 pi) was added to the
control cells. Culture medium was changed after 2, 8, and 24 h of culture. Samples
of culture medium were stored at -20°C before radioimmunoassay, without
extraction, for PGF2a, PGE2, and 6-keto-PGFia.
Results:
For epithelial cells, indomethacin (14 pM) and NS-398 (16 pM) significantly
(p<0.05, n=4) inhibited the outputs of PGF2a, PGE2 and 6-keto-PGFia after 2, 8
and 24 h of culture (Figure 3.4.^.1). For stromal cells, indomethacin (14 pM) and
NS-398 (16 pM) significantly (p<0.05, n=4) inhibited the outputs of PGF2a and
162
■ Control
& Indo (14 |iM)































Figure 3.4.3.1. Effects of indomethacin (indo) and NS-398 on mean
(±SEM, n=4) outputs of PGF2ot, PGE2 and 6-keto-PGFla from the day 7
guinea-pig (i) epithelial and (ii) stromal cells in culture. * Significantly
(p<0.05) inhibited by indomethacin or NS-398 treatment.
6-keto-PGFia after 2, 8 and 24 h, and PGE2 output after 2 and 8 h but not after 24
h of culture. There was no difference between the potencies of indomethacin and
NS-398 in inhibiting the outputs of all 3 PGs from the epithelial and stromal cells
in culture.
Discussion:
The inhibitory effect of indomethacin on prostaglandin synthesis by the guinea-pig
uterus seen in this study is in agreement with previous reports (Poyser, 1985a).
Indomethacin inhibits prostaglandin synthesis by inhibiting the prostaglandin H
synthase (PGHS) enzyme (Miyamato et al., 1974; Miyamato et al., 1976; Rome &
Lands, 1975). Recently, two isoforms of PGHS, namely PGHS-1 and PGHS-2
have been identified: PGHS-1, which is constitutively expressed in many cell types
and tissues, and PGHS-2, which is an inducible form (Maier, et al., 1990; Fu et
al., 1990; Wong & Richards, 1991; Sirois & Richards, 1992; Wimsatt et al.,
1993). PGHS-2 but not PGHS-1 has been induced by interleukin-la in human
dermal fibroblasts (Seibert & Masferrer, 1994), by lipopolysaccharide in rat
alveolar macrophages (Lee et al., 1992) and by hCG in granulosa cells of rat
preovulatory follicles (Sirois & Richards, 1992). The induction of PGHS-2 in
ovine cotyledonary tissue during late gestation has also been reported (Wimsatt et
al., 1993). Indomethacin is a non-selective PGHS inhibitor, that is it inhibits both
PGHS-1 and PGHS-2 activities (see Seibert & Masferrer, 1994).
NS-398 inhibited prostaglandin production by the day 7 and day 15 guinea-pig
endometrial homogenates, by day 7 endometrium and myometrium in culture, and
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by cultured epithelial and stromal cells obtained from day 7 guinea-pig
endometrium. It has been shown that NS-398 selectively inhibits PGHS-2 activity
in vitro without affecting PGHS-1 activity (Futaki et al., 1994, Masferrer et al.,
1994). Hence, it is likely that NS-398 inhibits PGHS-2 activity in the guinea-pig
endometrium and myometrium. This implies that the guinea-pig uterus (both the
endometrium and myometrium) contains functionally active PGHS-2. It is not
known that whether PGHS-1 is also present in the guinea-pig uterus. A selective
PGHS-1 inhibitor would be a useful tool to investigate whether guinea-pig uterus
contains functionally active PGHS-1 as well as PGHS-2 at both stages of the
oestrous cycle examined here. The finding that indomethacin and NS-398 had
similar potencies in inhibiting PG production by day 7 endometrium and
myometrium (except for 6-keto-PGFia output from myometrium) in culture, by
cultured epithelial and stromal cells obtained from the day 7 guinea-pig
endometrium, and by day 15 guinea-pig endometrium homogenates indicates that
both indomethacin and NS-398 were inhibiting PGHS-2 activity in these systems.
Nevertheless, indomethacin at an approximately similar concentration was
significantly more potent than NS-398 in inhibiting the synthesis of PGF2a and 6-
keto-PGFia by day 7 guinea-pig endometrial homogenates and the output of 6-keto-
PGFia from the myometrium in culture. This suggests that indomethacin apart
from inhibiting PGHS-2, inhibits some other enzyme responsible for PGF2« and 6-
keto-PGFia production by day 7 guinea-pig endometrium homogenates and 6-keto-
PGFia by day 7 myometrium in culture. Overall, this study indicates that PGHS-2
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is present in the guinea-pig uterus, and that PGHS-2 is the predominant
prostaglandin-forming enzyme in the guinea-pig uterus.
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3.5 DETECTION OF PROSTAGLANDIN H SYNTHASE-2 (PGHS-2) IN
THE GUINEA-PIG ENDOMETRIUM.
Introduction:
It has been shown in various tissue that at least two different PGHS isoforms exist,
denoted as PGHS-1 (Mr 69 kDa) and PGHS-2 (Mr 72 kDa). In the previous
experiment (see Section 3.4), NS-398 (a selective inhibitor of PGHS-2) inhibited
prostaglandin production by the guinea-pig uterus, implicating the presence of
PGHS-2 enzyme in the guinea-pig endometrium. As a result, in this experiment,
immunoblotting was used to detect the presence of PGHS-2 in endometrium from
the day 6 and day 17 guinea-pig uterus.
Methods:
(a) Immunoblotting:
Soluble cell extracts from guinea-pig endometrium were prepared as described in
Section 2.1.7.1. In summary, endometrial tissue from guinea-pigs on days 6 and
17 of the oestrous cycle was prepared as described in Section 2.1.4. All tissues
were homogenised in PE buffer (10 mM potassium phosphate, pH 6.8, and 1 mM
EDTA) containing 10 mM 3-[(3-cholamidopropyl) dimethyl-ammonio]-l-propane-
sulfonate (CHAPS). The homogenates were centrifuged for 5 min at 30000 g at
4°C. The supernatant was subjected to the total protein assay as described in
Section 2.1.7.2. A known amount of protein (70 pg/ml) was subjected to a one
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dimensional SDS-PAGE immunoblotting procedure as described in Section
2.1.7.3. Proteins were precipitated by a chloroform/methanol technique. The pellet
was re-suspended in 10 pi of sample (Laemmli) buffer (see Section 2.2.7.7.1 for
composition) and boiled for 10 min. Molecular weight markers (MWM) were
diluted (1:5) with Laemmli buffer and boiled for 10 min. Samples and MWM were
allowed to cool and then loaded directly onto a 10%-15% SDS gels via a sample
applicator 8/1 as follows. Lanes 1, 3, 5 and 7 were loaded with 1 pi of Molecular
Weight Markers (MWM), lanes 2 and 4 with 1 pi of day 6 protein samples, and
lanes 6 and 8 with 1 pi of day 17 protein samples. Gels were then run on a
Pharmacia PhastSystem (separation & control unit) as described in Section 2.1.7.3.
(b) Western Blotting:
Western blotting was as described in Section 2.1.7.3. Briefly, "Transfer
Membrane" of equal size to a SDS gel was soaked in methanol for 30 s, washing
with MQ water, followed by soaking in Transfer Buffer (see Section 2.2.7.7.2 for
composition) at pH 8.2 until use. After the gels were run, they were then
transferred on to a "Transfer Membrane" and run on a Pharmacia PhastSystem
(separation & control unit) as described in Section 2.1.7.3. The blotting took 15
min after which it was removed from the machine. The blotting paper was washed
with MQ water 5 times, placed in 10 ml of 5% BSA in Tris Buffer Saline (TBS)
(see Section 2.2.7.7.3 for composition) solution at pH 7.6, and was shaken gently
for 3 h. The 5% BSA was acting as the blocking agent in order to reduce the
background by blocking the sites on the Transfer Membrane. After 3 h, this
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solution was discarded and replaced with primary antibody (PGHS-2) (1:10,
PGHS-2:MQ water). The "Transfer Membrane" was incubated with primary
antibody at 4°C overnight on a shaking plate. The following morning, the primary
antibody was discarded. The "Transfer Membrane" was washed 5 times with 3 ml
of TBS containing 1% Tween-20 (TTBS; 1% BSA&0.1% Tween-20, diluted 1:10
with MQ water) for 20 s, and then three times with 10 ml TTBS for 5 min each
time. The TTBS solution was discarded and the "Transfer Membrane" was
incubated with conjugated secondary antibody (bionated peroxidase labelled anti-
rabbit antibody) (5 pi of secondary antibody in 5 ml of TTBS + 2 drops of
solution A & 2 drops of solution B from Elite ABC Kit Vectastain) for 90 min.
The "Transfer Membrane" was then washed 3 times with 10 ml TTBS for 5 min
each time, and incubated with peroxidase substrate kit (DAB Kit) for 10 min until
colour was developed. The "Transfer Membrane" was then washed under running
tap water five times and allowed to dry at room temperature.
Results:
Western blotting analyses show that PGHS-2 (Mr 72 kDa) was present in the
soluble extracts of guinea-pig endometrium obtained on both days 6 and 17 of the
oestrous cycle (Figure 3.5.1).
Discussion:
Interleukin-la (IL-la) induces the synthesis of PGHS-2, as well as the synthesis
and release of PGF2a in response to stimulation by exogenous arachidonic acid in
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Figure 3.5.1. Immunodetection of PGHS-2 in day 6 and day 17
guinea-pig endometrium. Soluble cell extract proteins (7 fig) were
resolved by one-dimentional SDS-PAGE and electrophoretically
transferred to nitro-cellulose filters. Prostaglandin H synthase-2
was detected by a polyclonal rabbit IgG antibody raised against
murine PGHS-2 (Cascade Biochem Ltd, Berkshire, England).
Molecular Weight Marker (lanes 1, 3, 5 and 7), Day 6
endometrium (lanes 2 & 4) and Day 17 endometrium (lanes 6 &
8).








human cell line (ECV304) (Risimaki et al., 1994). However, IL-la did not
increase PGHS-1 mRNA. In rat alveolar macrophages, lipopolysaccharide (LPS)
induced selective expression of the PGHS-2 without affecting PGHS-1 synthesis
(Lee et al., 1992). Dexamethasone inhibits PGHS-2 mRNA expression and PG
output (Masferrer et al., 1994), indicating that PG output is associated with
increased in PGHS-2 concentration.
The presence of PGHS-2 in the soluble extracts of guinea-pig endometrium
obtained from day 6 (a day of low PG output) and day 17 (a day of high PG
output) indicates that increased output of PGF2a from guinea-pig uterus at the end
of the oestrous cycle dose not depend upon the "inducible" form of PGHS (i.e.
PGHS-2) being synthesised specifically at the end of the oestrous cycle.
Protein inhibitors, such as actinomycin D, cycloheximide and puromycin, inhibit
PG output from the guinea-pig endometrium in culture (Riley & Poyser, 1989) and
from cultured guinea-pig endometrial cells (see Section 3.3.2). However, it has
been reported that IL-la-stimulated PGHS-2 mRNA expression is potentiated by
cycloheximide, pactamycin and puromycin, although it is inhibited by actinomycin
D (Risimaki et al., 1994). These finding suggests that either (a) inhibition of PG
output from guinea-pig uterus by protein inhibitors is not due to inhibition of
PGHS-2 synthesis, (b) the PGHS-2 present in the guinea-pig uterus is different
from the one reported by Risimaki et al. (1994) in human cell line (ECV304) or (c)
cycloheximide and puromycin having non-specific effect on human cell line
(ECV304) in the presence of interleukin-la.
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It has been reported that PGHS-2, but not PGHS-1, level and activity in cotyledons
of sheep increases during late gestation, indicating that PGHS-2, rather than
PGHS-1, is associated with the increased PG synthesis in this tissue (Wimsatt et
al., 1993). However, Salamonsen and Findlay (1990) reported that, in the sheep,
conceptus-induced changes in PGF2a output do not occur via changes in the
concentration or cellular localisation of PG synthase, but rather the activity of the
enzyme is modified. A similar hypothesis has also been stated by Keirse et al.
(1977) who reported that, in human, the conceptus-induced changes in PGF2a
release do not occur via changes in the concentration or cellular localisation of
PGHS, but rather the activity of the enzyme is modified. This may also be the case
in the guinea-pig uterus, such that, oestradiol acting on a progesterone-primed
uterus modifies the activity of the PGHS-2 present in the uterus (by controlling




The basal output of PGF20 was approximately 14-fold higher from day 15 guinea-
pig uterus than from day 7 guinea-pig uterus superfused in vitro (see Section
3.1.1). It is well-documented that, in the guinea-pig uterus, the endometrium is the
major site of production of the uterine luteolytic hormone, i.e. PGF2a, (Poyser,
1983a). When guinea-pig endometrium was cultured, the basal PGF2a output was
approximately 20-fold higher on day 15 guinea-pig than on day 7 (see Section
3.1.3). There was little or no difference between day 7 and day 15 in the basal
outputs of PGE2 and 6-keto-PGFla from tissues obtained from the guinea-pig
uterus (see Sections 3.1.1 & 3.1.3).
The basal outputs of PGF2(X, PGE2 and 6-keto-PGFia from day 7 guinea-pig uterus
superfused in vitro were similar. However, the output of PGF2a was up to 20-fold
higher than the outputs of PGE2 and 6-keto-PGFia from the day 15 guinea-pig
uterus superfused in vitro (see Section 3.1.1). The same pattern of PG output from
the day 15 uterus was also seen in culture. The basal amount of PGF2a produced
from day 15 guinea-pig endometrium in culture was up to 14-fold higher than the
amounts of PGE2 and 6-keto-PGF]a produced (see Section 3.1.3). When
endometrium was homogenized and incubated, PGF2a was the major PG
synthesized by both day 7 and day 15 guinea-pig endometrium. Between days 7
and 15, PGF2a production significantly increased 3-fold, but PGE2 and 6-keto-
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PGFia production showed no changes (see Section 3.4.1). These findings are in
agreement with previous reports (Poyser, 1979; Leaver & Seawright, 1982;
Poyser, 1983a, b; Poyser & Brydon, 1983; Riley & Poyser, 1987a; Leckie &
Poyser, 1990a, b), and reflect the higher PGF2a concentrations observed in guinea-
pig uterine venous plasma that occur towards the end of the oestrous cycle
(Blatchley et al., 1972).
It was mentioned earlier that the endometrium is the major site of PGF2a synthesis;
however, the endometrium consists of two major cell types which produce
prostaglandin, namely epithelial and stromal cells (Schatz & Gurpide, 1983; Schatz
et al., 1985; Fortier et al., 1988; Watson et al., 1992). There are conflicting
reports as to which of the above cell types (i.e. epithelial and stromal cells) is the
main site for prostaglandin production. Gal et al. (1982) have reported that, in
human, endometrial stromal cells are the major cell type producing prostaglandin.
PGE2 was the major PG produced, followed by PGF2a (Gal et al., 1982). This
report was confirmed by Casey et al. (1985). However, other studies indicate that
epithelial cells produce more PGF2a than stromal cells (Schatz et al. 1985; Smith &
Kelly, 1988). Smith and Kelly (1988) reported that PGF2a was the major PG
produced by both epithelial and stromal cells followed by PGE2.
Isolated endometrial epithelial cells from ewes produced more PGF2a than the
stromal cells, whereas PGE2 output from the stromal cells was greater than from
the epithelial cells (Cherny & Findlay, 1990; Kim & Fortier, 1995). A similar
result was reported regarding prostaglandin production by endometrial cells of the
cow. It was reported that, in the cow, PGF2a output from epithelial cells is about
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13-fold higher than from stromal cells, while PGE2 output from stromal cells is
about 3-fold greater than from epithelial cells (Fortier et al., 1988). In the mare,
however, it was reported that there was no significant difference in PGF
production between epithelial and stromal cells at 2 and 8 h, but, by 24 h of
culture, epithelial cells produced significantly more PGF than stromal cells
(Watson et al., 1992).
In the studies presented in this thesis, guinea-pig endometrial epithelial cells
produced significantly more prostaglandin than stromal cells (see Sections 3.1.4 to
3.1.6). Even after 2 h of culture, the basal outputs of PGF201, PGE2, and 6-keto-
PGFia were 200-, 170-, and 150-fold greater from epithelial cells than from
stromal cells obtained from day 7 guinea-pig endometrium. Similarly, the basal
outputs of PGF2«, PGE2 and 6-keto-PGFia were 800-, 330- and 310-fold greater
from epithelial cells than from stromal cells obtained from day 15 guinea-pig
endometrium. These findings clearly indicates that, in the guinea-pig, epithelial
cells are the major site of prostaglandin production by the endometrium. This
suggests that, with regard to prostaglandin production, guinea-pig endometrial cells
behave similar to human endometrial cells as it has been shown that epithelial cells
are the major prostaglandin producing cells in the human endometrium (Schatz &
Gurpide, 1983; Schatz et al. 1985; Smith & Kelly, 1988). Although there were no
significant differences among the outputs of PGF2a, PGE2 and 6-keto-PGFia from
epithelial cells obtained from day 7 guinea-pig endometrium, stromal cells
produced significantly more PGE2 than PGF201.
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The basal output of PGF2a from epithelial cells obtained from day 15 guinea-pig
endometrium was significantly higher (4-fold) than from epithelial cells obtained
from day 7 endometrium (see Section 3.1.4). There were no significant increases
in the outputs of PGE2 and 6-keto-PGFia from epithelial cells, and in the outputs of
PGF2a, PGE2 and 6-keto-PGFia from stromal cells between days 7 and 15 guinea-
pig endometrium. This indicates that, in the guinea-pig, the increase in uterine
PGF2a output seen on day 15 (i.e. at the end of the oestrous cycle) is due to an
increase in PGF2a synthesis by epithelial cells and not by stromal cells.
Caffeine significantly increased the outputs of PGF2a, PGE2 and 6-keto-PGFia
from the day 7 and day 15 guinea-pig uterus superfused in vitro. Theophylline also
significantly increased the outputs of PGF2a and 6-keto-PGFia, but not PGE2
output from the day 7 guinea-pig uterus superfused in vitro. Caffeine and
theophylline are phosphodiesterase (PDE) inhibitors. In many tissues their
pharmacological effects are believed to be due to their inhibitory effects on the
activity of PDE (see Daly 1993) which increases cAMP concentrations. In the
guinea-pig, it has been reported that an increase in cAMP level does not lead to an
increase in PG output from the endometrium (Poyser, 1987a). In the present study,
in general, forskolin (which increases cAMP levels) did not increase the outputs of
PGF2(X, PGE2 and 6-keto-PGFia from day 7 guinea-pig endometrium tissue in
culture or from cultured epithelial (with the exception of PGF2a after 8 h of
culture) and stromal cells. These results indicates that the caffeine- and
theophylline-induced rise in guinea-pig uterine PG output are probably not
mediated via an inhibition of PDE activity.
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The caffeine-induced increase in prostaglandin output from the guinea-pig uterus
superfused in vitro was not affected by calmodulin inhibitors (W-7 & TFP)
indicating that the caffeine effect is not mediated by calmodulin. In fact W-7
greatly potentiated the stimulatory effect of caffeine on PGF2a output and, to a
lesser extent, on PGE2 output. Moreover, the caffeine-induced increase in
prostaglandin production by the guinea-pig uterus superfused in vitro was not
affected by the lack of extracellular calcium, suggesting that effect of caffeine does
not depend on the presence of extracellular calcium. Since calcium is necessary for
PG production by the guinea-pig uterus (Riley & Poyser, 1987b), it is possible that
caffeine exerts its stimulatory effect on PG synthesis by releasing calcium from an
internal calcium store. It is well documented that caffeine and theophylline release
calcium from an intracellular calcium pool. Caffeine causes intracellular calcium
release from vascular endothelial cells, skinned myocardial fibres of rat, isolated
snail neurones and bovine adrenal chromaffin cells by acting on ryanodine
receptors (RYR) type 1 and 2 (RYR-1 & RYR-2) (Zhang et al., 1993; Su &
Shang, 1993; Kostyuk & Kirischuk, 1993; Cheek et al., 1993). This effect of
caffeine is blocked by ruthenium red and high concentrations of RY (see Sorrentino
& Volpe, 1993). TMB-8 (an intracellular calcium antagonist) completely abolished
the caffeine-induced increase in the output of PGF2a, but had no effect on the
caffeine-induced increases in outputs of PGE2 and 6-keto-PGFia. This finding
suggests that, in the guinea-pig, the stimulation of uterine PGF2a synthesis and
release by caffeine is dependent on intracellular calcium. The stimulation of
guinea-pig uterine PGE2 and 6-keto-PGFia synthesis and release by caffeine is
175
either not dependent upon intracellular calcium, or is dependent on an intracellular
calcium store which is not affected by TMB-8. Ryanodine and ruthenium red did
not affect the stimulatory action of caffeine on prostaglandin output from the
guinea-pig uterus superfused in vitro. Ryanodine alone or in combination with
caffeine had no effect on the outputs of prostaglandin from the day 7 guinea-pig
uterus superfused in vitro, from the day 7 guinea-pig endometrium in culture, and
from the day 7 and day 15 guinea-pig endometrial cells in culture. These results
indicate that the caffeine-induced increases in the outputs of prostaglandins from
uterine tissue are not mediated by the activation of RYR-1 or RYR-2. Another
RYR type (RYR-3) has recently been identified in mink lung which binds RY but it
is not activated by caffeine. Hence, it is unlikely that the stimulatory effect of
caffeine on uterine PG production is mediated by the activation of RYR-3. It has
been reported that rat liver hepatocytes contain an intracellular calcium pool which
is not sensitive to RY or theophylline but is activated by caffeine (McNulty &
Taylor, 1993). Thus, it is possible that the caffeine-sensitive calcium store present
in hepatocytes is also present in the guinea-pig uterus, and is involved in the
caffeine-induced stimulation of uterine PG output. However, theophylline also
induced increases in PG output from the guinea-pig uterus, an effect which was not
seen in hepatocytes (McNulty & Taylor, 1993). These findings suggest that the
mechanism by which theophylline induces PG output from the uterus may be
different from that of caffeine or, if caffeine and theophylline are acting through
the same mechanism, then the caffeine effects on the uterus are different from the
caffeine effect on hepatocytes.
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Donoso et al. (1994) have investigated the effects of methylxanthines on changes in
intracellular calcium concentrations in rat ventricular myocytes. Caffeine (10 mM)
and theophylline (10 mM) produced a transient rise of [Ca2+]; in rat cardiac
myocytes (Donoso et al., 1994). In the studies presented here, both caffeine and
theophylline stimulated prostaglandin production from the day 7 guinea-pig uterus
superfused in vitro. Thus, if caffeine and theophylline stimulate uterine PG output
via a similar mechanism, and if these stimulatory effects of caffeine and
theophylline involve the mobilization of intracellular calcium, then the effects of
caffeine on the uterus and on the cardiac myocytes are possibly via a similar
mechanism.
When changes in the free cytosolic calcium concentration in epithelial and stromal
cells obtained from day 7 and day 15 guinea-pig endometrium were measured,
caffeine or theophylline failed to increase the intracellular free calcium
concentration. In fact, caffeine and, to a lesser extent, theophylline reduced the
free cytosolic calcium concentrations in both day 7 and day 15 endometrial cells.
These results may suggest that either the stimulatory effects of caffeine and
theophylline on guinea-pig uterine prostaglandin synthesis and release are not
mediated by an increase in cytosolic free calcium concentration, or it is possible
that caffeine and theophylline release calcium from an internal calcium pool in the
short term (i.e. the time taken to perform uterine superfusion between 1-2 h) but in
the longer period of time required to prepare isolated cells, the effects of caffeine
are reversed due to this longer time factor or to some other factors such as the
processes involved in cell separation. But how do caffeine and theophylline
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decrease the intracellular free calcium concentrations in epithelial and stromal
cells? In general, calcium is moved between four different pools: extracellular
milieu, cytoplasm, mitochondria, and a non-mitochondrial pool (endoplasmic (ER)
and sarcoplasmic reticulum (SR)). A cell-specific, subcompartmentalization of
these pools is likely to occur. The calcium transport system is composed of a
variety of cytosolic and membrane bound proteins that bind calcium with high
affinity. The most important of the former group are calmodulin and troponin C
which, in addition to contributing to the buffering of cytosolic calcium, also
function as cofactors in different calcium-dependent processes (see Thastrup,
1990). The true transport of calcium is carried out by membrane proteins such as
channels (receptor or voltage operated), pumps (Ca /ATPases), exchangers, and
electrophoretic uniports. A decrease in intracellular free calcium concentration can
be achieved by the appropriate interference with any of the above mentioned
calcium-transport systems, as well as by chelating the free calcium (as is seen with
EGTA or EDTA).
It has been reported that caffeine at concentrations ranging from 1 mM to 10 mM
does not increase the intracellular free calcium concentration in Hela cells (Diarra
& Sauve, 1992) which is similar to the results obtained in this study. In fact,
Diarra and Sauve (1992) have postulated that caffeine causes a refilling of the
histamine-related calcium pools in Hela cells and thereby lowering the intracellular
free calcium concentration. This hypothesis was based on the observation that a
calcium release in response to a second application of the agonist (histamine) was
always measured in cells which were exposed to caffeine during the first
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application of the agonist, but not in control condition (i.e. cells which were not
exposed to caffeine during the first histamine application). It is possible that
caffeine may have a similar effect in guinea-pig endometrial cells (i.e. induce
calcium sequestration into non-mitochondrial calcium pools). It is also possible that
caffeine and theophylline decrease the intracellular free calcium concentration by
increasing calcium uptake by mitochondria. In order to achieve reduction of free
2_j_ . , .
cytosolic calcium levels, caffeine should (a) activate ER Ca /ATPase, (b) inhibit
mitochondrial Na /Ca exchange, and/or (c) activate mitochondrial calcium
uniport. Alternatively, caffeine could reduce the intracellular free calcium
concentration by acting on Ca2+/ATPase or the Na+/Ca2+ exchange in the
plasmalemma membrane resulting in a greater pumping of calcium to the
extracellular matrix. One other possibility is that caffeine actually chelates the free
intracellular calcium thus reducing the cytosolic free calcium concentration. The
last effect is possible, since caffeine exerted its effect within 1 second and the
effect was not reversed over the next 20 min. A similar effect was also seen by the
addition of 10 mM EGTA. There have been no previous reports which have shown
that caffeine actually decreases the basal concentration of the free calcium in the
cytosol of any intact cell type. The report by Diarra and Sauve (1992) in which
caffeine lowered the intracellular free calcium concentration examined the effect of
caffeine on stimulated cells where the intracellular free calcium concentrations
were already elevated up to 600 nM. In the present study the basal free cytosolic
calcium concentrations in epithelial and stromal cells were between 70 to 120 nM.
How caffeine lowered the intracellular calcium concentration below the basal levels
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in epithelial and stromal cells from guinea-pig endometrium is not clear, and
further study is required to examine the possibilities stated above.
Caffeine and theophylline increased the outputs of prostaglandins from guinea-pig
endometrium tissue in culture as well as from the guinea-pig uterus superfused in
vitro. However, both caffeine and theophylline despite increasing the outputs of
PGE2 and 6-keto-PGFia from cultured epithelial and stromal cells, failed to
increase PGF2a output from cultured epithelial and stromal cells. In fact, both
caffeine and theophylline inhibited PGF2a output from epithelial and stromal cells
in culture. TMB-8 alone or in combination with caffeine inhibited the output of
PGF2a from epithelial cells, indicating the involvement of intracellular calcium in
PGF2a synthesis by guinea-pig endometrial cells in culture. A similar effect on
PGF2a synthesis by cultured endometrial cells was also seen by berberine, which is
thought to inhibit calcium release from the sarcoplasmic (endoplasmic) reticulum
(Chiou et al., 1991). Berberine also inhibited PGF2a output from epithelial cells,
indicating that PGF2a output from epithelial cells may depend upon the release of
intracellular calcium. This was further highlighted by the action of thapsigargin. It
has been shown that thapsigargin release calcium from an internal pool (Herchuelz
& Leburn, 1993, Wegner, et al., 1994). In the present study, thapsigargin
stimulated the output of PGF2a from epithelial but not from stromal cells after 2 h
of culture. Thus, it is possible that within the first 2 h of culture, thapsigargin
induced the release of calcium from an internal store and, as a result, increased the
output of PGF2a from epithelial cells. However, after 8 and 24 h of culture,
thapsigargin inhibited PGF2a output from epithelial cells. The latter action of
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thapsigargin may be due to its ability to inhibit the endoplasmic reticulum
Ca2+/ATPase (see Thastrup, 1990; Chen & van Breemen, 1993; Tanaka &
Tashjian, 1993) and the subsequent depletion of calcium from pools in the
endoplasmic reticulum which may, in turn, result in the lack of sufficient
intracellular free calcium to maintain basal PGF2a output. Thapsigargin did not
prevent the stimulatory effect of caffeine on the outputs of PGE2 and 6-keto-PGFia
from stromal cells after 2 h of culture indicating that, if the stimulatory effects of
caffeine on PGE2 and 6-keto-PGFia synthesis from stromal cells is dependent upon
the release of intracellular calcium, this calcium pool is not thapsigargin sensitive.
However, caffeine prevented the stimulatory effect of thapsigargin on PGF2a output
from epithelial cells after 2 h of culture, suggesting that any thapsigargin-induced
increase in intracellular calcium is either sequestered (Diarra & Sauve, 1992) or
chelated by caffeine.
Although caffeine and theophylline decrease PGF2a output from isolated epithelial
cells, the question is raised as to why caffeine and theophylline did not inhibit
PGF2a output from guinea-pig endometrium in culture? One possible explanation is
that, to see a true effect of methylxanthines on the guinea-pig uterine PG output, it
is necessary for the epithelial and stromal cells to be in direct contact with each
other. The interaction between stromal and epithelial cells has been shown in the
human endometrial cycle (Roberts et al., 1988). Roberts et al. (1988) have
reported four significant changes in human endometrium in the transition from the
early proliferative phase (days 5 to 9) to the early secretory phases (days 15 to 19).
These changes include: (1) an increase in the number and size of lamina densa
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distribution, (2) an increase in the number and size of gap junctions, (3) an
increase in the number of epithelial cells, and (4) an increase in close contacts
between stromal and epithelial cells (Roberts et al., 1988). If close contacts
between guinea-pig epithelial and stromal cells are vital with regard to PG output
due to the effects of stimulus, then it is possible that methylxanthines would have
different effects on endometrial tissue and endometrial cells in culture.
Caffeine has also ability to interfere with protein synthesis. In the rat striatum,
caffeine induces neurotensin and cholecystokinin mRNA synthesis (Schiffmann &
Vanderhaeghen, 1993). However, in rat brain caffeine decreases glial cell numbers
(Marret et al., 1993). Hence, it is possible that, in the long term, caffeine inhibits
PGF2« output by inhibiting protein synthesis from the guinea-pig endometrial cells
in culture, as protein synthesis inhibitor (actinomycin D, cycloheximide and
puromycin) inhibited PG output from both epithelial and stromal cells in culture.
However, caffeine did not inhibit PGF2a output from day 7 guinea-pig
endometrium in culture. In fact, caffeine stimulated PGF2« output after 8 and 24 h
of culture. It has been reported previously that actinomycin D, cycloheximide and
puromycin inhibit the outputs of prostaglandin from guinea-pig endometrium in
culture (Poyser & Riley, 1987; Riley & Poyser, 1989). Thus it appears unlikely
that caffeine is inhibiting PG output in cultured epithelial and stromal cells by
inhibiting protein synthesis. The inhibitory effects of actinomycin D,
cycloheximide and puromycin on the outputs of PGF2a, PGE2 and 6-keto-PGFia
from cultured epithelial and stromal cells obtained from day 7 guinea-pig
endometrium is in agreement with previous reports which have shown that these
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compounds inhibited prostaglandin production from the guinea-pig endometrium in
culture by inhibiting protein synthesis (Poyser & Riley, 1987; Riley & Poyser,
1989). Thus the synthesis of prostaglandins, in particular PGF2a, from guinea-pig
epithelial cells, is dependent upon the synthesis of fresh protein(s).
It has been shown that caffeine and ryanodine (RY) release calcium from cardiac
muscle and from vascular smooth muscle (Komori & Bolton, 1989; Hisayama et
al., 1990; Donoso et al., 1994). Caffeine and ryanodine both stimulated the
outputs of PGF2o, PGE2 and 6-keto-PGFia from the rat mesenteric vascular bed.
The PG-releasing effect of caffeine was similar to its effect on the guinea-pig
uterus. However, the ryanodine effect was in contrast to its ineffectiveness on
guinea-pig uterus. These findings suggest that, if caffeine and RY are stimulating
prostaglandin production by the same mechanism in blood vessels, then caffeine is
probably stimulating prostaglandin synthesis in the uterus by a different
mechanism.
It has been reported that calmodulin inhibitors, in particular TFP, cause a transient
rise in PGF2a and 6-keto-PGFia outputs from guinea-pig uterus superfused in vitro
(Poyser, 1985a). However, they inhibited A23187-induced increase in PG output
from the guinea-pig uterus superfused in vitro (Poyser, 1985a, b). Furthermore,
W-7 and TFP inhibited PGF2a output from guinea-pig endometrium in culture
(Riley & Poyser, 1987b). In the studies presented in this thesis, TFP but not W-7
caused a transient rise in the outputs of PGF2a and 6-keto-PGFia from the guinea-
pig uterus superfused in vitro. Moreover, both W-7 and TFP decreased the outputs
of PGF2a and, to a much lesser extent, 6-keto-PGF]a from both epithelial and
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stromal cells in culture. These findings indicate that calmodulin has a role in
maintaining the basal outputs of PGF2a and 6-keto-PGFia, but not of PGE2, from
the guinea-pig endometrial cells.
The stimulatory effect of A23187 on uterine PG output may be due to it causing a
calcium influx through the cell membrane, which in turn, stimulates PLA2 (Poyser,
1984; Poyser, 1987b). Bonney et al. (1987) have shown that there are two types of
PLA2 in human endometrium; PLA2 type 1 is mainly present in epithelial cells and
PLA2 type 2 is mainly present in stromal cells. PLA2 type 1 is calcium dependent
whereas PLA2 type 2 is calcium-independent (Bonney et al., 1987). Consequently
A23187 time-dependently stimulated arachidonic acid release from human
epithelial but not from stromal cells in culture (Bonney et al., 1991). However, in
the present study, during 2 h of culture A23187 stimulated PG output by both
epithelial and stromal cells obtained from day 7 guinea-pig endometrium indicating
that the PLA2 present in guinea-pig endometrial epithelial and stromal cells is
similar to and may be the counterpart of human PLA2 type 1. Although, A23187
showed a stimulatory effect during the first 2 h of culture, this stimulation was lost
by 8 h, and A23187 inhibited PG output after 24 h of culture from both epithelial
and stromal cells. It has been reported that the guinea-pig uterus superfused in vitro
exhibits a partial refractoriness to repeated stimulation by A23187 (Poyser, 1991;
Poyser & Ferguson, 1993). Thus this lack of stimulatory effect of A23187 on
PGF2a output from cultured endometrial cells after 8 h of culture may be due to
this refractoriness effect. However, the phenomenon of refractoriness does not
explain the inhibitory effects of A23187 on the output of prostaglandins after 24 h
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of culture. How prolonged treatment with A23187 inhibits PG output merits
further study.
Melittin has been shown to stimulate prostaglandin production by the guinea-pig
uterus superfused in vitro (Johnson & Poyser, 1991) and to stimulate PLA2 in
mouse 3T3-4a fibroblasts (Shier, 1979). The effects of melittin on mouse 3T3-4a
fibroblasts and on the guinea-pig uterus have been shown to be dependent upon the
presence of calcium. The stimulatory effect of melittin on PG output from the
guinea-pig uterus was partially inhibited by the lack of extracellular calcium, but
was completely inhibited by TMB-8 (Johnson and Poyser, 1991). In mouse 3T3-4a
fibroblasts, stimulation of PLA2 by melittin was also dependent upon calcium, as
the addition of EDTA to the culture medium prevented the rise in PG production
by melittin (Shier, 1979). Johnson and Poyser (1991) have reported that melittin
stimulates the outputs of PGF2a and 6-keto-PGFia, but not of PGE2, from the day 7
guinea-pig uterus superfused in vitro. Melittin stimulated PGF2a output, and to a
much lesser extent, the outputs of PGE2 and 6-keto-PGFia from epithelial but not
from stromal cells. On the other hand, exogenous PLA2 mainly increased the
output of PGE2, and to a lesser extent, the outputs of PGF2a and 6-keto-PGFi„
from both epithelial and stromal cells in culture. These results suggest that there is
a preferential stimulation of PGE2 output by exogenous PLA2, while melittin (a
stimulator of endogenous PLA2) stimulates mainly PGF2a production. The activity
of PLA2 is the rate-limiting step in PG synthesis. It has been reported that
formation of specific prostaglandin is influenced by substrate concentration. Flower
et al. (1973) have shown that, in bovine seminal vesicles, PGE2 formation was at
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the maximum at a relatively low concentration of arachidonic acid. High
concentration of arachidonic acid inhibited PGE2 formation and stimulated PGF2a
formation to a maximal level (Flower et al., 1973). Thus, it is possible that
exogenous PLA2 and melittin exert their effects on uterine PG output due to
different levels of availability of arachidonic acid. The finding that melittin was
ineffective in increasing PG output from stromal cells indicates that melittin has not
stimulated the endogenous PLA2 present in guinea-pig stromal cells suggesting that
the PLA2 present in stromal cells, which is possibly activated by A23187, is
unresponsive to melittin. Interestingly, aristolochic acid (a PLA2 inhibitor)
inhibited only the output of PGF2a from epithelial, but not from stromal cells,
suggesting that the mechanism by which melittin and aristolochic acid modulate
PGF2a output from guinea-pig uterus is similar, and this mechanism is different
from the mechanism by which exogenous PLA2 stimulates PG outputs from the
guinea-pig uterus. Also, the result with aristolochic acid indicates that PGF2a
synthesis in guinea-pig epithelial cells is dependent upon the activation of PLA2 in
these cells.
Previous studies have shown that PLA2 is a calcium-dependent enzyme (Dey et al.,
1982; Downing & Poyser, 1983; Bonney, 1985). It has been shown that exogenous
PLA2 induces prostaglandin synthesis by and release form the guinea-pig uterus
superfused in vitro in the presence (Poyser, 1987a; Poyser, 1991; Poyser &
Ferguson, 1993) or absence (Scott, M., Scotland, R.A. & Poyser, N.L.,
unpublished observations) of extracellular calcium. Thus it seems that exogenous
PLA2 exerts its stimulatory effect on PG synthesis, at least in part, by releasing
186
intracellular calcium especially as TMB-8 inhibits the action of PLA2 (Poyser,
1987a). Intracellular calcium measurements carried out in this thesis support this
hypothesis. Exogenous PLA2 dose-dependently increased the intracellular free
calcium concentrations of guinea-pig epithelial and stromal cells. Platelet activating
factor (PAF) has also been shown to stimulate PG output from guinea-pig uterus
superfused in vitro, in the presence or absence of extracellular calcium (Norman &
Poyser, 1992). PAF has also been shown to stimulate PGE2 synthesis (Smith &
Kelly, 1988) and calcium release from human endometrial cells in the presence or
absence of extracellular calcium (Ahmed & Smith, 1992; Ahmed et al., 1994). In
the study presented in this thesis, PAF also dose-dependently increased intracellular
calcium concentrations of epithelial and stromal cells in the presence or absence of
extracellular calcium. In human endometrium, PAF stimulates PLC and thereby
the formation of IP3 and DAG (Barzaghi et al., 1989; Ahmed & Smith, 1992;
Ahmed et al., 1994) and this generated IP3 releases intracellular calcium from an
IP3-sensitive calcium store (Berridge, 1984; see Berridge & Irvine, 1989; see
Berridge, 1993). If the effect of PAF on human and guinea-pig endometrial cells is
via a similar mechanism, it is possible that PAF stimulates PG output from the
guinea-pig uterus by stimulating IP3 formation. This IP3 then releases calcium from
an IP3-sensitive calcium store, resulting in the activation of PLA2 and the
subsequent synthesis of prostaglandin. However, it is not known whether the
increase in intracellular free calcium released by PAF in guinea-pig endometrial
cells is due to an increase in the formation of IP3.
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In the guinea-pig, oestradiol acting on a progesterone-primed uterus is the
physiological stimulus for the increase in the output of PGF2« at the end of the
oestrous cycle (Poyser, 1983a, b). In the present study, oestradiol-170 and
progesterone failed to increase prostaglandin outputs from cultured endometrial
cells obtained from the day 7 guinea-pig uterus. In fact, oestradiol and
progesterone inhibited the outputs of PGF2« from epithelial cells and of PGE2 from
stromal cells. These inhibitory effects of oestradiol and progesterone are in
agreement with previous studies regarding the effects of these two steroid or
hormones on PG output from guinea-pig endometrium in culture (Riley & Poyser,
1987a). The finding that progesterone suppressed PG output from cultured guinea-
pig endometrial cells in this study is in agreement with similar studies on human
endometrial cells (Zhang & Davis, 1991; Mitchell & Smith, 1992). In the human,
oestradiol stimulates PGF2« output from endometrium in vitro (Abel & Baird,
1980; Schatz et al., 1985). Thus, it seems that the effect of oestradiol in vitro
differs among species, having an inhibitory effect on the output of PGF2« from
guinea-pig uterus but stimulating PGF2a output from human endometrium (Abel &
Baird, 1980; Schatz et al., 1985). However, progesterone clearly exerts an
inhibitory effect on endometrial cells with respect to PG output in several species.
The inhibitory effect of progesterone on prostaglandin output from cultured guinea-
pig endometrial cells may be due to its ability to inhibit arachidonic acid release,
since it has been shown that progesterone inhibits arachidonic acid release from
human endometrial epithelial cells (Wilson et al., 1986).
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It is well documented that PGF2a output from the guinea-pig uterus increases
towards the end of the oestrous cycle. The synthesis of PGF2a involves the action
of prostaglandin H synthase (PGHS) on arachidonic acid. Indomethacin, a non¬
steroidal anti-inflammatory drug (NSAID), has been shown to inhibit PG synthesis
by PGHS (Miyamato et ah, 1974; Rome & Land, 1975). In the guinea-pig, the
endometrial PGHS concentration increases after day 11 of the cycle (Poyser,
1983a). Recently, two isoforms of PGHS, namely PGHS-1 and PGHS-2, have
been identified: PGHS-1 is constitutively expressed in many cells types and tissues,
and PGHS-2 is an inducible form (Maier et al., 1990; Wong & Richards, 1991;
Wimsatt et al., 1993). In the present study, indomethacin (a non-selective NSAID)
inhibited the production of PGF2a, PGE, and 6-keto-PGFia by guinea-pig uterine
tissues, an effect reported previously on guinea-pig uterus superfused in vitro
(Poyser, 1985a). Indomethacin also inhibited PG production by endometrium
homogenates, cultured endometrium and cultured endometrial cells. A novel
PGHS-2 inhibitor (Futaki et al., 1994; Masferrer et ah, 1994), NS-398, also
inhibited prostaglandin production by day 7 and day 15 guinea-pig endometrial
homogenates, by day 7 endometrium and myometrium in culture, and by cultured
epithelial and stromal cells obtained from day 7 guinea-pig endometrium. These
finding clearly indicate that the guinea-pig uterus (both the endometrium and
myometrium) contains PGHS-2 at both stages of the oestrous cycle. This
hypothesis was further supported by the finding that Western blotting analyses
indicated the presence of PGHS-2 (Mr 72 kDa) (Maier et ah, 1990; Fu et ah,
1990; Wong & Richards, 1991) in the soluble extracts of guinea-pig endometrium
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obtained on both the day 6 (a day of low PG output) and day 17 (a day of high PG
output) of the oestrous cycle. Furthermore, NS-398 was as effective as
indomethacin in inhibiting the outputs of PGF2a, PGE2 and 6-keto-PGFia from
guinea-pig uterus, suggesting that in the guinea-pig, PGHS-2 is the predominant
PG-forming enzyme. However, it has been shown that the endometrial PGHS
concentration increases after day 11 of the cycle (Poyser, 1983a). Thus, these
findings indicating that, in the guinea-pig uterus, oestradiol acting on a
progesterone-primed uterus stimulates further endometrial PGHS-2 synthesis.
In summary, the studies in this thesis have shown that, in the guinea-pig, epithelial
Cblls in the endometrium are the major cell type responsible for the uterine
prostaglandin synthesis. The effects of methylxanthines on PGF2a but not on PGE2
and 6-keto-PGF ia production by the guinea-pig uterus depends on the experimental
protocol. The effects of methylxanthines on PG synthesis by the guinea-pig uterus
are not mediated by the activation of any of the known RY receptors. Although it
was not possible to demonstrate a calcium releasing effect for methylxanthines,
however, such an effect cannot be completely ruled out. The findings also suggest
that the release of intracellular calcium as well as the activity of calmodulin are
necessary to maintain basal PGF2a output from cultured epithelial cells. It is
proposed that the increased output of PGF2a from the guinea-pig uterus at the end
of the oestrous cycle is not associated with PGHS-2 solely being synthesized
specifically at the end of the oestrous cycle. PGHS-2 is probably present in the
endometrium throughout the cycle, and its concentration in the endometrium
increases after day 11.
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4.2 FUTURE WORK
In order to further elucidate the mechanisms of actions of methylxanthines on
prostaglandin production by the guinea-pig uterus, it is necessary to evaluate
possible effects of these compounds on protein synthesis by the guinea-pig
endometrium, in particular by the endometrial cells. Binding studies using [3H]RY
should also be carried out so that the presence or absence of RYR can be
determined. With regards to the inhibitory effect of methylxanthines on the free
cytosolic calcium concentrations of epithelial and stromal cells, the effects of these
compounds on calcium-transport systems should be investigated. This could be
_l_2
done by investigating the effects of caffeine and theophylline on Ca /ATPases of
endoplasmic reticulum and plasmalemma membrane, on the uniport transport of
mitochondria, and on membrane calcium channels. Also, the possible importance
of epithelial and stromal cell contact in guinea-pig endometrium in the regulation
of endometrial PGF2a synthesis should always be taken into consideration.
Present and previous studies have indicated that the release of intracellular calcium
is necessary for increased PGF2a synthesis by the guinea-pig endometrium (Leckie
& Poyser, 1991a). Previous study (Ning & Poyser, 1984) have indicated that
stimulation of the PI cycle is not involved. The present study has shown that
calcium release through the activation of typical ryanodine receptor is probably
also not involved. Consequently, future studies will need to investigate what other
possible intracellular stores of calcium are involved in endometrial PGF2a synthesis
by the epithelial cells.
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In order to determine whether changes in PGHS concentration observed at the end
of the guinea-pig oestrous cycle, is due to an increase in the contents of PGHS-1 or
PGHS-2, the effects of ovarian steroids (i.e. oestradiol and progesterone) should be
studied on PGHS (i.e. PGHS-1 and PGHS-2) concentration of guinea-pig
endometrium. Thus, it is necessary to develop an antibody specific to PGHS-1.
The availability of specific PGHS-1 inhibitors would also help to determine the
degree of importance of either PGHS-1 or PGHS-2 with respect to prostaglandin
production at the early or late stages of the guinea-pig oestrous cycle.
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The effect of caffeine on prostaglandin output from the
guinea-pig uterus
E.K. Naderali & 'N.L. Poyser
Department of Pharmacology, University of Edinburgh Medical School, 1 George Square, Edinburgh EH8 9JZ
1 Caffeine inpreased the outputs of prostaglandin F2!1 (PGF2a), PGE2 and 6-keto-PGFla from the
guinea-pig uterus on days 7 and 15 of the oestrous cycle. The effect on PGE2 output depended on the
age of the animals and was absent in younger guinea-pigs (<4 months). Theophylline also stimulated
the outputs of PGF2a and 6-keto-PGFla but not the output of PGE2, from the day 7 guinea-pig uterus.
2 The stimulatory effects of caffeine on the outputs of PGF2a, PGE2 and 6-keto-PGFla from the
guinea-pig uterus were not prevented by lack of extracellular calcium, ryanodine or ruthenium red (both
inhibitors of calcium release via the ryanodine receptor), although the increase in PGF2„ output tended
to be slower when extracellular calcium was absent. Also, ryanodine flattened and broadened the peak
of increased PGF2„ release.
3 The calmodulin antagonists, W-7 and trifluoperazine, had no inhibitory effect on the caffeine-
stimulated increases in uterine prostaglandin output. In fact, W-7 (but not trifluoperazine) greatly
potentiated the action of caffeine on uterine PGF2a output, but had little or no potentiating effect on the
action of caffeine on uterine PGE2 and 6-keto-PGF,« outputs.
4 TMB-8, an intracellular calcium antagonist, inhibited the increase in PGF2„ output produced by
caffeine without preventing the increases in outputs of PGE2 and 6-keto-PGF,».
5 These studies suggest that caffeine stimulates uterine PGF2„ synthesis and release by a mechanism
dependent upon intracellular calcium, but this mechanism is not mediated by activation of any of the
three well-characterized ryanodine receptors or by calmodulin. Furthermore, the increases in the
synthesis and release of PGE2 and 6-keto-PGFla in the guinea-pig uterus induced by caffeine appear to
involve mechanism(s) different from that which stimulates PGF2a production.
Keywords: Caffeine; prostaglandins; uterus; ryanodine; ruthenium red; TMB-8; trifluoperazine, W-7; theophylline
Introduction
Prostaglandins produced by the uterus are involved in several
reproductive processes. In many non-primate mammalian
species, increased prostaglandin F2a (PGF2») production by
the endometrium is responsible for terminating the life-span
of the corpus luteum and thereby regulating the length of an
oestrous cycle or a pseudopregnancy and, in some species, a
pregnancy (see Horton & Poyser, 1976; Poyser, 1981). In
women, there is an increase in the amounts of PGF2a and, to
a lesser extent, PGE2 produced by the endometrium at men¬
struation (see Poyser, 1981). Since prostaglandins contract
the uterus and affect the vasculature, it is assumed that they
have a role in the menstrual process. An overproduction of
PGF2, by the endometrium is the probable cause of dys-
menorrhoea (Lundstrom et al., 1976), whereas an imbalance
of uterine prostaglandin production in favour of prostacyclin
(PG12) may be the cause of menorrhagia (Smith et al., 1981).
The reasons for these disorders of menstruation are un¬
known, but may be due to intrinsic factors, such as the
higher than normal production of endogenous hormones
which affect uterine prostaglandin synthesis (e.g. vasopressin;
Akerlund et al., 1979), or to extrinsic factors (e.g. dietary
substances).
Previous experiments in the rat, guinea-pig and man have
shown that increased endometrial prostaglandin synthesis is
associated with increased activity of phospholipase A2, a
calcium-dependent enzyme (Dey et al., 1982; Downing &
Poyser, 1983; Bonney, 1985). In the guinea-pig, it was con¬
sidered that the activation of phospholipase A2 by calcium
(Downing & Poyser, 1983) leads to the release of arachidonic
acid from phosphatidylcholine and phosphatidylethanolamine
(Ning & Poyser, 1984) which, in turn, results in increased
1 Author for correspondence.
PGF2„ synthesis by and release from the endometrium. Sub¬
sequent studies in the guinea-pig indicated that increased
uterine prostaglandin production is dependent upon the
release of intracellular calcium (Riley & Poyser, 1987a;
Leckie & Poyser, 1990; Johnson & Poyser, 1991). However,
there is no increase in inositol turnover in the guinea-pig
endometrium at the end of the oestrous cycle when PGF2a
synthesis is high (Ning & Poyser, 1984). This finding
indicates that the stimulation of endometrial PGF2a synthesis
is not dependent on the generation of inositol-1,4,5-
trisphosphate (IP3) and, therefore, does not involve the
release of calcium from an IP3-sensitive store.
Studies on several cell types have indicated that only part
of the calcium stored in the endoplasmic reticulum is IP3-
sensitive and there is another store of calcium which can be
released by caffeine. This latter pool of calcium was first
described in skeletal and cardiac muscle. The release of cal¬
cium from this pool is modulated by ryanodine, and the
receptors involved are called ryanodine receptors. Initial
studies indicated that there were two types of the receptor;
Types 1 and 2 are found in skeletal and cardiac muscle,
respectively. Ryanodine can cause an initial release of cal¬
cium and then blocks the action of caffeine. Ruthenium red
inhibits the calcium-releasing action of caffeine at the level of
the ryanodine receptor. Ryanodine receptor Types 1 and 2
are not exclusively confined to skeletal and cardiac muscle
and are present in other tissues. In addition, it is now clear
that there are more than two types of ryanodine receptor (see
Sorrentino & Volpe, 1993). Consequently, since caffeine (a
dietary substance) releases calcium from various cell types
and since uterine prostaglandin production is calcium-depen¬
dent, the effect of caffeine on uterine prostaglandin produc¬
tion in the guinea-pig has been investigated. As the initial
experiments showed that caffeine does stimulate uterine pro-
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staglandin synthesis and release, further experiments were
performed to investigate some of the mechanisms by which
caffeine may exert this stimulatory effect.
Methods
Procedures
Fifty-two virgin, Dunkin-Hartley guinea-pigs (600-900 g)
were examined daily and a vaginal smear was taken when the
vagina was open. Day 1 of the cycle was taken as the day
preceding the post-ovulatory influx of leucocytes when cor-
nification was at a maximum. All guinea-pigs had exhibited
at least two cycles of normal length (about 16-17 days)
before being killed (by stunning and incising the neck) on
day 7 or day 15 of the cycle. Each uterus was removed and
separated into its two uterine horns. The uterine horns were
weighed, 'opened' by cutting longitudinally and suspended in
an organ bath with one end attached to a lever so that
isometric contractions of the uterus were observed. Each
uterine horn was superfused with Krebs solution (5 ml min-')
at 37°C, as described by Poyser & Brydon (1983), and was
superfused initially for a settling period of 60 min. Samples
of superfusate were then collected for 10-min periods over
the next 80 min (i.e. 8 samples per uterine horn) in experi¬
ments 1, 2 and 8, and over 100 min (i.e. 10 samples per
uterine horn) in experiments 3 to 7. The uterine horns in
each experiment were treated as described below.
Treatments
In expt 1, caffeine (lOmmoll-1) was present in the Krebs
solution superfusing one uterine horn from each of five
animals on day 7 of the oestrous cycle and from five animals
on day 15 of the cycle during the collection of samples 4 and
5. The other uterine horn from each animal was untreated. In
expt 2, one uterine horn from each of five animals on day 7
of the cycle was superfused with normal Krebs solution and
the other uterine horn was superfused with Krebs solution
from which the calcium chloride had been omitted (calcium-
depleted Krebs solution). Caffeine (lOmmoll-1) was present
in both types of Krebs solution during the collection of
samples 4 and 5.
In experiments 3 to 7, both uterine horns from 4 or 5
guinea-pigs on day 7 of the cycle were superfused with
normal Krebs solution, and caffeine (lOmmoll-') was pres¬
ent in the solution superfusing both uterine horns during the
collection of samples 6 and 7. The following additions were
made to the Krebs solution superfusing one uterine horn
from each animal during the collection of samples 4 to 7:
Expt 3: 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
hydrochloride (TMB-8; an intracellular calcium antagonist,
Malagodi & Chiou, 1974; 150pmoll-1; n = 5); Expt 4:
Ryanodine (2, 20 or 200 pmol l-'; n = 4); Expt 5: Ruthenium
red (10 or lOOpmoll"1; n = 4); Expt 6: N-(6-aminohexyl)-5-
chloro-l-naphthalene-sulphonamide (W-7; a calmodulin anta¬
gonist, Hidaka el al., 1978; 150/xmoll-'; n = 4). Expt 7:
Trifluoperazine (a calmodulin antagonist, Levin & Weiss,
1977; 100 pmol l-'; n = 4).
In experiments 6 and 7, the concentrations of W-7 and
trifluoperazine used had previously been shown to be suffic¬
ient to inhibit the increase in PGF2oi output induced by
A23187 from the guinea-pig uterus (Poyser, 1985a,b).
In expt 8, both uterine horns from each of four animals on
day 7 of the cycle were superfused with normal Krebs solu¬
tion, and theophylline (10 mmol l-') was present in the Krebs
solution superfusing one uterine horn from each animal dur¬
ing the collection of samples 4 and 5.
Solutions of each compound were freshly made up in
Krebs solution before use, except for ryanodine. A concen¬
trated solution of ryanodine was prepared in ethanol and
stored at — 20°C. The appropriate concentration of ryano¬
dine in Krebs solution was prepared by adding up 0.25 ml ol
the ethanolic solution to 250 ml Krebs solution. Krebs solu¬
tion superfusing the control uterine horn during the same
time period contained an equivalent concentration of
ethanol.
Assays
After collection, the pH of each sample was lowered to 4.0
with 1 M HC1 and the prostaglandins were extracted by
shaking twice with 50 ml ethyl acetate. The two ethyl acetate
fractions were combined and evaporated to dryness on a
rotary evaporator. The recoveries of PGF2a and PGE2 by this
method are >90% and the recovery of 6-keto-PGFla by this,
method is >80% (Poyser & Scott, 1980; Swan & Poyser,
1983). Each dried extract was re-dissolved in 10 ml ethyl
acetate and stored at — 20°C. The amounts of PGF2„, PGE2
and 6-keto-PGFl01 present in each sample were measured by
radioimmunoassay using antibodies raised in this laboratory;
the cross-reactivities have been reported elsewhere (Poyser,
1987). The intra-assay coefficients of variation were <12%
for all three assays. The inter-assay coefficients of variation
were 19.9%, 11.5% and 18.8% for the PGF2„, PGE2 and
6-keto-PGF|a assays, respectively. The detection limit was
20-40 pg per assay tube. Since prostaglandins are not stored
in the guinea-pig uterus (Poyser, 1972), prostaglandin release
into the superfusing fluid reflects fresh prostaglandin syn¬
thesis particularly as their release is inhibited by indo-
methacin (Poyser, 1985b).
Sources of material
Caffeine, ruthenium red, TMB-8, W-7, trifluoperazine and
theophylline were purchased from Sigma Chemical Co.,
Poole, Dorset; ryanodine was purchased from Calbiochem-
Novabiochem, Nottingham.
Statistical tests
Changes in the output of prostaglandins with time were
analysed by Duncan's multiple range test. Other comparisons
were made using Student's t test, or if the variances of the
two groups were significantly different by the Variance ratio
F test, by a modified t test for unequal variances (see Steel &
Torrie, 1980).
Results
Caffeine significantly (P<0.05) increased the outputs of
PGF2a and 6-keto-PGFla from the day 7 and day 15 guinea-
pig uterus, and of PGE2 from the day 15 uterus (Figure 1).
Caffeine significantly (P<0.05) increased the outputs of
PGF2a, PGE2 and 6-keto-PGFla from day 7 guinea-pig
uterine horns superfused with calcium-containing or calcium-
depleted Krebs solution. However, the stimulatory effect of i
caffeine on PGF2a output tended to be reduced during the f
first 10 min period of treatment in calcium-depleted Krebs
solution compared to normal Krebs solution (Figure 2).
TMB-8 caused small, but significant (P<0.05) increases in
the outputs of PGF2a, PGE2 and 6-keto-PGFla from the day i
7 guinea-pig uterus, an effect reported previously (Poyser,
1985a). However, TMB-8 prevented the increase in PGF2a
output produced by caffeine without preventing the increases
in outputs of PGE2 and 6-keto-PGF|a induced by caffeine
(Figure 3).
Ryanodine alone had no effects on the outputs of PGF2„
and PGE, from the day 7 guinea-pig uterus, although ryano¬
dine (20 and 200pmoll-1) significantly (P<0.05) increased
the output of 6-keto-PGFla. Ryanodine (2 to 200pmoll-1)
did not inhibit the increase in outputs of PGF2a and 6-keto-
PGFla induced by caffeine from the day 7 guinea-pig uterus
(Figure 4). However, ryanodine (20 and 200pmoll-')
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Figure 1 Mean (± s.e. mean, n = 5) outputs of (a) prostaglandin F2ot (PGF2a), (b) PGE2 and (c) 6-keto-PGFlct from the (i) day 7
and (ii) day 15 guinea-pig uterus superfused in vitro in the presence (•) and absence (O) of caffeine. *Significantly (P<0.05)
higher than before caffeine treatment.
delayed both the increase and subsequent decrease in PGF2«
output produced by caffeine such that the 'peak of increased
PGF2« release' was flatter and broader. PGE2 output was not
affected by caffeine or ryanodine in this experiment (Figure
4).
In the absence of ruthenium red, caffeine increased the
outputs of PGF2a, PGE2 and 6-keto-PGF,,, from the day 7
guinea-pig uterus 2.3, 2.1 and 3.8 fold, respectively. In the
presence of ruthenium red (lOpmoll-1), caffeine increased
the outputs of PGF2„, PGE2 and 6-keto-PGF,„ by 2.5, 1.9
and 3.8 fold, respectively. In the presence of ruthenium red
(lOOpmol 1~'), caffeine increased the outputs of PGF2„, PGE2
and 6-keto-PGF,„ 2.1, 2.3 and 3.9 fold, respectively.
Therefore, ruthenium red at both concentrations used had no
significant effect on the increases in outputs of PGF2>, PGE2
and 6-keto-PGFl01 produced by caffeine from the day 7
guinea-pig uterus.
W-7 had no inhibitory effect on the increases in output of
PGF2„, PGE2 and 6-keto-PGF,„ produced by caffeine from
the day 7 guinea-pig uterus. In fact, W-7 caused a 3 fold
potentiation of the increase in PGF2„ output induced by
caffeine. W-7 also caused a much smaller potentiation of the
increase in PGE2 output and had no effect on the increase in
6-keto-PGF,a output produced by caffeine from the day 7
guinea-pig uterus (Figure 5). Trifluoperazine produced small
increases in the outputs of PGF2a and 6-keto-PGFlei from the
day 7 guinea-pig uterus, an effect noted previously (Poyser,
1985b). However, trifluoperazine had no effect on the inc¬
reases in PGF2a and 6-keto-PGFla produced by caffeine from
the day 7 guinea-pig uterus. In this experiment, PGE2 output
from the uterus increased after the caffeine treatment had
finished in both the control and trifluoperazine-treated
uterine horns (Figure 5). Theophylline significantly (P<0.05)
increased the outputs of PGF2a and 6-keto-PGF,,, from the
day 7 guinea-pig uterus 3.6 and 4.3 fold, respectively.
Theophylline had no significant effect on uterine PGE2 out¬
put.
Caffeine, ryanodine (2, 20 or 200pmoll_1). ruthenium red
(100 but not lOpmolF1) and theophylline relaxed the super-
fused uterine horns and abolished any occasional spontan¬
eous contractions. W-7 and TMB-8 caused an initial contrac¬
tion of the uterus which lasted about 3 min. Following the




Figure 2 Effect of caffeine on the mean (± s.e. mean, n = 5) outputs
of (a) prostaglandin (PGFZJ, (b) PGE2 and (c) 6-keto-PGFla
from the day 7 guinea-pig uterus superfused in vitro in the presence
of normal Krebs solution (O) and calcium-depleted Krebs solution
(•). *Significantly (/><0.05) higher than before caffeine treat¬
ment.
subsequent relaxation, the uterine horns continued to exhibit
the occasional spontaneous contraction. Trifluoperazine had
no effect on the contractile state of the uterus.
Discussion
The basal outputs of PGF2«, PGE2 and 6-keto-PGFl01 from
the day 7 guinea-pig uterus were typically low. However, by
day 15 the output of PGF2„ from the uterus had increased
approximately 20 fold whereas the outputs of PGE2 and
6-keto-PGFl01 showed little change. This is in agreement with
previous findings (Poyser & Brydon, 1983). Studies in ovari-
ectomized guinea-pigs have shown that oestradiol acting on a
uterus which has been primed with progesterone for 10 days
is the optimum stimulus for this selective increase in uterine
PGF2s synthesis and release (Poyser, 1983a). During the oes-
trous cycle, progesterone output from the ovary is increased





Figure 3 Effect of caffeine on the mean (± s.e. mean, n = 5) outputs
of (a) prostaglandin F2a (PGF2a), (b) PGE2 and (c) 6-keto-PGFla
from the day 7 guinea-pig uterus superfused in vitro in the presence
(•) and absence (O) of TMB-8. Significantly (P< 0.05) higher than
before TMB-8 treatment alone. 'Significantly (P<0.05) increased by
caffeine treatment. T Significantly (/,<0.05) lower following the end
of caffeine treatment but significantly higher than before TMB-8
treatment.
after day 10 (Joshi et al., 1973). This increase in oestradiol
output from the ovary precedes an increase in PGF2a output
from the uterus by 24 h (Blatchley et al., 1972; Earthy et al.,
1975; Antonini et al., 1976). Oestradiol acting on a pro¬
gesterone-primed uterus appears to be the physiological
stimulus for increased PGF2o, production by the guinea-pig
uterus towards the end of the cycle, especially as treatment of
guinea-pigs with a progesterone receptor antagonist or an
oestrogen receptor antagonist from days 11 to 14 of the cycle
prevents the increase in uterine PGF2(1 output seen on day 15
(Poyser, 1993). Oxytocin has no stimulatory effect on uterine
PGF2a output in guinea-pigs (Poyser & Brydon, 1983; Riley
& Poyser, 1987b). The guinea-pig uterus is a good animal
model for the human uterus when studying the factors
controlling prostaglandin production since oestradiol acting
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Figure 4 Effect of caffeine on the mean (±s.e. mean, n = 4) outputs of (a) prostaglandin F2a (PGF2a), (b) PGE2 and (c)
6-keto-PGF|a from the day 7 guinea-pig uterus superfused in vitro in the absence (O) and presence of ryanodine (•) at
concentrations of (i) 2pmoll~', (ii) 20pmoll_1 and (iii) 200/xmoll"1. +Significantly (.P<0.05) higher than before ryanodine
treatment. *Significantly (F><0.05) higher than before caffeine treatment. TSignificantly (/><0.05) lower following the end of
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on a progesterone-primed uterus is the optimum stimulus for
increased PGF2a production by the human uterus (Smith et
al., 1984), and oxytocin has only a weak stimulatory effect on
PGF2> production by the nonpregnant human uterus (Leaver
6 Richmond, 1984).
Caffeine caused 3 to 4 fold increases in the outputs of
PGF2i and 6-keto-PGFla from the guinea-pig uterus on days
7 and 15 of the oestrous cycle. PGF2a and 6-keto-PGFi0( are
the major prostaglandins synthesized by the endometrium
and myometrium, respectively (Poyser, 1983b), although the
endometrium synthesizes and secretes 6-keto-PGFltl also
(Riley & Poyser, 1987a,b). The effects of caffeine on uterine
PGE2 output were variable. Sometimes caffeine increased
PGE2 output whereas other times it had no effect. In one
instance, the stimulatory effect of caffeine on PGE2 output
was delayed. Subsequent analysis of the guinea-pig ages
showed that caffeine had no effect on uterine PGE2 output in
younger animals (<4 months) in which basal PGE2 tended
to be higher, but stimulated uterine PGE2 output in older
animals (>4 months) in which basal PGE2 output tended to
be lower. Basal PGE2 output, but not basal PGF2ot output,
from the rat uterus also decreases with age and this appears
to be due to a reduced response of the ageing uterus to
oestradiol and progesterone (Brown et al., 1984). A similar
phenomenon in guinea-pigs may explain the reduced basal
output of PGE2 in older animals. However, why the older
guinea-pigs should be responsive to caffeine is not clear,
except that a lower basal output allows any increase in
output to be seen more easily. There is more variability in the
output of PGF2„ and, to a lesser extent, of the other two
prostaglandins on day 15 since output increases progressively
at the end of the cycle. Since the cycle may last from 15 to 18
days, day 15 in one animal may not be exactly equivalent to
day 15 in another animal which may account for the greater
variability in output. This does not apply to day 7 since
prostaglandin output from the uterus is consistently low
between days 3 and 10 of the cycle. For these reasons,
guinea-pig uteri on day 7 of the cycle rather than on day 15
of the cycle were used since the outputs of PGF2a, PGE2 and
6-keto-PGFla are lower and show less variability. The guinea-
pigs used on day 7 in any one experiment were approxi¬
mately of the same age.
Caffeine increased the outputs of PGF2a, PGE2 and 6-keto-
PGFla from the day 7 guinea-pig uterus when superfused
with calcium-depleted Krebs solution. However, the increase
in PGF2> output but not the increases in PGE2 and 6-keto-
PGFla outputs tended to be slower than when calcium-
containing Krebs solution was used. Thus the action of
caffeine on PGF2„ output, but not on PGE2 and 6-keto-
PGF1(l outputs, may depend to a small extent on the presence
of extracellular calcium. Therefore, the mechanism by which
caffeine stimulates PGF2„ synthesis and release may be
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Figure 5 Effect of caffeine on the mean (±s.e. mean, n = 4) outputs of (a) prostaglandin F2> (PGF2a), (b) PGE, and (c)
6-keto-PGF,, from the day 7 guinea-pig uterus superfused in vitro in the absence (O) and presence (•) of (i) lOOpmol 1"' W-7 and
(ii) 150pmoll"' trifluoperazine (TFP). 'Significantly (P<0.05) higher than before trifluoperazine treatment alone. *Significantly
(/><0.05) higher than before caffeine treatment. TSignificantly (P<0.05) lower following the end of caffeine treatment but
significantly higher than before trifluoperazine treatment. 'Significantly (P<0.05) higher than corresponding control value (i.e.









































different from the mechanisms by which caffeine stimulates
the synthesis and release of PGE; and PG12 (measured as
6-keto-PGFla). TMB-8 (an intracellular calcium antagonist)
completely prevented the stimulatory effect of caffeine on
uterine PGF2a output without affecting the stimulatory effect
of caffeine on the outputs of PGE2 and 6-keto-PGFla. This
finding suggests that the stimulation of uterine PGF2« syn¬
thesis and release by caffeine is dependent on intracellular
calcium, but the stimulation of uterine PGE2 and PG12 syn¬
thesis by caffeine is independent of intracellular calcium or is
dependent on a pool of intracellular calcium not affected by
TMB-8. Therefore these results provide further evidence that
the mechanism by which caffeine stimulates uterine PGF2a
synthesis and release is different from the mechanisms by
which caffeine stimulates the synthesis and release of PGE2
and PG12 in the uterus. The stimulatory action of caffeine on
uterine prostaglandin output was not prevented by the cal¬
modulin antagonists, W-7 and trifluoperazine, indicating that
calmodulin does not mediate this action of caffeine. In fact,
W-7 greatly potentiated the stimulatory effect of caffeine on
PGF2a output. However, W-7 only weakly potentiated the
stimulatory effect of caffeine on PGE2 output and had no
effect on the stimulatory effect of caffeine on 6-keto-PGFl01
output. Also, trifluoperazine did not potentiate these actions
of caffeine. Therefore, W-7 was probably not producing its
potentiating effect by inhibiting calmodulin and, since W-7
affected the stimulation of PGF2a output to a much greater
extent than the stimulation of PGE2 and 6-keto-PGFla out¬
puts, the mechanism by which caffeine stimulates uterine
PGF2c, synthesis and release again appears to be different from
the mechanisms by which caffeine stimulates the synthesis
and release of PGE2 and PG12 in the uterus. The reason why
W-7 should potentiate the stimulatory action of caffeine on
uterine PGF2a synthesis and release is not clear. Oestradiol
CAFFEINE ON UTERINE PROSTAGLANDIN OUTPUT 109
acting on a progesterone-primed uterus can selectively 'switch
on' PGF2a synthesis by the guinea-pig uterus (Poyser, 1983a),
so perhaps W-7 is promoting the 'switching on' by caffeine of
this steroid-dependent pathway of PGF2a synthesis.
Caffeine acts on ryanodine receptors Types 1 and 2 to
release intracellular calcium, an effect blocked by ruthenium
red and high concentrations of ryanodine (see Sorrentino &
Volpe, 1993). Ruthenium red and ryanodine had no inhibi¬
tory effect on the increase in output of PGF2„, PGE2 and
6-keto-PGFla induced by caffeine from the day 7 guinea-pig
uterus. Thus caffeine appears to stimulate uterine prostaglan¬
din synthesis by mechanisms which are not dependent upon
the activation of Type 1 or Type 2 ryanodine receptors.
. Plowever, the fact that ruthenium red and ryanodine caused
the uterus to relax and abolished spontaneous contractile
activity suggests that these two compounds are possibly pre¬
venting the release of calcium from an intracellular calcium
pool. Ryanodine at the two higher concentrations (20 and
200 trmol l"1) altered the time course of the increase in PGF2a
output produced by caffeine. The 'peak of increased release'
was flatter and broader in the presence of ryanodine. In
addition, ryanodine alone at the two higher concentrations
increased the output of 6-keto-PGFla. Why ryanodine should
have these two actions is not apparent.
A third type of ryanodine receptor has been described in
mink lung epithelial cells (see Sorrentino & Volpc, 1993).
This receptor is also present in rat brain and smooth muscle
(McPherson & Campbell, 1993). However, this receptor,
although binding ryanodine, is not activated by caffeine.
Thus it is unlikely that caffeine is stimulating uterine prosta¬
glandin synthesis by acting on a ryanodine Type 3 receptor.
Caffeine-sensitive calcium stores have been reported as being
present in adrenal chromaffin cells (Burgoyne et al., 1989),
liver (Shoshan-Barmatz, 1990) and pancreas (Schmid et al.,
1990). The receptor type involved in the chromaffin cells and
liver may be one of the three main ryanodine types. How¬
ever, the receptor type involved in the pancreas is not one of
these three ryanodine types since it is not sensitive to
ryanodine, but it is blocked by ruthenium red (Dehlinger-
Kremer et al., 1991). Consequently, since in the present study
the effects of caffeine are not prevented by ryanodine or
ruthenium red, caffeine does not appear to be stimulating
PGF2(X synthesis in the guinea-pig uterus by acting on any of
the caffeine and/or ryanodine intracellular calcium pools des¬
cribed so far. Recently, an intracellular calcium pool has
been described in hepatocytes which is caffeine-sensitive and
ryanodine-insensitive. Additionally, the effect of caffeine in
hepatocytes is not blocked by ruthenium red (McNulty &
Taylor, 1993). This stimulation by caffeine and lack of inhibi¬
tion by ryanodine and ruthenium red in hepatocytes is
exactly the same profile as that seen in the stimulation of
PGF2a output by caffeine in the guinea-pig uterus. Thus, it is
possible that caffeine-sensitive calcium pool present in
hepatocytes is also present in the uterus and is involved in
the stimulation of uterine PGF2a synthesis by caffeine. How¬
ever, theophylline also stimulated uterine prostaglandin syn¬
thesis yet theophylline does not release calcium in hepa¬
tocytes (McNulty & Taylor, 1993). Theophylline may be
acting to stimulate uterine prostaglandin synthesis by a
mechanism different from that of caffeine or, if caffeine and
theophylline are acting through the same mechanism, then
caffeine may be stimulating calcium release in hepatocytes
and PGF2„ synthesis in the uterus by different mechan¬
isms.
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The Effect of Caffeine on Prostaglandin Output from the Perfused
Mesenteric Vascular Bed of the Rat
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ABSTRACT. Caffeine significantly (p < 0.05) increased the output of prostacyclin (PGI2) from the perfused
rat mesenteric vascular bed. The outputs of PGE2 and PGF2a were also increased by caffeine. This stimulatory
response to caffeine did not show rapid desensitization. Ryanodine also increased PG output, suggesting
that caffeine may be acting via the stimulation of a ryanodine receptor. The increased production of a
vasodilator such as PGI2 from blood vessels following exposure to caffeine may explain why caffeine has
a beneficial effect in angina.
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INTRODUCTION
It is generally believed that high caffeine intake (in the
form of coffee and other beverages) may cause coronary
heart disease and acute myocardial infarction. However,
only 50% of the recent case-control and perspective
studies have shown any statistically significant corre¬
lation between coffee intake and the risk of developing
coronary heart disease or acute myocardial infarction
(1). Consequently, it is not proven that caffeine has
detrimental effects on health. In fact, as stated in a recent
review, 'positive effects of coffee are being increasingly
reported. Coffee has been shown to be an effective
bronchodilator in young patients with asthma, and as a
booster of pain-free walking time for patients with
chronic stable angina. Ingestion of one and two cups
of coffee increased the exercise duration until onset of
angina by 8% and 12%, respectively, whereas decaffe¬
inated coffee had no effect' (2). Why caffeine should
have a beneficial effect in angina is not clear. Drugs
used to treat angina are mostly vasodilators, so caffeine
may stimulate the production by blood vessels of a
vasodilator such as prostacyclin (PGI2), especially as
PGI2 plays an important role in the regulation of vas¬
cular tone (3). Consequently, the effect of caffeine on
prostaglandin output from blood vessels, using the
perfused mesenteric vascular bed of the rat, has been
studied.
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METHODS
The mesenteric vascular bed of male rats (250-300 g)
was perfused in vitro with McEwen's solution (4 ml/
min), which was heated to 37°C and aerated with 5%
carbon dioxide and 95% oxygen, as described by
Lennon and Poyser (4). After an initial settling period of
30 min, samples of perfusate were collected for periods
of 1 min. In experiment 1 (n = 6), caffeine in increasing
doses (1 pig to 1 mg) was injected into the perfusing
fluid at intervals of 15 min. In experiment 2 (n = 4),
three successive injections of 1 mg caffeine at 15 min
intervals were made into the perfusing fluid. In expe¬
riment 3 (« = 7), 10 (ig and 50 pg ryanodine were
injected into the perfusing fluid with an interval of 3
min between doses. In experiments 1 and 2, samples of
perfusate were collected from 2 min before to 6 min
after, and at 9 and 13 min after caffeine administration.
In experiment 3, samples of perfusate were collected
from 1 min before the first dose to 2 min after the second
dose of ryanodine (i.e. for 6 min altogether). The
amounts of 6-keto-PGFla, PGE2 and PGF2a in the sam¬
ples of perfusate were measured by radioimmunoassays
previously described (4). The intra-assay coefficients
of variation were < 12% for all three assays. The inter-
assay coefficients of variation were 9.5%, 9.8% and
9.1% for the 6-keto-PFG|a, PGE2 and PGF2a assays,
respectively.
Sources of material
Caffeine and ryanodine were purchased from Sigma
415
416 Prostaglandins Leukotrienes and Essential Fatty Acids
Chemical Co., Poole, Dorset. UK, and from Calbiochem-
Novabiochem, Nottingham, UK, respectively.
Statistical tests
The results were analysed by one-way analysis of
variance (ANOVA) and by the paired t-test.
RESULTS
Caffeine doses:-




6-Keto-PGFla was the major prostaglandin released
from the rat mesenteric vascular bed; the basal outputs
of PGE2 and PGF2a were 50-70% lower. Caffeine sig¬
nificantly (p < 0.05) increased the output of 6-keto-
PGF]a at doses between l pg and 1 mg by 1.7- to
3.3-fold. The maximum effect was obtained with 5 pg
caffeine. Caffeine also increased the outputs of PGE2
and PGF2a between 1.3- and 2.4-fold. These increases
were significant (p <0.05) at the higher doses (Fig. 1).
The maximum increase in PG output usually occurred
within the first minute following caffeine administration,
and an increase in PG output lasted for at least 2 min.
Caffeine (1 mg) administered three times at 15 min
Caffeine doses:-
























Fig. 2 Effects of a high dose of caffeine (1 mg) administered three
times on mean (± SEM, n = 4) outputs of 6-keto-PGFla, PGE2 and
PGF2(x from the perfused mesenteric vascular bed of the rat.
*Significantly (p < 0.05) increased by caffeine.
intervals significantly (p < 0.05) increased the ouput of
6-keto-PGFlcx between 2.4- and 3.6-fold following each
dose of caffeine. The outputs of PGE2 and PGF2a
increased between 1.4- and 2.3-fold, although these
increases were not statistically significant (Fig. 2).
Ryanodine (10 pg) increased the outputs of 6-keto-
PGFla, PGE2 and PGF2a by 1.3- to 1.6-fold, but these
increases were statistically significant (p < 0.05) only
for PGE2 and PGF2(X. Ryanodine (50 pg) significantly
(p < 0.05) increased the outputs of 6-keto-PGFla, PGE2




Fig. 1 Effects of caffeine on mean (± SEM, n = 6) outputs of 6-
keto-PGFla, PGE2 and PGF2a from the perfused mesenteric vascular
bed of the rat. *Significantly (p < 0.05) increased by caffeine.
DISCUSSION
Caffeine stimulated the output of PGI2 (measured as 6-
keto-PGF,a), together with smaller quantities of PGE2
and PGF2a, from the perfused mesenteric vascular bed
of the rat. Both the smooth muscle and endothelial cells
of rat blood vessels synthesize PGI2 (as well as PGE2
and PGF2a), with the smooth muscle having the higher
synthesizing capacity per unit length of vessel (4). The
average cup of coffee contains about 100 mg caffeine
and, after drinking 300 ml of a beverage containing

















Fig. 3 Effects of ryanodine on mean (± SEM, n = 7) outputs of 6-keto-PGFla, PGE2 and PGF2a from the perfused mesenteric vascular bed of the
rat. *Significantly (p < 0.05) increased by ryanodine treatment.
250 mg caffeine, the peak plasma concentration of
caffeine obtained 1 h later is between 4.2 and 26 |ig/ml
(5). Caffeine (5 (ig) administered into the perfused rat
mesenteric vascular bed produced a maximum increase
in PGI2 output, and even 1 ug caffeine produced an
increase in PGI2 output which was 50% of the maximum
increase. Due to dilution effects, the concentration of
caffeine reaching the mesenteric blood vessels would
be considerably less than 5 and 1 pg/ml, respectively. If
human blood vessels are as responsive to caffeine as rat
blood vessels, then the concentration of caffeine in the
blood after swallowing one or two cups of coffee would
appear sufficient to stimulate PGI2 synthesis by blood
vessels. Furthermore, the administration of a high dose
(1 mg) of caffeine at 15 rnin intervals over a period of
30 min to the perfused rat mesenteric vascular bed
did not result in any reduction in the response. Conse¬
quently, tolerance does not occur rapidly, so the repeated
intake of caffeine over a short period should not reduce
its stimulatory effect on PGI2 output.
Since PGs are not stored in tissues, their release is
immediately preceded by their synthesis. The rate-limiting
step in PG synthesis is the release of arachidonic acid
from phospholipids, usually by the action of phospho-
lipase (PL) A2. This enzyme requires calcium to be
active, so substances which stimulate PG synthesis
usually have to increase the intracellular free calcium
concentration. Caffeine can release intracellular calcium
by acting on ryanodine receptors (6), and caffeine
releases intracellular calcium in both vascular smooth
muscle and endothelial cells (7-9). Ryanodine, like
caffeine, rapidly increased the output of PGL from the
perfused rat mesenteric vascular bed. After allowances
are made for ryanodine's higher molecular weight,
caffeine and ryanodine were of similar potency. Conse¬
quently, caffeine and ryanodine may be initiating vascular
PGI2 synthesis and release by the same mechanism, i.e.
through releasing intracellular calcium by combining
with a ryanodine receptor.
Overall, caffeine stimulated the output of PGI2 (a
vasodilator) from rat blood vessels by a mechanism
which does not rapidly become desensitized. Experi¬
ments in dogs have shown that PGI2 in low doses
induces hypotension accompanied with increases in
cardiac ouput, stroke volume and increased cardiac
contractility (10). Similar actions of PGL in humans
may explain, at least in part, the beneficial effect of
caffeine in patients suffering from angina, assuming that
in humans (as in the rat) caffeine stimulates the production
of PGI2 by blood vessels.
Acknowledgement
E. K. Naderali is a MRC research student.
References
1. Franchesci S. Coffee and myocardial infarction - review
of epidemiological evidence. In: Garrattini S, ed.
Caffeine, coffee and health. New York: Raven Press,
1993: 195-211.
2. Heyden S. Coffee and cardiovascular disease - a
personal view after 30 years of research. In: Garrattini S,
ed. Caffeine, coffee and health. New York: Raven Press,
1993:177-193.
3. Moncada S, Palmer R M J. Higgs E A. Prostacyclin and
endothelium-derived relaxing factor: biological
interactions and siginificance. In: Verstraete M,
Vermylen J, Lijnen R, Arnout J, eds. Thrombosis and
Haemostasis. Leuven: Leuven University Press,
1987:587-618.
4. Lennon E A, Poyser N L. Production of prostaglandins I2,
E2 and F20 by blood vessels of normotensive and
hypertensive male and female rats. Prostaglandins
Leukotrienes Med 1986; 25: 71-89.
5. Robertson D, Frolich J C, Carr R K et al. Effects of
caffeine on plasma renin activity, catecholamines and
blood pressure. New Engl J Med 1978; 298: 181-186.
6. Berridge M J. Inositol trisphosphate and calcium
signalling. Nature 1993; 362: 315-323.
7. Komori S, Bolton T B. Actions of guanine nucleotides
418 Prostaglandins Leukotrienes and Essential Fatty Acids
and cyclic nucleotides on calcium stores in single patch-
clamped smooth muscle cells from rabbit portal vein. Br
J Pharmacol 1989; 97: 973-982.
8. Watanabe C, Yamamoto H, Hirano K, Kobayashi S,
Kanaide H. Mechanisms of caffeine-induced contraction
and relaxation of rat aortic smooth muscle. J Physiol
(Lond) 1992; 456: 193-213.
9. Zhang A M, Cheng T P O, Altura B T, Altura B M.
Mg2+ and caffeine-induced Ca2+ release in human
vascular endothelial cells. Br J Pharmacol 1993;
109: 291-292.
10. Allan G, Follenfant M J, Lidbury P, Oliver P L, Whittle B
J R. The cardiovascular and platelet actions of 9|3-methyl
carbacyclin (ciprostene), a chemically stable analogue of
prostacyclin, in the dog and monkey. Br J Pharmacol
1985; 85:547-555.
